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Chapters 3, 4, and 6 of this thesis have been organized as manuscripts to be submitted for 
publication in the primary literature, although target journals have yet to be chosen. Chapter 5 of 
this thesis has been published in the Journal of Wildlife Diseases*. Therefore some repetition of 
















*Heffernan J, Mineau P, Falk R, and Wickstrom M. 2012. Combined effect of short-term 
dehydration and sublethal acute oral dicrotophos exposure confounds the diagnosis of 
anticholinesterase exposure in common quail (Coturnix coturnix) using plasma cholinesterase 




Coturnix quail (Coturnix coturnix) were exposed to four different organophosphorus 
(OP) pesticides (dicrotphos (DCP), ethoprop (ETP), methamidophos (MMP), and naled (NLD)) 
either by oral gavage or by being enclosed upon a OP-sprayed simulated field of barley for 6 
hours in controlled, replicated experiments. The selected OPs varied in solubility. Responses 
were measured as inhibition of cholinesterase (ChE) activity in plasma and brain. Oral doses 
were at one-third the estimated median lethal dose while the spray application rates used were 
expected to produce 60% inhibition of plasma ChE activity 24 hours following removal from the 
field. Oral doses caused significant inhibition of ChE activity in plasma (33-93%, p<0.001) and 
brain (17-61%, p<0.001), confirming that each OP was a ChE inhibitor and bioavailable via the 
oral route. Recovery from inhibition of ChE activity following oral doses was relatively uniform 
in plasma (17.6 hours ≤ half-life (t1/2) ≤ 24.5 hours) but slower and more variable in brain (64.8 
hours ≤ t1/2 ≤ 128 hours). Responses to field exposures could not be explained by observations of 
consumption of contaminated feed. Responses to field exposures were inconsistent with those to 
oral doses with 3 of 4 OPs. The response to field exposures with MMP, the most hydrophilic OP, 
was generally consistent with the response to oral doses. ChE activity in both tissues was lower 
following field exposures than following oral doses, significantly so in brain (p<0.001), 
indicating the field dose was larger than the oral dose. Recovery from inhibition of ChE activity 
in plasma (t1/2=17.7 hours) and brain (t1/2=125 hours) following simulated field exposures were 
within the ranges observed following oral doses. The response to field exposures with DCP and 
NLD, the OPs of intermediate solubility, varied from the response to oral doses. ChE activity in 
plasma was significantly lower following field exposures than following oral doses (p ≤ 0.002), 
while the opposite significant relationship was observed in brain (p ≤ 0.009). Recovery from 
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inhibition of ChE activity was prolonged in plasma (DCP, t1/2=41.3 hours; NLD, t1/2=34.7 hours) 
and brain (DCP, t1/2=34.7 hours) relative to recovery following oral doses. The response to field 
exposure to ETP, the most lipophilic OP, obviously differed from the response to oral doses. 
Field exposures produced only moderate inhibition of ChE activity in plasma and no significant 
inhibition of ChE activity in brain. The conclusion drawn was that the exposure of quail to the 
OPs on the simulated field was primarily via the dermal route and that quail skin served as a 
reservoir for storage and delayed release of the OPs, a reservoir effect that increased with 
increasing lipophilicity of the OP. 
Polynomial regression was used to investigate the extent to which inhibition of ChE 
activity in the brains of quail exposed for 6 hours on the simulated field could be predicted by 
log of the octanol:water partition coefficients (Kow) of the OPs. Quadratic polynomial curves 
were significantly fit to brain ChE activity inhibition data at both 24 (r
2
=0.888, p<0.001) and 72 
hours (r
2
=0.871, p<0.001) post-exposure. These curves indicate that OPs having log Kow in the 
range of 0 to 1.5 will be those most rapidly absorbed and distributed under field conditions. A 
similar effort to predict the further inhibition of brain ChE activity in quail associated with the 
additional exposure to the pesticide spray itself yielded a significant quadratic polynomial curve 
at 24 hours post-exposure (r
2
=0.621, p=0.013). Comments are provided as to the utility and 
relevance of the findings in ecological risk assessment for pesticide registration. 
Quail were exposed to DCP and dehydration in controlled, crossed experiments to 
determine if dehydration could confound the diagnosis of OP exposure using inhibition of ChE 
activity in quail tissues. Measures of plasma osmolality (Posm) and hematocrit (Hct) quantified 
dehydration. DCP exposure caused significant inhibition of ChE activity in brain (38%, p<0.001) 
and plasma (26%, p<0.001). Dehydration caused a significant increase in plasma ChE activity 
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(min. 55%, p<0.001). Variation in the change in plasma ChE activity in response to dehydration 
was significantly and positively correlated with dehydration-induced variation in both the change 
in Posm (r
2
=0.284, p<0.001) and the change in Hct (r
2
=0.081, p=0.018). The observed correlations 
suggest plasma ChE activity in quail is not limited to plasma but instead occupies some larger 
pool of body water. The effects of dehydration on plasma ChE activity masked the inhibitory 
effects of DCP. Combined dehydration and DCP exposure produced plasma ChE activity that 
was not significantly different from control values. A method to adjust plasma ChE activities for 
the confounding effects of dehydration and enable the diagnosis of OP exposure in dehydrated, 
DCP-exposed quail was developed. 
Quail received radio telemetry implants measuring body temperature and heart rate and 
were given sublethal oral doses of DCP, ETP, MMP, NLD, and vehicle alone. Observations were 
made before and after exposure and under thermoneutral and cold-stressed conditions. 
Significant hypothermia and tachycardia were observed under thermoneutral conditions 
following doses of DCP (1.20ºC, p<0.001; 98.4 beats per minute (bpm), p<0.001) and ETP 
(1.21ºC, p=0.004; 133 bpm, p<0.001). A set of quail exposed to ETP and NLD, but excluded 
from statistical analyses, failed to thermoregulate under cold-stressed conditions, suggesting that 
effects on thermoregulation which are sublethal under thermoneutral conditions can become 
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I suggest to you all that much insight has been gained in the pursuit of fine beer. 
 
 
“When a quantity is measured with all possible precision many times in succession, the 
figures expressing the results do not absolutely agree, and even when the average of results, 
which differ but little, is taken, we have no means of knowing that we have obtained an actually 
true result, and the limits of our powers are that we can place greater odds in our favour that the 
results obtained do not differ more than a certain amount from the truth.” 
 
“Statistical examination in each case may help much, but no statistical methods will ever 
replace thought as a way of avoiding pitfalls, though they may help us to bridge them.” 
 
Both above by William S. “Student” Gosset 




“…only naughty brewers take n so small that the difference is not of the order of the 
probable error!” 
 
Karl Pearson in writing to Gossett, 1912 
 
 
All quotes above in 
Pearson, Egon S. 1939. “Student” as statistician. Biometrika 30: 210-250. 
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MV   molecular volume 
MW   molecular weight 
n   sample size 
NC   negative control 
NCT   nicotine 
NLD   naled 
NSAIDs  non-steroidal anti-inflammatory drugs 
NTG   nitroglycerine 
OC   organochlorine 
OLS   ordinary least squares 
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SD   standard deviation 
SE   standard error 
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Std   standard 
TBW   total body water 
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Tt   body temperature under thermoneutral conditions 
TP   toxic potential 
UK   United Kingdom 
Unk   unknown 
US, USA  United States of America 
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This thesis is part of a larger terrestrial effects research project developed by Drs. Pierre 
Mineau and John Elliot, Research Scientists with Environment Canada. The focus of their 
project was on developing means to quantify the exposure of and mitigate impacts on birds and 
species at risk resulting from pesticide use in agricultural lands. The project consisted of three 
distinct subprojects, of which this thesis describes one. The two related subprojects examined i) 
the impacts of selected pesticides, including chlorpyrifos, on terrestrial wildlife on intensely 
farmed lands in southwestern British Columbia and ii) the impact of rodenticides on species 
listed in the Species at Risk Act and occurring within the Okanagan valley of British Columbia. 
The subproject described in this thesis was developed to compare the contributions of various 
routes of exposure (i.e. food-borne, dermal, other) to the effects of pesticide sprays on non-target 
birds under simulated field conditions and to establish the extent to which the physicochemical 
properties of the active ingredients in the sprays influence their contributions to effects of the 
various routes of exposure and then to construct a predictive exposure model. The intent was to 
produce an exposure model of utility to regulators in Canada and abroad in estimating the risks 
of pesticide sprays to birds from various routes of exposure. 
A set of controlled, replicated spray exposure experiments was completed on simulated 
cereal crops with a model non-target game bird. All pesticides were organophosphorus (OP) 





1.2 Collaborators and Facilities 
Research efforts were supervised by Dr. Mark Wickstrom of the Toxicology Centre, 
University of Saskatchewan. All spray exposures were conducted within an experimental spray 
room at Agriculture and Agri-Food Canada (AAFC) at the University of Saskatchewan under the 
supervision of Dr. Tom Wolf. Spray applications at AAFC were performed by Brian Caldwell, a 
licensed applicator. All plant material used in the experiments was grown under greenhouse 
conditions at AAFC while soil used on the simulated field was obtained from nearby AAFC 
lands. Initial effects assays were conducted by Prairie Diagnostic Services at the Western 
College of Veterinary Medicine (WCVM), University of Saskatchewan under the supervision of 
Dr. Barry Blakley. Later, all experimental effects assays were completed by the author in the 
Biochemical Toxicology Laboratory in the Toxicology Centre, University of Saskatchewan. All 




A commercial formulation of chlorpyrifos (Lorsban
TM
 4E, chlorpyrifos 480 g/L, Dow 
AgroSciences Canada Inc.), an organophosphorothioate compound requiring bioactivation in 
vivo, was used in initial pilot studies conducted prior to the experiments because it was being the 
compound of interest in related research by Environment Canada. It was later replaced by a set 
of commercial formulations of directly toxic organophosphate compounds to avoid any 
potentially confounding effect related to the need for in vivo bioactivation. The commercial 
formulations selected for the bulk of the research were BIDRIN
®
 8 (dicrotophos (DCP) 82.0%, 
Amvac Chemical Corporation), MOCAP
®





 480 (methamidophos (MMP) 480 g/L, Bayer CropScience Inc.), and DIBROM
®
 
(naled (NLD) 864 g/L, United Agri Produces Canada Inc.). These organophosphate compounds 
were selected for their common acute toxicity and mechanism of action and their diversity in 
physicochemical properties. 
 
1.4 Model Species 
Two different model species were used in this research; northern bobwhite (Colinus 
virginianus) and coturnix quail (Coturnix coturnix). The northern bobwhite (Silver Maple Game 
Farm, Millbank, Ontario, Canada) was originally selected as the model species as it is a game 
bird that is commonly used in toxicology tests and, as such, there are data available on the 
toxicity of numerous compounds to this species. Unfortunately, the supply of this species for 
experimental purposes could not be assured and its use was limited to some initial pilot studies. 
The coturnix quail (Fircrest Farms Ltd., Langley, British Columbia, Canada) was subsequently 
selected as the model species for the bulk of the pilot studies and all experiments as its supply 
was reliable. Information on the toxicity of compounds to this species and its physiology was 
obtained from primary literature using this species and the closely related Japanese quail 
(Coturnix japonica). 
 
1.5 Research Goals 
There are several components to the thesis research program. The primary focus of the 
thesis is to quantify the extent to which different routes of exposure contribute to the toxicity of 
OP pesticides in birds under simulated field conditions. Closely related to this effort is the 
development of a predictive avian-OP spray exposure model that requires only the 
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physicochemical properties for the OPs, oral toxicity, and field application rates as input. 
Secondary effort is focused on the feasibility of using radio telemetry implants to investigate 
how OP exposure influences cardiac and thermoregulatory function in birds under different 
temperature regimes. The final component of the thesis is an investigation of whether or not 
short term dehydration confounds the diagnosis of anticholinesterase exposure in birds. Each of 
these components is intended to address an existing need. 
The current avian ecological risk assessment screening level model has changed little 
since its development in the 1970s (Fite 1994). The fundamental assumption of this model is that 
consumption of contaminated food is the primary source of exposure of birds to pesticides (Fite 
1994). The realism of this paradigm has been questioned (Driver et al. 1991, Matz et al. 1998, 
Mineau 2002, Vyas et al. 2006). Further, the extensive field investigations required by higher tier 
risk assessments to validate the presumption of ‘no effect’ of pesticide use on a compound by 
compound basis are cost prohibitive (Mineau 2002). Hence, there is an existing need for 
predictive exposure models that can both estimate the toxicity from multiple exposure routes and 
be applied broadly to classes of related compounds. Controlled, replicated exposures of birds to 
four different OP pesticide sprays are proposed under simulated field conditions to determine the 
relative contributions of different exposure routes. Results of the experiment will be used in 
building a predictive exposure model. 
Numerous sublethal effects of OP pesticides are known, including effects on avian 
physiology (Rattner and Fairbrother 1991). It has been suggested that sublethal effects can 
contribute to the decline of bird populations (Walker 2003). However, little empirical evidence 
exists to explain how the sublethal effects of pesticides in birds can influence population 
parameters (Heinz 1989). Substantial investigation and the application of novel tools to the 
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problem are both required if this matter is to be better understood (Heinz 1989). The use of radio 
telemetry implants are proposed to investigate how sublethal OP exposure affects heart rate and 
thermoregulatory function in birds under different temperature regimes and to demonstrate the 
feasibility of using these techniques with birds. 
The number of methods used to diagnose anticholinesterase exposure is vastly exceeded 
by the number of factors that can confound such a diagnosis. Diagnosis of anticholinesterase 
exposure in birds typically relies on measurement of cholinesterase activity in brain, plasma, or 
both tissues (Rattner and Fairbrother 1991). Brain, the tissue arguably most useful in the 
diagnosis of anticholinesterase exposure (Rattner and Fairbrother 1991), cannot be sampled 
without killing the subject. Plasma can be sampled with little harm (Thompson 1991) and is 
more sensitive to anticholinesterase exposure than brain (Ludke et al. 1975). Unfortunately the 
utility of plasma in the diagnosis of anticholinesterase exposure is limited by the high variability 
of cholinesterase activity in plasma (Thompson 1999). This variability in plasma is due to 
several factors. Within a species, brain ChE activity may vary with age (Grue and Hunter, 1984; 
Custer and Ohlendorf, 1989) and nutrition (Rattner, 1982) while that in plasma may vary with 
sex (Ludke et al., 1975; Hill, 1989; Maul and Farris, 2004), age (Ludke et al., 1975; Fairbrother 
et al., 1990), hormone status (Fairbrother et al., 1989), time of day (Cobos et al., 2010), and 
season (Hill and Murray, 1987). Such factors may be problematic in the diagnosis of 
anticholinesterase exposure and hamper efforts to investigate and monitor the effects of 
pesticides on birds. The affect of dehydration on cholinesterase activity in birds has not been 
studied and is a potential confounding factor in the diagnosis of anticholinesterase exposure. A 
controlled, replicated experiment is proposed to examine how dehydration affects brain and 
plasma cholinesterase activity in birds. 
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The several working hypotheses of this proposal are that: 1) oral, dermal and other routes 
of exposure all contribute to OP toxicity in birds in the field; 2) the contribution of different 
routes of exposure to total toxicity in OP exposures can be explained by the physicochemical 
properties of the OPs; 3) sublethal exposure of OPs to birds disrupts normal cardiac and 
thermoregulatory functions in birds; and 4) short term dehydration can confound the use of ChE 
inhibition to diagnose OP exposure. 
This research is specifically intended to: 
i. Determine the contributions of various routes of exposure to total toxicity in birds from 
spray applications of a set of OP pesticides of varying physicochemical properties under 
simulated field conditions; 
ii. Develop an exposure model for predicting the contributions of the oral, dermal, and 
potentially other routes of exposure to total toxicity of OP pesticide sprays in birds based 
upon the physicochemical properties of the OP itself and its application rate; 
iii. Determine if short term dehydration of birds confounds the diagnosis of OP-exposure 
using measures of ChE activity in brain or plasma; and 
iv. Determine if sublethal oral exposure to OPs adversely effects cardiac and 
thermoregulatory function in birds under different temperature regimes (18°C and 4°C) 
using radio telemetry implants. 
 
1.6 Thesis Structure 
Chapter 2 is a literature review describing the current state of knowledge relating to the 
exposure of and effects upon birds resulting from the use of organophosphorus pesticides on 
agricultural lands, including comments on regulatory practice and modeling as they relate to 
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assessing the risk to birds from use of these compounds. Chapter 3 describes the pesticide spray 
exposure experiment on a simulated cereal crop while Chapter 4 describes the predictive 
exposure model developed from observations presented in Chapter 3. Chapter 5 describes the 
investigation into whether dehydration can confound the diagnosis of anticholinesterase pesticide 
exposure in birds. Chapter 6 describes the investigation into the sublethal effects of 
anticholinesterase exposure in birds on thermoregulation and cardiac function. Chapter 7 
presents comments on, and arguments for, the further investigation of how different routes of 





2.0 LITERATURE REVIEW 
2.1 Toxicity of Organophosphate Pesticides to Non-target Organisms 
2.1.1 Cholinesterase Inhibition as a Biomarker of Exposure and Effect 
Aldridge and Davison (1953) first described the mechanism of action of several OP 
compounds in inhibiting the activity of cholinesterase. OP compounds of the general formula 
(R)2(X)PO were found to produce identical inhibited cholinesterase for constant R groups while 
the X group was varied (Aldridge and Davison 1953). The X group was labile in hydrolysis of 
the OP compounds and phosphorylation was confirmed as the mechanism of cholinesterase 
(ChE) inhibition (Aldridge and Davison 1953). This mechanism of action is common in the 
several uses of OP compounds including therapy, nerve gases, and, of course, pesticides (Pope et 
al. 2005). 
Fukuto (1990) provided a concise description of the mechanism of action of the OP 
pesticides. Here the target is acetylcholinesterase (AChE), an enzyme essential in nervous 
transmission and common to many animals including humans, birds, and insects. In its 
endogenous function, AChE is acetylated at a serine hydroxyl moiety by the neurotransmitter 
acetylcholine (ACh) while the neurotransmitter is degraded to choline. The acetylated AChE 
then rapidly breaks down to acetic acid and the original enzyme while the choline is recycled in 
the production of new ACh. In the case of inhibition, a reaction occurs between the AChE and 
the OP pesticide molecule in which AChE is phosphorylated at the same serine hydroxyl moiety 
while the X group leaves the reaction. The phosphorylated AChE is very stable and inhibited. A 
local increase in ACh results when AChE inhibition is sufficiently large. 
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In vertebrates, the interaction of ACh and AChE is critical in nervous transmission at 
cholinergic, synaptic, and neuromuscular junctions (Pope et al. 2005). The inhibition of AChE 
and resulting build up of ACh in these junctions produce several effects described generally as 
cholinergic toxicity. In mammals, stimulation of secretory organs and smooth muscle tissues 
produce recognizable symptoms of cholinergic toxicity including salivation, lacrimation, 
urination, and defecation. Other symptoms include constriction of the iris, involuntary 
movements, paralysis, and cardiac arrhythmia. Mortality is typically due to respiratory failure 
from excessive secretions within the airways and respiratory muscle paralysis. Symptoms and 
lethality in birds are similar. 
Inhibition of cholinesterase (ChE) activity in tissues of birds is routinely used to diagnose 
exposure to OP and carbamate pesticides (Thompson 1999). Avian ChE activity is commonly 
measured in brain (Fleming and Bradbury 1981, DeWeese et al. 1983, Niethammer and Baskett 
1983, McEwen et al. 1986, Robinson et al. 1988, Rendon-von Osten et al. 2005) and plasma 
(Fleming and Bradbury 1981, Fairbrother et al. 1989, McInnes et al. 1996, Wilson et al. 2001, 
Maul and Farris 2005, Fildes et al. 2006). Brain is the preferred tissue for investigating 
anticholinesterase exposure in bird carcasses because of the preponderance of ChE activity in the 
organ (Rattner and Fairbrother 1991) and the persistence of inhibition in the brain (Westlake et 
al. 1981). Plasma is commonly used to assess exposure in live birds as sampling is non-lethal 
(Thompson 1991, Fossi et al. 1992), it is sensitive to anticholinesterase exposure (Ludke et al. 
1975), and because repeated measures in plasma provide the ability to perceive changes within 
an individual bird (Fairbrother et al. 1989). The utility of inhibition of plasma ChE activity as a 
measure of exposure is diminished by the high degree of variability in normal ChE activity 
(Thompson 1999) and the short duration of its inhibition from anticholinesterase exposure 
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(Westlake et al. 1981). Diagnosis of anticholinesterase exposure in birds may also be made with 
the reactivation of ChE activity in these tissues (Stansley 1993, Smith et al. 1995, Maul and 
Farris 2005). 
Greater than 20% and >50% inhibition of ChE in brain are accepted as being diagnostic 
of sublethal and lethal exposures to anticholinesterases, respectively (Ludke et al. 1975). 
Although no similar diagnostic thresholds exist for plasma ChE activity, correlations have been 
observed between the peak inhibition of ChE activity in brain and plasma over a range of OP 
acute oral doses (Fossi et al. 1992). 
Several confounding factors must be considered in making a diagnosis of exposure with 
either brain or plasma ChE inhibition (Rattner and Fairbrother 1991). Within a species, brain 
ChE activity may vary with age (Grue and Hunter 1984; Custer and Ohlendorf 1989) and 
nutrition (Rattner 1982), while that in plasma may vary with sex (Ludke et al. 1975; Hill 1989; 
Maul and Farris 2004), age (Ludke et al. 1975; Fairbrother et al. 1990), hormone status 
(Fairbrother et al. 1989), time of day (Cobos et al. 2010), and season (Hill and Murray 1987). 
However, the effect of hydration state on ChE activity in the tissues of birds appears to have 
been little studied, apparently limited to waterfowl possessing salt glands (Herin et al. 1978, 
Rattner et al. 1983). The effects of anticholinesterase exposure and an osmoregulatory challenge 
on ChE activity has been studied in mallards (Anas platyrhynchos) (Herin et al. 1978). Salt gland 
and brain acetylcholinesterase (AChE) activity in mallard ducklings were significantly inhibited 
by dietary chlorpyrifos exposure while the effects of salt loading in drinking water on these 
endpoints was not significant (Herin et al. 1978). Similarly, ingestion of fenthion by American 
black ducks (Anas rubripes) caused significant inhibition of both brain and plasma ChE activity, 
while the effect of saline drinking water on these endpoints was not significant (Rattner et al. 
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1983). Further, no change from normal brain AChE activity was found in the carcasses of 
waterfowl that died of salt toxicosis in North Dakota (Windingstad et al. 1987) and New Mexico 
(Meteyer et al. 1997). 
It seems obvious that wild birds experience periods of water shortage and abundance due 
to environmental conditions and so can become ephemerally dehydrated. Dehydration of birds 
can also be the consequence of disease (Joyner et al. 2006, Neimanis et al. 2007) and toxicity 
resulting from exposure to environmental pollutants (Wynne and Stringfield 2007). Therefore if 
dehydration is a confounder in the diagnosis of anticholinesterase exposure, then it is a 
confounder that may frequently be problematic. 
 
2.1.2 Physiological and Organismal Responses 
Direct mortality is not the only adverse effect of anticholinesterase exposure in birds 
(Grue et al. 1991, Pope et al. 2005). Outward symptoms in birds of sublethal cholinergic toxicity 
include ataxia, blindness, convulsions, dyspnea, hyperexcitability, incoordination, lethargy, 
piloerection, slurred vocalizations, and tremors, among others (Grue et al. 1991). Sublethal 
effects on behavior can impair survival and reproduction (Grue et al. 1991). Behavioural effects 
include altered activity patterns, reduced food and water intake, aggression, and adverse effects 
in nest defense and parental care (Grue et al. 1991). There are also adverse effects on 
thermoregulation and cardiac function (Grue et al. 1991). 
Although obviously related, more is probably known about how thermal stress affects OP 
toxicity in birds than about how OP toxicity affects the ability of birds to thermoregulate. 
Thermal stress increased the lethality of OP pesticides in American kestrels (Falco sparverius) 
(Rattner and Franson 1984), mallard ducklings (Fleming et al. 1985), Japanese quail (Coturnix 
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japonica)(Rattner et al. 1987), and northern bobwhite (Maguire and Williams 1987). Rattner and 
Franson (1984) exposed American kestrels to graded doses of methyl parathion by post-oral 
gavage. Kestrels were subsequently exposed to thermoneutral (+22°C) or cold-stressed (-5°C) 
conditions for 10 hours. Kestrels exhibited pronounced hypothermia in association with 50% or 
greater depression of plasma and brain ChE activity. The magnitude and duration of the 
hypothermic response increased with dose. Three of the 5 kestrels exposed to 2.25 mg/kg methyl 
parathion and placed in cold-stressed conditions died whereas there was no mortality in a similar 
group under thermoneutral conditions. Fleming et al. (1985) exposed day old mallard ducklings 
to graded dietary concentrations of temephos for 7 days. Ducklings in the dietary exposures were 
housed in either heated (39–41°C) or non-heated brooders (10-18°C). Duckling mortality was 
greater in the non-heated brooders than in the heated brooders at all dietary concentrations of 
temephos. High duckling mortality was observed only in the unheated brooders at the highest 
dietary concentration of temephos. Rattner et al. (1987) conducted median lethal dose 
experiments with ethyl parathion and Japanese quail exposed acutely or chronically to the 
elevated, thermoneutral, or reduced temperatures of 37, 26, or 4°C, respectively. The median 
lethal dose calculated for ethyl parathion was significantly lower for quail exposed chronically to 
either elevated or reduced temperatures relative to the thermoneutral group. Acute heat exposure 
also resulted in a significantly lower median lethal dose of ethyl parathion in quail. Acute cold 
exposure resulted in a non-significant reduction in the medial lethal dose. Maguire and Williams 
(1987) exposed juvenile northern bobwhite to chlorpyrifos in a standard avian dietary test under 
constant cold-stressed conditions. Dietary chlorpyrifos concentrations varied from 100 to 1000 
ppm while ambient temperatures ranged from 27.5 to 35.0°C. A dose-response relationship was 
apparent between chlorpyrifos concentration and the magnitude of observed hypothermia. 
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Survival of juvenile bobwhite decreased significantly under cold-stressed conditions. The 
estimated median lethal dietary chlorpyrifos concentrations were 531, 497, 345, and 283 ppm at 
35.0, 32.5, 30.0, and 27.5°C, respectively. 
The effects of OP pesticides on cardiac function in birds have been investigated 
(McFarland and Lacy 1968), although not extensively. There are more abundant data available in 
mammals (Gordon and Padnos 2000, Smith and Gordon 2005, Çetin et al. 2007). McFarland and 
Lacy (1968) observed tachycardia and heart block in Japanese quail, mallards and northern 
pintails (Anas acuta) injected intraveinously with parathion at 3.9-5.7, 0.61-1.70 and 1.57-2.02 
mg/kg, respectively. Gordon and Padnos (2000) observed significant bradycardia in rats exposed 
to chlorpyrifos at 25 mg/kg. In contrast, Smith and Gordon (2005) observed significant 
tachycardia in rats exposed to chlorpyrifos at the same dose. Çetin et al. (2007) observed 
significant bradycardia, decrease in cardiac output, and other measures of cardiac dysfunction in 
rabbits exposed to 375 ppm chlorpyrifos in drinking water. 
 
2.2 Ecological Risk Assessment for Pesticide Registration 
2.2.1 The Regulatory Framework in North America 
The regulatory frameworks governing pesticide use in Canada and the United States 
(USA) are similar. Pesticide products must be registered with the relevant agencies in each 
nation for their sale and use to be legal. Pesticide registration is at once an administrative, legal, 
and scientific process, wherein the risks to human health and the environment are evaluated. 
Registration results in strict limits and conditions for the production, storage, use, and disposal of 
pesticides. Pesticide products are re-evaluated on a regular basis. 
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In Canada, the Pesticide Management Regulatory Agency (PMRA), a branch of Health 
Canada, is responsible for pesticide registration. The PMRA is granted the authority for pesticide 
registration under Canada’s Pest Control Products Act. In the USA, it is the Environmental 
Protection Agency (EPA) that is responsible for pesticide registration under the Federal 
Insecticide, Fungicide, and Rodenticide Act (FIFRA). 
 
2.2.2 The Current Paradigm in the Assessment of Pesticide Risks 
The current avian pesticide assessment model was developed for the EPA in 1975 and 
has changed little since (Fite 1994). Briefly, it is a tiered process utilizing a series of tests 
beginning with laboratory tests and proceeding to field tests when unacceptable hazards are 
identified (Fite 1994). 
The initial screening level ecological risk assessment (ERA) methodology adopted by the 
United States EPA for registration of pesticides under the Federal Insecticide, Fungicide, and 
Rodenticide Act (FIFRA) is based on a quotient method (QM), in which a risk quotient (RQ) 
results from the ratio of an estimate of exposure over a reference measure of toxicity (Urban and 
Cook 1986). The resulting RQs are compared to established screening criteria (Fite 1994). The 
model exposure estimates are based on the assumption that contaminated food items are the sole 
source of exposure (Fite 1994). Residues on vegetative food items are estimated based on the 
data of Hoerger and Kenaga (1972). Residues on insect food items are estimated based on the 
data of Kenaga (1973). 
Toxicity thresholds are established using standardized laboratory acute oral and dietary 
tests using single species (Fite 1994). The species used are either northern bobwhite or mallards. 
Toxicity tests estimate the quantity of pesticide required to produce an effect in the species. 
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When mortality is the endpoint, the toxicity threshold is presented as a median lethal dose (LD50) 
or median lethal concentration (LC50) in feed. Screening criteria serve to separate pesticides into 
three categories; those with acceptable hazards, those with unacceptable hazards that may be 
mitigated by product labeling, and those with unacceptable hazards. It is presumed that the 
screening criteria provide a margin of safety for pesticides with acceptable hazards such that 
there will be minimal impact on birds. Several assumptions and uncertainties inherent in the 
model. The fundamental assumption of this model is that consumption of contaminated food is 
the primary source of exposure of birds to pesticides. Further, the model fails to account for 
within-species and between-species differences in sensitivities to pesticides. Differences between 
laboratory and field conditions are not examined for pesticides with acceptable hazards, even 
though there are bound to be differences in one or more of duration of exposure, environment, 
behavior, cohort etc. Further, as pesticides with acceptable hazards are never field tested, the 
margins of safety inherent in the screening criteria for categorizing pesticides are rarely 
examined. 
 
2.2.3 Criticism of Ecological Risk Assessment Practice 
Ecological risk assessment (ERA) has been adopted widely in a variety of regulatory 
settings (Suter II 2008). Further, ERA practice has been adapted to suit the policy and regulatory 
needs within these settings (Suter II 2008). Despite its widespread use, there exists polarity in 
opinion regarding the utility and practice of ERA (Power and Adams 1997). Proponents argue it 
is a valuable tool integrating science with decision making (Barnthouse 2008). Detractors argue 
ERA practice routinely oversimplifies ecological problems and fails to validate its predictions 
(Power and Adams 1997). Both proponents and detractors recognize that ERA is an evolving 
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practice and that it can and will be improved (Barnthouse 2008, Kapustka 2008).  Challenges 
facing ERA practice include the need for validation (Power and Adams 1997) and improved 
methods to deal both with dynamic ecological processes and with potential biases of and 
limitations imposed upon practitioners (Kapustka 2008). 
Much of the criticism directed at ERA generally is also directed specifically towards the 
QM in use in screening level ERA in pesticide registration. Bascietto et al. (1990) describe 
several weaknesses in the QM, including failing to characterize dose-response relationships, 
failing to account for differences between laboratory and field conditions, being of unknown 
reliability, and providing no means to quantify uncertainty. Further, there exist abundant records 
of avian mortality resulting from pesticide use (Fleischli et al. 2004) and an investigation of one 
such incident concluded that the use of some OPs may adversely impact sage grouse 
(Centrocercus urophasianus) populations (Blus et al. 1989). 
Reports of bird kills from OP pesticide poisoning have been made worldwide (Fleischli et 
al. 2004), but comprehensive reviews and analyses of these reports are uncommon (Greig-Smith 
1994, Mineau 2002, Fleischli et al. 2004). A review of United States Geological Survey National 
Wildlife Health Center voluntary reports of avian mortality caused by anticholinesterase 
pesticides in the United States between 1980 and 2000 found that OP compounds were 
responsible for 249 of the 335 reported incidents of confirmed or suspected poisoning (Fleischli 
et al. 2004). Reports were received from 42 different states (Fleischli et al. 2004). Total reported 
avian mortality from confirmed or suspected anticholinesterase poisoning, both OPs and 
carbamates, was 8877 birds of 103 different species in 12 different Orders (Fleischli et al. 2004). 
The three OPs, famphur, diazinon, and fenthion, were implicated in 116 of these incidents having 
a total mortality of at least 1984 birds (Fleischli et al. 2004). Fifteen other OPs were also 
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involved in these incidents of avian mortality (Fleischli et al. 2004). Greig-Smith (1994) lists 
incidents of bird poisoning in England and Wales as recorded in the United Kingdom Wildlife 
Incident Investigation Scheme during the period of 1980 to 1989. Only incidents in which more 
than 50 birds were found dead and the cause was attributed to the approved use of pesticides 
were recorded by the scheme (Greig-Smith 1994). Eight different OPs were involved in 12 
incidents of mortality of more than 1000 birds in 12 species (Greig-Smith 1994). Both Fleischli 
et al. (2004) and Greig-Smith (1994) noted that the incident reports they reviewed underestimate 
the mortality associated with a particular incident and fail to identify all occurrences of bird 
mortality from pesticide use. Vyas (1999) described several factors associated with pesticide-
caused mortality that explain why incident reports underestimate the scope and magnitude of 
avian mortality from pesticides. Pesticide-caused bird mortality must first occur, then be 
observed, then be reported, and finally be confirmed (Vyas 1999). As failures in observation, 
reporting, and confirmation are known, confirmed reports of pesticide poisoning of birds 
strongly imply that such incidents may be common (Vyas 1999). 
Blus et al. (1989) investigated reports of sage grouse die-offs in Idaho from 1981 by 
radio-tagging grouse in the summers of 1985 and 1986. A total of 82 seemingly healthy sage 
grouse within a larger local population were tagged in the two summers. Fifteen of the 82 tagged 
grouse subsequently entered fields sprayed with either dimethoate or methamidophos applied at 
maximum label rates. Mortality rates in tagged grouse were 5 and 16% in 1985 and 1986, 
respectively. Other observations of the local sage grouse population revealed  >30% mortality 
among grouse occupying an alfalfa field at the time it was sprayed with dimethoate. Sixty-three 
carcasses were recovered from this alfalfa field and the brains of 43 of those exhibited  >50% 
inhibition of ChE activity. Further, tagging and monitoring of 31 intoxicated grouse captured on 
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a dimethoate-sprayed alfalfa field revealed a greater than 60% mortality rate in these grouse. 
They concluded that some OPs may adversely affect sage grouse populations. 
Efforts to estimate the actual avian mortality associated with the use of a specific 
pesticide based upon incident reports have been few because data are generally lacking for single 
pesticides (Mineau 2005). Mineau examined data from the US EPA’s special review of the 
granular formulation of carbofuran, an anticholinesterase pesticide of the carbamate variety, and 
estimated bird losses. This product was chosen because the EPA special review had generated 
the best available data set for such an exercise. The estimated worst case scenario for granular 
carbofuran on corn was a kill rate in the range of 3 to 16 birds per hectare. There were 
approximately 5.7 million hectares of granular carbofuran-treated corn in the US in 1978. By 
extrapolation, this single formulation of a single anticholinesterase pesticide on a single crop 
may therefore have been responsible for 17 to 91 million bird deaths in 1 year. Only a few 
reports of bird kills resulting from granular carbofuran use preceded the EPA special review 
leading to the conclusion that the absence of carcasses is not necessarily an indication of safe 
pesticide use. 
Lethal risks to birds have also been estimated based upon avian mortality data sets for all 
anticholinesterase pesticides applied as sprays (Mineau 2002, Mineau and Whiteside 2006). 
These efforts were used to compare products and develop predictive models (Mineau 2002) and 
to describe how lethal risks to birds have varied over time with crop, state, and active ingredient 
in the US (Mineau and Whiteside 2006). The models of Mineau (2002) were applied to data sets 
for specific pesticide-crop combinations on a state by state basis in the US from 1991 to 2003 
(Mineau and Whiteside 2006). Lethal risks to birds in the US generally declined from 1991 to 
2003 in association with the introduction of new pesticides of novel chemistry (Mineau and 
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Whiteside 2006). No similar trend was observed in association with anticholinesterase pesticides 
alone (Mineau and Whiteside 2006). 
 
2.2.4 Validation of Ecological Risk Assessment Practice 
There are only a few published studies that have attempted to field validate the QM used 
in screening level ERA for pesticide registration, some with mammals (Edge et al. 1996, Wang 
et al. 1999, Edge and Schauber 2000) and others with birds (Matz et al. 1998, Vyas et al. 2006). 
The publications of Edge et al. (1996), Wang et al. (1999), and Edge and Schauber (2000) are 
among several published by a group conducting QM validation work with small rodents, 
typically the grey-tailed vole (Microtus canicaudus), in pen studies with azinphos-methyl (AM). 
Population-level impacts (i.e. mortality) were estimated using mark-recapture methods (Edge et 
al. 1996, Wang et al. 1999, Edge and Schauber 2000). Edge et al. (1996) observed significant 
dose-dependent declines in population size and survival of both sexes in vole populations 
exposed to AM sprayed on alfalfa in pens. These effects were of short duration, suggesting a 
compensatory response within the population (Edge et al. 1996). They concluded that the QM 
accurately predicted the risks to voles (Edge et al. 1996). Wang et al. (1999) conducted similar 
experiments with a vole population on dense pasture grasses in pens and found no effects on 
population parameters. The QM overestimated the hazards to the vole population under these 
conditions and this was attributed to the dense pasture grass canopy having sheltered the vole 
population from exposure to AM (Wang et al. 1999). Edge and Schauber (2000) studied the 
impacts of various application rates of AM on alfalfa to both voles and deer mice (Peromyscus 
maniculatus) in pens. They were able to predict of mortality in each species as they had access to 
data from dietary toxicity studies with AM for both species (Edge and Schauber 2000). They 
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found that their estimates of mortality based upon mark-recapture data correlated with both the 
QM predictions of risk and with predictions of mortality derived from dietary study data and 
estimates of residues on the field (Edge and Schauber 2000). The extent to which such findings 
with resident, generally r-selected rodents are applicable to migratory, more k-selected birds 
typical on agricultural lands in temperate North America, is highly debatable. Attempts to 
validate the QM using birds have, to date, relied on measures of impacts to individuals (Matz et 
al. 1998, Vyas et al. 2006), not populations. 
Comparisons of field and laboratory toxicity tests using OP pesticides and birds found 
that the EPA ecological risk assessment quotient method underestimates the risks to birds 
exposed to OPs in the field (Matz et al. 1998, Vyas et al. 2006). Matz et al. (1998) compared the 
results of a controlled field study with a standard laboratory dietary toxicity test using northern 
bobwhite chicks and a commercial formulation of the OP azinphos-methyl. Azinphos-methyl, 
applied in the field exposure at 770 g/ha, was examined using the EPA quotient method (Matz et 
al. 1998). Feed contamination was estimated at 40 ppm on insects and there was a presumption 
of little adverse ecological effects on the bobwhite (Matz et al. 1998). However, survival and 
brain ChE activity were both significantly lower in comparison to the field control groups (Matz 
et al. 1998). Further, results of standard laboratory toxicity tests using a dietary concentration of 
150 ppm found azinphos-methyl significantly less hazardous than when applied in the field at 
770 g/ha (Matz et al. 1998). Further still, the field application of azinphos-methyl at 770 g/ha 
remained toxic and lethal to bobwhite released onto the field 6 days after spraying, although the 
calculated half-life for azinphos-methyl in the field was only 2.5 to 4.5 days (Matz et al. 1998). 
The EPA QM clearly underestimated the risk of mortality to bobwhite chicks in the field (Matz 
et al. 1998). Matz et al. (1998) concluded that the risks to birds in the field differ from QM 
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predictions because the QM fails to account for routes of exposure other than oral, environmental 
variables, and indirect effects, among other factors. 
Vyas et al. (2006) conducted subacute dietary toxicity tests with diazinon and Canada 
goose (Branta canadensis) goslings under both field and laboratory conditions. Diazinon’s 
toxicity to goslings was significantly higher in the field than in the lab (Vyas et al. 2006). 
Laboratory estimates of the dietary diazinon LC50 for the technical grade and commercial 
formulations were 623 and 634 ppm diazinon, respectively (Vyas et al. 2006). The field estimate 
of the dietary LC50 for the commercial formulation was 3.6 ppm diazinon (Vyas et al. 2006). 
After accounting for differences in moisture content in feed between the lab and field, Vyas et al. 
(2006) estimated the toxicity of diazinon to goslings was about an order of magnitude higher in 
the field than in the lab. An influence of the field on the toxicity of diazinon was inferred (Vyas 
et al. 2006). Vyas et al. (2006) noted that goslings in the field tests were exposed to diazinon via 
multiple routes and were also subject to environmental stressors that might increase their 
susceptibility to diazinon. 
 
2.3 Estimation of Contributions to Toxicity from Different Routes of Exposure 
2.3.1 Laboratory-based Estimates of Toxicity from Different Routes of Exposure 
There has been little investigation of dermal exposure of birds to pesticides, probably 
because there is no regulatory requirement for such work in avian ecological risk assessment. 
Some OPs are more toxic via the dermal route relative to the oral route (Schafer, Jr. et al. 1973, 
Hudson et al. 1979), that the effects of OPs are both delayed and prolonged via the dermal route 
relative to the oral route (Henderson et al. 1994), and that the physicochemical properties of 
chemicals influence both their absorption into circulation (Rogers, Jr. et al. 1974) and their 
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storage in other tissues (Henderson et al. 1994). Schafer, Jr. et al. (1973) compared oral and 
dermal toxicities of 17 pesticides, primarily OPs, in red-billed weaver birds (Quelea quelea) and 
house sparrows (Passer domesticus). Three pesticides, including the OPs dicrotophos and 
parathion, were of equivalent toxicity via the oral and dermal routes in the weaver bird (Schafer, 
Jr. et al. 1973). Dicrotophos and fenthion were more toxic to house sparrows via the dermal route 
than the oral route (Schafer, Jr. et al. 1973). Hudson et al. (1979) compared the toxicity of 18 
different OPs via the oral and dermal routes of exposure in mallards. Three OPs, ethoprop, 
fenitrothion, and methyl parathion, were more toxic dermally than orally in mallards (Hudson et 
al. 1979). Hudson et al. (1979) recommended a mammalian dermal toxicity index (DTI), 
describing the relative hazard of dermal to oral exposure, be used as a screening tool to select 
pesticides for dermal toxicity testing in birds. Henderson et al. (1994) examined the oral and 
dermal toxicity of three lipophilic OPs in the domestic pigeon (Columba livia). The onset of 
effects from dermal OP exposure was delayed relative to effects resulting from oral exposure 
(Henderson et al. 1994). Inhibition of plasma ChE from dermal OP exposure was prolonged 
relative to that observed from oral OP exposure (Henderson et al. 1994). Henderson et al. (1994) 
inferred the presence of a reservoir within the pigeon body for storage of the dermally absorbed 
lipophilic OPs and slow release into circulation. Rogers, Jr. et al. (1974) investigated the 
percutaneous absorption of numerous chemicals through the skin of the foot and into circulation 
in the red-winged blackbird (Agelaius phoeniceus). Absorption into circulation was inversely 
related to the experimentally determined epidermis:water partition coefficients for the chemicals 
(Rogers, Jr. et al. 1994). Hydrophilic chemicals entered circulation more readily than lipophilic 
chemicals (Rogers, Jr. et al. 1974). 
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Kramer et al. (2002a, 2002b) compared the pharmacokinetics and pharmacodynamics of 
the intravenous, oral, and dermal routes of exposure of methyl parathion (MP) in rats. In 
comparing pharmacokinetics, rats were dosed intravenously via injection and orally via gavage 
with MP at the rate of 1.5 mg/kg, while graded dermal doses of MP in ethanol were applied to 
clipped, undamaged skin at the rates of 6.25, 12.5, and 25 mg/kg (Kramer et al. 2002a). 
Comparisons revealed that the pharmacokinetics of MP in rats are complex and dependent upon 
route of exposure. Peak mean (SE) concentration of MP in rat blood reached 804.9 (52.2) ng/mL 
only 2.5 minutes following intravenous injection and then declined rapidly to levels not 
detectable within 36 to 72 hours. The half-life of MP in rats following intravenous injection was 
6.6 hours. Peak mean (SE) concentration of MP in rat blood following oral gavage was 31.2 
(11.3) ng/mL at approximately 15 minutes following gavage, although the time to peak was 
highly variable (range 10 to 60 minutes), and then declined in a manner consistent with 
observation following intravenous injection. The peak concentration of MP in blood following 
oral gavage was more than an order of magnitude lower than following intravenous injection and 
oral bioavailability was estimated at only 20%. The pharmacokinetics of MP in rats following 
dermal exposures differed markedly from exposures to either intravenous or oral doses. 
Concentration of MP in rat blood following a dermal dose of 6.25 mg/kg increased slowly to a 
mean (SE) peak of 40.0 (13.0) ng/mL over a period of up to 26 hours and then declined to levels 
that were not detectable over a period of 74 to 96 hours. At the higher dermal doses of MP of 
12.5 and 25 mg/kg, mean (SE) peak concentrations of MP in blood were 110.0 (47.2) and 143.6 
(32.6) ng/mL, respectively. The decay of MP concentrations in rat blood at both higher dermal 
doses was proportionally longer and still detectable at the end of the protocol, 122 hours post-
exposure. They inferred limited diffusion across rat skin following dermal exposures that 
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restricted bioavailability to approximately 50 percent of the applied dose. Whereas the 
pharmacokinetics of MP in rats following intravenous and oral doses were best described by 
three-compartment models, the pharmacokinetics of MP in rats following dermal doses were best 
described by two-compartment models. Dermal exposures altered the pharmacokinetics of MP in 
rats with respect to the intravenous and oral routes of exposure. Whereas intravenous and oral 
doses of MP in rats resulted in MP partitioning into a deep lipophilic compartment, MP failed to 
enter this compartment following dermal exposures. Instead, the primary reservoir for MP in rats 
following dermal exposures was rat skin itself, from which MP was slowly released. In related 
work using similar dosing methods, Kramer et al. (2002b) described the pharmacodynamics of 
MP in rats. The intravenous and oral doses used were 2.5 mg/kg while the graded dermal doses 
were 6.25, 12, 25, and 50 mg/kg. Cholinesterase activity in rat red blood cells was examined 
using repeated measures. Peak inhibition of ChE activity following both intravenous and oral 
exposures occurred rapidly and recovered completely within 30 to 48 hours. In contrast, peak 
inhibition of rat ChE activity was dose-dependent, developed slowly (>6 hours to peak), and 
prolonged in duration (>48 hours). At the highest dermal dose, little recovery of ChE activity 
was apparent until 122 hours post-dose while full recovery of ChE activity took 14 to 21 days. 
Qiao et al. (1994) examined the pharmacokinetics of radio-labeled parathion (PA) and its 
metabolites in weanling pigs following intravenous and dermal doses. Intravenous and dermal 
doses of PA were equivalent (300 µg) but the intravenous dose was given via an ear vein cannula 
while the dermal dose was applied in ethanol vehicle over 7.5 cm
2
 of clipped, undamaged skin. 
Parathion was rapidly cleared from blood following the intravenous dose. Greater than 99% of 
PA was cleared from blood within the first 15 minutes post intravenous dose and neither PA nor 
its metabolites were detected in blood after 6 hours. The pharmacokinetic model fit to the 
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observations predicted dynamic, fluctuating concentrations of PA and its metabolites during the 
first 24 hours post-intravenous dose, then relatively low and stable levels, and complete 
clearance from pigs within 48 hours. In contrast, PA and its metabolites persisted in pig blood 
throughout the 168 hour experimental protocol following dermal dosing. The rate limiting 
pharmacokinetic step was inferred to be partitioning of PA from the vehicle/skin surface into the 
lipophilic stratum corneum (SC) of the pig skin. They estimated that 90 to 96% of the PA 
absorbed into the SC would eventually diffuse into the more hydrophilic viable epidermis (VE). 
 
2.3.2 Simulated Field-based Estimates of Toxicity from Different Routes of Exposure 
Mineau et al. (1990) compared the responses of zebra finches (Taeniopygia guttata) to 
either graded simulated forest sprays of fenitrothion in a spray chamber or graded oral doses of 
fenitrothion by gavage. Four different groups of zebra finches (each n=10) were exposed at the 
fenitrothion spray rates of 38, 51, 139, and 255 g/ha. Five different groups of zebra finches (each 
n=5) were exposed to fenitrothion oral doses of 0, 5, 10, 20, and 40 mg/kg. Responses of finches 
to fenitrothion simulated forest spray exposures displayed an obvious threshold effect. 
Significant reductions in brain ChE activity and body weight were only observed at the highest 
fenitrothion spray rate. They noted their spray chamber exposures lacked a dietary component 
and argued instead that an equivalent oral dose rate could be estimated for their spray chamber 
exposures based upon peak inhibition of ChE activity. The response in the high spray rate group 
was estimated to be equivalent to the response to an oral gavage dose of approximately 13 
mg/kg. 
The investigation of Driver et al. (1991) is perhaps the only effort to date to quantify the 
relative contribution of different routes of exposure to pesticide toxicity in a bird species under 
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simulated field conditions. Northern bobwhite were exposed to sprays of the OP methyl 
parathion in an enclosed wind tunnel apparatus containing a cotton crop. Four routes of exposure 
were isolated in the exposures; inhalation, direct consumption of contaminated feed, indirect 
consumption from preening, and dermal. Inhalation was isolated by enclosing bobwhite in 
Gortex
®
 body bags while exposing only the beak. Consumption of contaminated feed was 
isolated by comparing effects in bobwhite fed dead contaminated mealworms and bobwhite fed 
dead clean mealworms. Preening was isolated by comparing effects in bobwhite left free to preen 
with bobwhite wearing neck collars that prevented preening. The dermal contribution was 
established by measuring effects in free-ranging bobwhite and subtracting the effects found in 
the other isolated routes of exposure. Methyl parathion was applied to the simulated field at 1.2 
kg/ha. Contaminated feed was produced in similar spray applications and then transferred to a 
clean simulated feed to isolate consumption of contaminated feed. Cholinesterase inhibition was 
measured in all groups at 1, 4, 8, 24, and 48 hours following application of the OP spray. The 
contributions to ChE inhibition by the different routes of exposure varied with post spray period. 
At 1 hour post-spray, the ranking of exposure routes by relative contribution to toxicity was 
inhalation>preening>dermal and no effects were observed from ingestion of contaminated feed. 
At 4 hours post-spray, the ranking was preening>ingestion>dermal>inhalation. At each of 8, 24, 
and 48 hours post-spray, the ranking was dermal>ingestion>preening>inhalation. Ingestion of 
contaminated feed contributed no more than 20% to total toxicity in the bobwhite in all of the 
post-spray periods examined. They noted the stark contrast between their findings and the 
assumption that consumption of contaminated feed is the main route for exposure to pesticides 





There are two principle modeling strategies in use in the study of dermal exposures 
(Fitzpatrick et al. 2004). First, quantitative structure-activity relationships (QSARs) and 
quantitative structure-permeability relationships (QSPRs) are used mainly to predict steady-state 
permeability coefficients for skin in people. QSARs and QSPRs may then be divided into two 
separate subsets, general and specific. General QSARs/QSPRs have been developed based upon 
large data sets from a wide variety of compounds without regard for a compound’s class or 
mechanism of action. Specific QSARs/QSPRs are typically focused on either a smaller numbers 
of compounds within a related class or on the influence of particular physicochemical properties 
on absorption. The second modeling strategy lies in mathematical modeling of the partitioning 
and transport processes involved in dermal absorption to predict the extent and rate of absorption 
through skin. 
Potts and Guy (1992) developed one of the earliest general QSAR models of skin 
permeability. Data on mammalian skin permeability (Kp) from a number of different 
experimental sources were compiled for use in the model building exercise. The largest and most 
diverse of the data sources included Kp data for more than 90 compounds of diverse solubility (-3 
≤ log Kow ≤ 6), varying molecular weight (18 ≤ MW ≤ 750), and different classes and 
mechanisms of action. Multiple regression was used to identify a relatively simple model for 
which skin permeability could be predicted (Eq. 2.1): 
log Kp  =  0.71log Kow  –  0.0061MW  –  6.3   (Eq. 2.1). 
This model fit the largest and most diverse of the data sets fairly well (r
2
=0.67). The model also 
offered some mechanistic insight. Permeation through mammalian skin was consistent with 
permeation through a single biological membrane except that permeation through mammalian 
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skin was much slower than through a single membrane as the diffusion pathlength through 
mammalian skin was much longer than that through a single membrane. 
In contrast, Moss and Cronin (2002) developed a specific QSRP upon re-analyzing 
published steroid Kp data on percutaneous absorption. They noted that numerous steroids had 
appeared as outliers in earlier QSPR models and that the quality of the steroid data used in 
developing these models had been questioned. They developed a specific QSPR model for the 
permeability of skin to steroids based upon new steroid Kp data.  This new QSPR model for 
steroids (Eq. 2.2)  
log Kp  =  0.74log Kow  –  0.0091MW  –  2.39   (Eq. 2.2) 
was both highly significant and consistent with prior published models. They concluded that 
steroids permeate through skin in the same manner as the majority of exogenous compounds 
studied. 
QSAR/QSPR methods have not been limited to predictions of mammalian Kp values 
under steady state condition. Cleek and Bunge (1993), for example, developed a generalized 
method that allowed for the inclusion of dermal absorption under non-steady state conditions 
when the compound is first being absorbed into the stratum corneum and before it has entered 
circulation. However, a comprehensive discussion of QSARs/QSPRs is beyond the scope of this 
exercise. The review of Moss et al. (2002) will serve in this capacity as it describes many of the 
QSARs/QSPRs developed to model skin permeation. Further, it is at least as important to 
understand the strengths and weaknesses of the different approaches in QSAR/QSPR modeling 
as it is to be familiar with all of the models developed. Geinoz et al. (2004) found that many 
QSARs/QSPRs had been developed using data compiled from different sources and that among-
source heterogeneity in experimental conditions contributed unexplained variance in the models. 
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They further noted that specific QSAR/QSPR models that are confined to compounds within 
classes are more reliable than more general models but also more limited in applicability (Geinoz 
et al. 2004). Lian et al. (2008) compared what they described as “empirical” and “mechanistic” 
QSARs/QSPRs. They noted that the more complex models often contained terms describing 
molecular structure which are only empirically related to skin permeation and reveal little 
mechanistic information. They found that the best predictions resulted from the mechanistic 
model of Mitragotri (2002) and that the second best predictions resulted from the empirical 
model of Potts and Guy (1992). The mechanistic model of Mitragotri (2002) was based in scaled 
particle theory for solute diffusion in lipid bilayers and used log Kow and solute radius to predict 
skin permeability. Lian et al. (2008) noted that, although Potts and Guy (1992) and Mitragotri 
(2002) took different approaches in developing their models (empirical and mechanistic, 
respectively), they shared two features. Both models assume that the lipid matrix within skin is 
the permeation pathway involved in dermal absorption and both models rely on measures of log 
Kow and solute size in making their predictions (Lian et al. 2008). Lian et al. (2008) concluded 
that additional complexity developed empirically did not result in more accurate predictions of 
skin permeation. 
Others have used QSARs/QSPRs to examine how absorption varies with log Kow (Yano 
et al. 1986, Hinz et al. 1991, Zhang et al. 2009). Yano et al. (1986) measured the absorption of 
two sets of homologous compounds, 8 salicylates and 10 non-steroidal anti-inflammatory drugs 
(NSAIDs), in human subjects. Two square centimeters of forearm skin was demarcated on 
healthy male human subjects. The test compounds were then applied to demarcated skin in 
volatile solvents using microsyringes at a uniform dose of 0.5 mg for each compound. 
Demarcated skin was covered with an aluminum foil patch for 4 hours after which the 
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unabsorbed compound was recovered from both the patch and demarcated skin with ether. The 
percent absorbed (%Abs) for each compound was estimated from the recoveries determined 
following removal of patches. Quadratic polynomial equations were fit to the scatter plots of log 
Kow versus log %Abs for the salicylates and NSAIDs data sets (Eq. 2.3 and 2.4, respectively), 
 log %Abs  =  –0.323(log Kow)
2
  +  1.575(log Kow)  +  0.010  (r
2
=0.931, Eq. 2.3) 
 log %Abs  =  –0.203(log Kow)
2
  +  0.985(log Kow)  +  0.514  (r
2
=0.929, Eq. 2.4). 
The optimal log Kow for dermal absorption was approximately 2.4 for both the salicylates and 
NSAIDs. 
Hinz et al. (1991) measured the skin permeation rate of radio-labeled phenol and 10 
radio-labeled para-substituted phenols across full-thickness isolated hairless mouse skin in 
vertical, glass flow-through diffusion cells. Log Kow for the phenols varied by more than 3 orders 
of magnitude. Skin was excised and used immediately following euthanasia of the mice. All 
phenols were applied to 3.1 cm
2
 of skin in an acetone vehicle at the rate of 4 µg/cm
2
. The 
receptor chamber contained phosphate-buffered saline (PBS) having an hourly turnover rate. 
Receptor solution was sampled every hour or two over a 48 hour period. Skin permeation for the 
phenols was characterized by the maximum skin permeation rate, Jmax. Hinz et al. (1991) fit both 
parabolic and bilinear models to the scatter plot of log Kow versus log Jmax. Statistical analysis 
indicated that both models adequately described variation in the data. The fit of the parabolic 
model (Eq. 2.5), 
 log Jmax  =  –0.30(log Kow)
2
  +  1.35(log Kow)  –  0.14  (r
2
=0.92, Eq. 2.5), 
to the data was highly significant (p<0.001) and the model was consistent with a change in the 




Similarly, Zhang et al. (2009) fit parabolic and bilinear equations to observations of Jmax 
for a set of phenols through full-thickness human abdominal skin. Log Kow for the phenols 
ranged from 1.95 to 3.52. Human skin was obtained from a single individual and mounted in 
horizontal, glass static diffusion cells. Dosing solutions in the donor chambers were described as 
providing an “infinite” dose as they were saturated phenol solutions of PBS in very large 
volumes relative to the skin diffusion area. Samples of the PBS in the receptor chamber were 
collected and replaced with fresh PBS at regular intervals over the next 7 hours. Jmax was equated 
to the steady-state skin permeation rate observed for each phenol. Both parabolic and bilinear 
models were fit to the scatter plot of log Jmax versus log Kow for the phenols under study. Here 
the fit of the bilinear model (r
2
=0.86) was somewhat better than the fit of the parabolic model 
(Eq. 2.6) 
  log Jmax  =  –1.2(log Kow)
2
  +  6.5(log Kow)  –  7.2  (r
2
=0.74, Eq. 2.6). 
They noted that their findings were largely consistent with those of Hinz et al. (1991) described 
previously. However, they differed from Hinz et al. (1991) in the inference made regarding the 
processes responsible for the convex shape of the model. They had deliberately selected phenols 
that differed little in MW or hydrogen bonding ability and concluded that the solubility of the 
phenols in the SC alone explained the shape of the relationship. 
Mathematical models of diffusion and partitioning processes, the second approach to 
modeling dermal absorption, also vary in their complexity from the simple, general 
pharmacokinetic (PK) model of percutaneous absorption of Guy et al. (1982) to the much more 
complex but specific physiologically-based pharmacokinetic pharmacodynamic (PBPKPD) 
model of chlorpyrifos exposure and effects of Timchalk et al. (2002). The model of Guy et al. 
(1982) is a 4-compartment general model for predicting the percutaneous absorption of a variety 
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of compounds. It describes the excretion of topically applied testosterone, benzoic acid, and 
hydrocortisone over time as being a function of 4 first-order rate constants, k1 through k4 (Guy et 
al. 1982). The rate constants k1, k2, k3, and k4 represent the rate of compound diffusion across the 
SC, the rate of compound diffusion across the VE, the delay rate of partitioning across the SC-
VE boundary associated with the SC’s reservoir effect (i.e. reflecting the extent to which a 
compound has a greater affinity for the lipophilic SC over the hydrophilic VE), and the 
elimination rate of the compound from dermal capillaries into urine, respectively (Guy et al. 
1982). Guy et al. (1982) noted that the ratio of k3/k2 for the three compounds under study were 
consistent with their relative hydrophobicities. This model was later validated for 11 additional 
compounds of widely varying solubility properties leading to the conclusion that the ratio k3/k2 
agreed reasonably well with octanol:water partition coefficients for the compounds under study 
(Guy et al. 1985). In contrast, the model of Timchalk et al. (2002) possesses 20 compartments, 8 
rate constants, and parameters for both blood flow and contaminant concentration in various 
tissues in modeling the multiroute pharmacokinetics, pharmacodynamics, metabolism, and 
excretion of chlorpyrifos in rats and man. Timchalk et al. (2002) concluded their model was 
capable of estimating tissue-specific chlorpyrifos dose and ChE inhibition within a variety of 
exposure scenarios. 
Mathematical models of dermal exposure have apparently never been developed for 
birds. However, there are avian PK models of alimentary exposure to pharmaceuticals (Pollet et 
al. 1985, Cortright et al. 2009) and persistent organic pollutants (Clark et al. 1987, MacLachlan 
2010). The PBPK models of Pollet et al. (1985) and Cortright et al. (2009) were developed for 
midazolam and chlortetracycline, respectively, in addressing concerns regarding the veterinary 
use of pharmaceuticals. The simple PK model of Clark et al. (1987) was developed to simulate 
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the kinetics of organochlorine (OC) residues in herring gulls (Larus argentatus) to better 
understand and predict temporal trends in OC concentrations in lakes where herring gulls feed. 
The PBPK model of MacLachlan (2010) was developed to predict the accumulation of lipophilic 
pesticides in poultry. The author knows of no similar mathematical model of the exposure of 
birds to any compound via the dermal route. The mammalian literature is therefore the source of 
mathematical models of dermal absorption and the following select articles are relevant to this 
endeavour. 
A PBPK model for the in vitro absorption of parathion, methyl parathion, and fenthion 
through pig skin isolated within a flow-through diffusion cell was developed by van der Merwe 
(2006). The model was mechanistic and rich in detail, although limited in application to the 
experimental conditions, and specific to OP pesticides listed. Among the phenomena studied 
were the effects of solvent and removal of the SC on absorption. The authors noted apparent 
deviations from the first-order kinetics predicted by Fick’s law in their observations with 
parathion and fenthion. Diffusivity and mass transfer were altered depending upon the solvent 
and solute concentrations used. They further commented that solvent-solute interactions that can 
be anticipated with absorption across biological barriers were incompatible with the mechanism 
of Brownian motion that forms the basis for Fick’s law. More importantly, they noted that for 
these 3 small, lipophilic OPs, absorption rate was limited by the diffusion of the OPs through 
skin as opposed to partitioning of the OPs into skin from the solvent. Only a small fraction of the 
OPs that partitioned into skin were absorbed into the receptor solution during their 8 hour 
experimental periods. They stated that small, lipophilic compounds such as these OPs are likely 




Mosquin et al. (2009) discussed the benefits of multiple biomarkers and multiple 
sampling periods in using PBPK models to infer exposures from biomarker data. This ‘inverse 
approach’ stands in contrast to the typical use of PBPK models and biomarker data to infer tissue 
concentrations of a compound given a known exposure. They employed a modified version the 
PBPKPD model of Timchalk et al. (2002) for chlorpyrifos in rats and humans and a simulated 
biomarker data set for two contrasting exposure scenarios. The two exposure scenarios simulated 
were one-time acute exposures to chlorpyrifos via either the oral or dermal route. Although the 
complete simulated biomarker data set included measures of 5 different biomarkers at 4 different 
time periods following exposure, only portions of the data set were used with the model to assess 
how the addition of more biomarkers or more sampling times improved model utility in 
reconstructing exposures. They found that both additional biomarkers and additional sampling 





3.0 SIMULATED FIELD EXPOSURES OF COTURNIX QUAIL TO 
ORGANOPHOSPHATE INSECTICIDE SPRAYS I: CONTRIBUTIONS TO TOXICITY 
FROM VARIOUS ROUTES OF EXPOSURE 
 
3.1 INTRODUCTION 
The current screening level ecological risk assessment quotient method used to evaluate 
the hazard to wild birds from the use of insecticidal sprays, including the anticholinesterase 
organophosphorus (OP) and carbamate (CM) compounds, relies on an exposure model that 
assumes consumption of contaminated food is the only route of exposure (Tiebout and Brugger 
1995). There are a number of lines of evidence that suggest dermal and other routes of exposure 
occur in the field and pose hazards to wild birds with the use of insecticidal sprays. This 
evidence includes comparisons of standard toxicity tests under field and laboratory conditions 
(Tiebout and Brugger 1995, Matz et al. 1998, Vyas et al. 2006), avian dermal toxicity studies 
(Schafer, Jr. et al. 1973, Rogers et al. 1974, Hudson et al. 1979, Henderson et al. 1994), the use 
of non-dietary routes of exposure in the design of avicides (Schwab 1968, Pope and Ward 1972, 
Schafer et al. 1984, Johns et al. 1992, Shumake and Scott 1996), the presence of insecticide 
residues on and in avian skin following insecticide spray application (Vyas et al. 2004, Vyas et 
al. 2007), studies of the field record of avian mortality from insecticidal sprays (Mineau 2002), 
and controlled exposures to insecticidal spray in chambers (Mineau et al. 1990) and under 
simulated field conditions (Driver et al. 1991). 
Tiebout and Brugger (1995) noted several assumptions of the quotient method, including 
that consumption of contaminated feed is the only route of exposure. They noted that the 
quotient method, while simple to apply and interpret, can also be insensitive, imprecise, and 
inaccurate. Comparisons of field and laboratory toxicity tests using OP pesticides and birds 
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found that the quotient method underestimated the risks to birds exposed to OPs in the field 
(Matz et al. 1998, Vyas et al. 2006). Matz et al. (1998) compared the results of a controlled field 
study with a standard laboratory dietary toxicity test using northern bobwhite chicks and a 
commercial formulation of the OP azinphos-methyl. Azinphos-methyl, applied in the field 
exposure at 770 g/ha, was examined using the quotient method. Feed contamination was 
estimated at 40 ppm on insects and there was a presumption of little adverse ecological effects on 
the bobwhite. However, survival and brain ChE activity were both significantly lower in 
comparison to the field control groups. Further, results of standard laboratory toxicity tests, using 
a dietary concentration of 150 ppm, found azinphos-methyl to be significantly less hazardous 
than when applied in the field at 770 g/ha. The field application of azinphos-methyl at 770 g/ha 
remained toxic and lethal to bobwhite released onto the field 6 days after spraying, although the 
calculated half-life for azinphos-methyl in the field was only 2.5 to 4.5 days. The quotient 
method clearly underestimated the risk of mortality to bobwhite chicks in the field. They 
concluded that the risks to birds in the field differ from quotient method predictions because the 
method fails to account for routes of exposure other than oral, environmental variables, and 
indirect effects, among other factors. 
Vyas et al. (2006) conducted subacute dietary toxicity tests with diazinon and Canada 
goose goslings under both field and laboratory conditions. Diazinon’s toxicity to goslings was 
significantly higher in the field than in the lab. Laboratory estimates of the dietary diazinon LC50 
for technical grade and commercial formulations were 623 and 634 ppm diazinon, respectively. 
The field estimate of the dietary LC50 for the commercial formulation was 3.6 ppm diazinon. 
After accounting for differences in moisture content in feed between the lab and field, they 
estimated the toxicity of diazinon to goslings was about an order of magnitude higher in the field 
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than in the lab. An influence of the field on the toxicity of diazinon was inferred. They noted that 
goslings in the field tests were exposed to diazinon via multiple routes and were also subject to 
environmental stressors that might increase their susceptibility to diazinon. 
Avian dermal exposure studies have revealed that some OPs are more toxic via the 
dermal route than by the oral route (Schafer Jr. et al. 1973, Hudson et al. 1979), that the effects 
of OPs are both delayed and prolonged via the dermal route relative to the oral route (Henderson 
et al. 1994), and that the physicochemical properties of chemicals influence both their absorption 
into circulation (Rogers, Jr. et al. 1974) and their storage in other tissues (Henderson et al. 1994). 
Schafer, Jr. et al. (1973) compared the oral and dermal toxicities of seventeen pesticides, 
primarily OPs, in red-billed weaver bird and house sparrow. Three pesticides, including the OPs 
dicrotophos and parathion, were of equivalent toxicity via the oral and dermal routes in the 
weaver bird. Dicrotophos and fenthion were more toxic to house sparrows via the dermal route 
than the oral route. Hudson et al. (1979) compared the toxicity of 18 different OPs via the oral 
and dermal routes of exposure in mallards. Three OPs, ethoprop, fenitrothion, and methyl 
parathion, were found more toxic dermally than orally in mallards. They recommended a 
mammalian dermal toxicity index (DTI) describing the relative hazard of dermal to oral exposure 
be used as a screening tool to select pesticides for dermal toxicity testing in birds. Henderson et 
al. (1994) examined the oral and dermal toxicity of three lipophilic OPs in the domestic pigeon. 
The onset of effects from dermal OP exposure was delayed relative to effects resulting from oral 
exposure. Inhibition of plasma ChE from dermal OP exposure was prolonged relative to that 
observed from oral OP exposure. They inferred that a reservoir existed within the pigeon body 
for storage of the dermally absorbed lipophilic OPs and slow release into circulation. Rogers, Jr. 
et al. (1974) investigated percutaneous absorption of numerous chemicals through the skin of the 
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foot and into circulation in the red-winged blackbird. Absorption into circulation was inversely 
related to the experimentally determined epidermis:water partition coefficients for the chemicals. 
Hydrophilic chemicals entered circulation more readily than lipophilic chemicals. 
Avicides are used in the control of bird pests.  Many routes of exposure are employed in 
the development and use of avicides (Schwab 1968, Pope and Ward 1972, Schafer, Jr. 1984, 
Johns et al. 1992, Shumake and Savarie 1996). Early efforts to control starlings and blackbirds in 
California used 3-chloro p-toluidine hydrochloride, an organochlorine, as a contact avicide in 
roost sprays (Schwab 1968). Schwab (1968) inferred several routes of exposure as contributing 
to the lethality of the organochlorine studied. The OPs fenthion and parathion have been used 
widely in Africa as contact avicides in roost sprays in the control of red-billed quelea (Pope and 
Ward 1972). Pope and Ward (1972) found that a commercial formulation of fenthion applied to 
feathers of the back of red-billed quelea resulted in LD50s of 80 to 220 mg/kg depending upon 
dilution and droplet size. The droplet size and solvent used to deliver fenthion to the bird were 
important as they influenced the ability of fenthion to wick through the plumage to the skin. 
Fenthion is also used as an avicide in wicked perches (Schafer, Jr. 1984). Dermal exposure is 
utilized as the perches deliver fenthion to the feet of target bird species. The use of 3-chloro-4-
methylbenzenamine, an organochlorine, as a respirable aerosol spray avicide against starlings 
and blackbirds was investigated by Johns et al. (1992). They found that ocular and body 
exposures were larger contributors to lethality of the organochlorine than inhalation. Shumake 
and Savarie (1996) explored use of OP-contaminated nest material in the control of weaver 
finches. A commercial insecticide formulation of fensulfothion was found to be the most 
effective avicide in nest material. Male weaver finches were disproportionately targeted due to 
their role in nest building. 
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The presence of residues on, or in, avian skin has rarely been examined. OP pesticide 
sprays are readily transferred from vegetation to bird feet and feathers (Vyas et al. 2004, Vyas et 
al. 2007).  Vyas et al. (2004) exposed Canada goose goslings to diazinon-sprayed turf by housing 
them on experimental turf plots, upon which they walked and grazed. All diazinon-exposed 
goslings died within 24 hours of exposure and diazinon residues were detected on their feet even 
after 7 days of decomposition. They proposed that feet be used for residue analyses for the 
diagnosis of OP poisoning when other tissues are unavailable. Vyas et al. (2007) released brown-
headed cowbirds (Molothrus ater) into an aviary containing azinphos-methyl-sprayed apple 
trees. Cowbirds released into the aviary at 1 hour post-spray were sampled at 36 hours and 7 
days post-spray while cowbirds released into the aviary at 4 days post-spray were sampled only 
at 7 days post-spray. The majority of cowbirds sampled from each exposure group had detectable 
residues on their skin plus feathers and feet. They claimed their finding of residues on these 
tissues demonstrated the importance of dermal exposure in avian ecological risk assessment. 
The field record of avian mortality suggests that exposure routes other than oral 
contribute to bird kills (Mineau 2002). Mineau (2002) developed logistic regression models to 
predict the probability of bird kills from spray application of anticholinesterase pesticides based 
upon a review of field studies following pesticide application. Three models were developed, one 
for each of field crops or pastures, forests, and orchards. Three independent variables, the toxic 
potential (TP) as a measure of acute oral toxicity and spray rate, an avian DTI, and Henry’s law 
constant (HLC) as a surrogate for potential inhalation exposure, all improved the models’ 
predictive ability. Generally, the ranking of the independent variables from most significant to 
least significant in their ability to improve model predictions was TP>DTI>HLC. Mineau (2002) 
stated that for two anticholinesterase pesticides of equal oral toxicity and spray rate the one 
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having the higher DTI was more likely to cause bird mortality and concluded that the models 
demonstrate the need to incorporate dermal, and in some instances inhalation toxicity, into avian 
ecological risk assessment. 
The field exposure of a small songbird to the spray of an OP insecticide was simulated 
under controlled conditions by Mineau et al. (1990) using zebra finches, fenitrothion and an 
experimental spray chamber. A spray exposure to fenitrothion at 255 g/ha was equated to an oral 
dose of 13.3 mg/kg based upon matching acetylcholinesterase inhibition in the brains of spray- 
and oral-exposed zebra finches.  However, exposures at lower spray rates did not produce the 
significant inhibition of brain acetylcholinesterase that had been anticipated (Mineau et al. 1990).  
They noted that their laboratory observations at these lower spray rates were in contrast to 
observations from the field and suggested that multiple routes of exposure may contribute to 
toxicity at low field application rates. 
Driver et al. (1991) attempted to quantify the relative contribution of different routes of 
exposure to pesticide toxicity in a bird species under simulated field conditions. Northern 
bobwhite were exposed to sprays of the OP methyl parathion in an enclosed wind tunnel 
apparatus containing a cotton crop. Four routes of exposure were isolated in the exposures; 
inhalation, direct consumption of contaminated feed, indirect consumption from preening, and 
dermal. Inhalation was isolated by enclosing bobwhite in Gortex
®
 body bags while exposing 
only the beak. Consumption of contaminated feed was isolated by comparing effects in bobwhite 
fed dead contaminated mealworms and bobwhite fed dead clean mealworms. Preening was 
isolated by comparing effects in bobwhite left free to preen with bobwhite wearing neck collars 
that prevented preening. The dermal contribution was established by measuring effects in free-
ranging bobwhite and subtracting the effects found in the other isolated routes of exposure. 
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Methyl parathion was applied to the simulated field at 1.2 kg/ha. Contaminated feed was 
produced in similar spray applications and then transferred to a clean simulated feed to isolate 
consumption of contaminated feed. Cholinesterase inhibition was measured in all groups at 1, 4, 
8, 24, and 48 hours following application of the OP spray. The contributions to ChE inhibition 
by the different routes of exposure varied with post spray period. At 1 hour post-spray, the 
ranking of exposure routes by relative contribution to toxicity was inhalation>preening>dermal 
and no effects were observed from ingestion of contaminated feed. At 4 hours post-spray, the 
ranking was preening>ingestion>dermal>inhalation. Thereafter, at each of 8, 24, and 48 hours 
post-spray, the ranking was of the contribution from different exposure routes was 
dermal>ingestion>preening>inhalation. Ingestion of contaminated feed contributed no more than 
20% to total toxicity in the bobwhite in any of the post-spray periods examined. Driver et al. 
(1991) noted the contrast between their findings and the assumption of avian ecological risk 
assessment that consumption of contaminated feed is the only route for exposure to pesticides. 
The body of knowledge on dermal exposures of birds to pesticides and other compounds 
appears modest in comparison to that developed in studies of dermal exposures with mammals. 
The dermal route of exposure is particularly important in human health risk assessment of 
occupational exposures to pesticides and in the design of pharmaceuticals (Fitzpatrick et al. 
2004). Generally, compounds with balanced lipid-water solubility are more readily absorbed 
through skin than compounds that are either extremely hydrophilic or extremely lipophilic (Lane 
et al. 2012). This phenomenon is observed because skin consists of a series of hydrophobic and 
hydrophilic barriers, the stratum corneum (SC) and viable epidermis (VE), respectively, between 
the external environment and the circulatory system (Lane et al. 2012). Extremely hydrophilic 
compounds do not readily partition into the SC while extremely lipophilic compounds enter the 
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SC with relative ease but then do not readily partition into the VE (Lane et al. 2012). In the latter 
case, a lipophilic compound will accumulate in the SC (Lane et al. 2012). This reservoir effect 
for lipophilic compounds in the SC is well known (Miselnicky et al. 1988), having been 
demonstrated with steroids as early as 1963 (Vickers 1963). Further, as the lipophilicity of a 
compound increases, so do the reservoir effect (Miselnicky et al. 1988) and retention time in the 
SC (Yagi et al. 1998).  Given the mechanisms involved in dermal absorption, it is effectively 
impossible for a bolus-type dose to be absorbed through skin (Guy 1996). Instead, a dermal dose 
results in an absorption profile that is relatively steady and prolonged in comparison to the 
peaked profile of short duration associated with equivalent oral bolus-type doses (Subedi et al. 
2010). This relationship is apparent in the observations of Kramer et al. (2002b) who compared 
cholinesterase activity in rats following either oral or dermal doses of the OP methyl parathion 
(MP). They found that the toxicodynamics of MP differed greatly between the two routes of 
exposure. Oral doses of MP (2.5 mg/kg) in rats produced maximum inhibition of ChE activity 
typically within an hour and activity recovered to normal levels typically within 30 to 48 hours. 
In comparison, dermal doses (6.25, 12, 25, and 50 mg/kg in ethanol) applied to skin (2 to 2.5 
cm
2
) on the necks of rats from which hair had been carefully clipped resulted in dose-dependent 
inhibition of ChE activity of a magnitude comparable to the oral dose. However, peak inhibition 
developed after a delay of 12 to 26 hours and complete recovery of ChE activity was delayed 
beyond 122 hours. They inferred that a reservoir exists within rat skin and gradual release of MP 
from skin into circulation as being responsible for the delayed and prolonged inhibition of ChE 
activity in rats following their dermal exposures. These effects of dermally absorbed MP in rats 
(Kramer et al. 2002) are consistent with the previously described observations of dermally 
absorbed lipophilic OPs in pigeons (Henderson et al. 1994). 
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This work tests the assumption that consumption of contaminated feed is the only route 
of exposure of wild birds to insecticidal sprays in a set of replicated, controlled spray exposure 
experiments conducted on a simulated field of barley using commercial formulations of four 
different OP compounds of varying physicochemical properties. Further, this work seeks to 
identify what routes of exposure, if not consumption of contaminated feed, actually do contribute 
to the toxicity of OP sprays under field conditions. 
 
3.2 MATERIALS AND METHODS 
3.2.1 Experiment 
3.2.1.1 Experimental Species 
Coturnix quail (Coturnix coturnix) were purchased from Fircrest Farms Ltd. (Langley, 
BC, Canada). All quail used in the study were males between 6 and 26 weeks of age. Each quail 
was assigned a number and tagged for identification purposes using a commercial poultry tagger 
shortly after their arrival. 
 
3.2.1.2 Animal Care and Housing 
The study was conducted in accordance with Protocol #20070071 approved by the 
Research Ethics Board of the University Committee on Animal Care and Supply at the 
University of Saskatchewan. All quail were housed indoors at the Animal Care Unit in the 
Western College of Veterinary Medicine, University of Saskatchewan. Quail were provided a 
commercial, medicated (amprolium 125 mg/kg), crumbled turkey starter feed (Federated Co-
operatives Limited, Saskatoon, SK, Canada) and water ad libidum. A 8 hours light:16 hours dark 
cycle was maintained throughout the study. 
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3.2.1.3 Experimental Designs 
A factorial experimental design was used to investigate the exposure to and toxicity of 
different OP insecticidal sprays to quail under varying simulated field exposure scenarios (Figure 
3.1). The design was grouped by four factors; OP insecticide (4 levels), exposure scenario (5 
levels), time (2 levels), and replicate (3 levels). The sample size was five quail per group and the 
study required six hundred birds. Quail were randomly assigned to different treatment groups. 
The dependent variables measured were cholinesterase activity in brain and plasma. 
Cholinesterase activity in brain was measured once in each bird at the end of the protocol. 
Cholinesterase activity in plasma was measured twice for each bird, once before exposure and 
once at the end of the protocol. 
 
 
   Time     
   72 hours post-exposure   
        
OP 24 hours post-exposure    
DCP n=5 n=5 n=5 n=5 n=5   
ETP n=5 n=5 n=5 n=5 n=5   
MMP n=5 n=5 n=5 n=5 n=5   
NLD n=5 n=5 n=5 n=5 n=5   
 NC PC FO FD FS   
   Treatment     
 
Figure 3.1. Experimental factorial design for a single replicate of the simulated field 
investigation illustrating grouping of quail by different levels of the factors Time (24 and 72 
hours post-exposure), Treatment (negative control (NC), positive control (oral gavage) (PC), 
field only (FO), field plus diet (FD), and field plus spray (FS)), and Organophosphate (OP) 
insecticide (dicrotophos (DCP), ethoprop (ETP), methamidophos (MMP), and naled (NLD)). 
The fourth factor, Replicate, for which there are three levels, is not illustrated. 
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3.2.1.4 Organophosphate Insecticides 
Organophosphate (OP) insecticides were selected representing a range of solubility 
properties from hydrophilic to lipophilic. Commercial spray formulations of dicrotophos (DCP; 
2-dimethyl cis-2-dimethylcarbamoyl-1-methylvinylphosphate)(BIDRIN
®
, 82.0% DCP by 
weight, Amvac Chemical Corporation), ethoprop (ETP; O-ethyl S,S-dipropyl 
phosphorodithioate)(MOCAP
®
, 69.6% ETP by weight, Bayer CropScience), methamidophos 
(MMP; O,S-dimethylphosphora-midothiolate)(MONITOR
®
, 480 g MMP/L, Bayer 
CropScience), and naled (NLD; 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate)(DIBROM
®
, 
864 g NLD/L, United Agri Products Canada Inc.) were used in the experiment. All formulations 
were either suspension or emulsifiable concentrates. Solubility and other physicochemical 
properties varied among the OP insecticides used (Table 3.1). 
Table 3.1. Estimated physicochemical and toxicological properties of dicrotophos (DCP), 
ethoprop (ETP), methamidophos (MMP), and naled (NLD). 
Compound DCP ETP MMP NLD 
log Kow
1
 –0.49 3.59 –0.80 1.38 
MW
2
 237.2 242.3 141.1 380.8 
LD50
3
 (mg/kg) 5.7 7.5 15 50 
1




estimated median lethal oral dose in Japanese quail, except for NLD where the estimated 
median lethal dose is in Northern bobwhite 
 
 
3.2.1.5 Simulated Field Set Up and Spray Application 
A 1.8 meter by 5.4 meter ‘table-top’ simulated field of barley was constructed for use in 
spray exposures (Appendix A). Rows of holes were cut into the ‘table-top’ to receive barley 
seedlings and simulate crop rows. Barley seedlings were grown to about 3 weeks age and 20 to 
25 centimeters height in forestry seedling cones (Ray Leach “Cone-tainer”TM Single Cell 
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System, Tangent, OR, US) under greenhouse conditions, then transferred to the spray room as 
needed. Locally available organic soil was spread over the simulated field around the barley 
seedlings to a depth of 3 to 4 cm. A set of cage panels was constructed to divide the field into 
three pens, each 1.8 meters by 1.8 meters, following application of pesticide spray for concurrent 
exposures in three scenarios; 1) field only (FO), 2) field plus dietary (FD), and 3) field plus spray 
(FS), each described in later subsections. 
The simulated field spray exposures were completed in the experimental spray room at 
Agriculture and Agri-Food Canada (AAFC) on the University of Saskatchewan campus. All 
surfaces around the simulated field in the spray room were covered with plastic drop sheets prior 
to the spray application. Spray was applied to field using five flat fan nozzles (XR Teejet 
8006VS) on a spray boom attached to a ceiling-mounted track to simulated vehicular spray 
application. The spray mix was applied to the simulated field at the rate of 100 litres per hectare. 
Generally, the cage was erected and quail placed in pens within 30 minutes following spray 
application. 
Application rates for use in the spray exposures were 2550 g DCP/ha, 1310 g ETP/ha, 
7800 g MMP/ha, and 33000 g NLD/ha. Application rates were estimated to produce 
approximately 60% inhibition of plasma cholinesterase at 24 hours post-exposure based upon 
dose-response relationships established in pilot studies. 
Three replicate sprays were completed with each pesticide. The field was disassembled 
and all contaminated soil, vegetation, and plastic sheets removed from the spray room following 
each exposure. The disassembled field, cage panels, and spray room were washed thoroughly 





Quail in all exposure groups, including both field exposure groups and control groups, 
were deprived of feed for a period of 24 hours prior to exposure. 
 
3.2.1.7 Field Only (FO) Exposure 
Quail were placed within a single pen for 6 hours in the FO exposure. Exposure was to 
sprayed soil and barley. Exposures in all replicates occurred within the time window of 0930 
hours and 1630 hours, with only slight variation among replicates. Ten quail were exposed in 
each replicate spray. Following exposure, quail were returned to housing where they were held in 
isolation pending tissue sampling and sacrifice. 
 
3.2.1.8 Field plus Dietary (FD) Exposure 
The commercial feed used in housing was added to a pen at the rate of 30 g/sq. m prior to 
the spray being applied in the FD exposures. Exposure was to sprayed soil, barley, and feed. 
These exposures were otherwise consistent with FO exposures. 
 
3.2.1.9 Field plus Spray (FS) Exposure 
Quail in the FS exposure were contained on the simulated field in open mesh cages 
during application of the spray and then introduced onto the field within a pen. No feed was 
added to the pen. Exposure was to direct spray, then sprayed soil and barley. These exposures 





3.2.1.10 Gut Content (GC) Spray Exposure 
A separate set of spray exposures were conducted on the simulated field to investigate 
feed consumption associated with each of the insecticides. A reduced scale simulated field was 
erected to provide a single pen. The pen was then subdivided into two 1.8 x 0.9 m subpens. Each 
subpen was used in either a FO or FD exposure (each n=5) that was otherwise consistent with 
experimental protocols. Quail were euthanized promptly following the 6 hour exposure and the 
contents of crops, gizzards, and small intestine collected for determination of the wet mass of gut 
contents in each quail. These exposures were not replicated save for a pilot GC spray exposure 
using ETP at 2100 g/ha. 
 
3.2.1.11 Control Groups 
Both negative control (NC) and positive control (PC) groups were included in each 
replicate. Negative control quail remained in housing as a pilot study using a water spray failed 
to find an effect of the simulated field exposure on cholinesterase activity in either of brain or 
plasma. Positive control quail were exposed by oral gavage at the Toxicology Centre on the day 
of spray exposure between 1300 and 1400 hours, then returned to housing and held in isolation. 
Dose rates for DCP (1.9 mg/kg), ETP (2.5 mg/kg), and MMP (5.0 mg/kg) were at one-third the 
estimated LD50 for each compound (Environment Canada, unpublished data) provided by a 
coauthor (Mineau). The dose rate for NLD (12 mg/kg) was reduced from the initial estimate (17 






3.2.2 Exposure and Toxicity 
3.2.2.1 Tissue Collection and Storage 
Blood samples were obtained from each quail prior to initiating the experiment and upon 
termination of the experiment. Approximately 400 µL of blood was collected by jugular 
veinipuncture using a heparinized 1 mL syringe with 27 gauge needle at each time. Blood 
samples were centrifuged immediately at 2400xG for 10 minutes at 4°C to separate plasma from 
red blood cells. Plasma was collected and stored at -80°C until prepared for assay. Quail were 
euthanized by cervical dislocation following collection of the terminal blood sample. Brain was 
dissected from each carcass and stored at -80°C until prepared for assay. 
 
3.2.2.2 Sample Preparation 
Plasma samples were diluted (dilution factor (DF)=12) in 0.5 M phosphate buffer (pH 8) 
prior to assay. Brain samples were first homogenized in 0.5 M phosphate buffer containing 0.5% 
Triton X-100 (v/v), while in an ice bath, using a Sonic Dismembrator Model 100 tissue 
homogenizer (Fisher Scientific) for 40 seconds, then further diluted (total DF=168) in the same 
buffer prior to assay. 
 
3.2.2.3 Cholinesterase Assay 
Determination of total ChE activity in tissues was accomplished using the assay of 
Ellman et al. (1961) as modified for a microplate reader by Gard and Hooper (1993). Briefly, 
enzyme activity was measured colorimetrically at 412 nm using acetylthiocholine iodide 
(AThCh)(>99%, Sigma-Aldrich, UK) as a substrate. Buffer (0.5 M phosphate, pH=8), a solution 





 M), sample preparation, and substrate in buffer (0.5 M phosphate, pH 8) 
(FC=1x10
-3
 M) were added to 96 well microtiter plates (Nalge Nunc International, Rochester, 
NY, USA)(total volume=260 µL). Buffer was maintained at 25°C while reagent solutions and 
samples were maintained in ice baths. Substrate was added last, immediately prior to assay, to 
initiate the reaction. ChE assay results were read on a SpectraMax
®
 190 microplate reader 
(Molecular Devices Corporation, Sunnyvale, CA, USA) set in absorbance mode and at 25°C. 
The contribution of BChE to total ChE activity in quail plasma was determined in a subset of the 
experimental birds using the selective BChE inhibitor tetraisopropyl pyrophosphoramide (iso-
OMPA)(Sigma-Aldrich, USA). Samples were incubated with iso-OMPA (incubation 
concentration 1x10
-4
 M) in buffer (0.5 M phosphate, pH=8) for 5 minutes at 25°C prior to 
addition of reagent and substrate. Activity remaining in samples pre-incubated with iso-OMPA 
was attributed to AChE. Activities in plasma and brain were collected over 2 and 6 minute run 
times, respectively, with readings every 12 seconds. An analytical AChE standard was prepared 
from the membranes of equine red blood cells in general accordance with the method developed 
for human red blood cells by Dodge et al. (1963) as modified by Hansen and Wilson (1999). 
This standard was run with all plasma samples assayed. A second analytical standard was 
prepared from the pooled brains of several unexposed quail consistent with the brain sample 
preparation methods described above. Both analytical standards were run with all brain samples 
assayed. All measures were made in triplicate. Activity in a sample was the mean of at least 2 of 
the 3 measures obtained. One of the triplicate measures of sample activity was rejected in cases 





3.2.2.4 Reconstruction of Exposure and Toxicity 
Recovery from inhibition of ChE activity in plasma and brain at 24 to 72 hours post-
exposure was examined for each OP. Comparisons were made between the PC groups, all 




Data in all analyses were tested for normality and homogeneity of variance. Observations 
were examined using analysis of variance (ANOVA) to test for main and interaction effects. Post 
hoc means tests were completed to differentiate between treatment levels using Tukey’s HSD 
method. Select comparisons between groups were made using independent samples t tests. 
Significance was associated with p≤0.05. Findings approaching significance (0.10≥p>0.05) are 
also reported. All analyses were run on PASW Statistics 18 (IBM, Chicago, IL, USA). 
 
3.3 RESULTS 
3.3.1 Pilot Studies 
Spray rate-dependent inhibition of quail plasma ChE activity at 24 hours post-exposure 
was evident in pilot study sprays with all compounds. One way ANOVA revealed significant 
effects of application rate for each of DCP (F2=4.992, p=0.029), ETP (F2=6.524, p=0.018), MMP 
(F2=9.966, p=0.003) and NLD (F2=23.766, p<0.001). 
Ordinary least squares (OLS) linear regression revealed significant relationships between 
pesticide concentrations in sprays and inhibition of plasma ChE activity at 24 hours post-
exposure (Figure 3.2A to 3.2D)(DCP, F1=10.883, p=0.006; ETP, F1=14.493, p=0.003; MMP, 
52 
 
F1=21.484, p<0.001; NLD, F1=50.542, p<0.001). The observed relationships between compound 
application rates and inhibition of quail plasma ChE activity were used to estimate the spray 
rates required for 60% inhibition of plasma ChE activity. These rates were 2550, 1310, 7800, and 
33000 g compound/ha for DCP, ETP, MMP, and NLD, respectively. 
 
3.3.2 Acetylcholinesterase Activity in Plasma 
 The contribution of AChE to total plasma ChE activity was investigated in plasma from 
48 quail later submitted to simulated field exposures with DCP. No AChE activity was detected 
in half of the quail plasma samples analyzed. Low levels of AChE activity were reported by the 
microplate reader in the other half of the samples (maximum plasma AChE activity=0.12 mol 
substrate hydrolyzed/min./mL). However, inspection of the plots generated by the microplate 
reader software revealed non-linear relations. Further, a microplate in which activity had been 
reported was left to stand for 24 hours at room temperature following assay. No visible yellow 
colour developed in wells containing samples while wells containing standards developed a deep 
yellow hue. No AChE activity was apparent in quail plasma. 
 
3.3.3 Pre-exposure plasma 
Significant effects appeared in the analysis of pre-exposure plasma data. These effects 
were not apparent during assays due to the natural high variability in plasma ChE activity 
because these effects were small relative to the effects in post-exposure plasma samples analyzed 
during the same period. However, these effects became apparent once statistical analyses of pre-
exposure plasma data were completed. They were then investigated. 
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Figure 3.2. Linear variation in plasma cholinesterase (ChE) activity in quail with different 
concentrations of the active ingredient used in four pilot study sprays each performed with a 
commercial formulation of a different organophosphate (OP) pesticide where the active 
ingredient and its commercial formulation are: A) dicrotophos (DCP) in BIDRIN
®
 8; B) 
ethoprop (ETP) in MOCAP
®
; C) methamidophos (MMP) in MONITOR
®
; and D) naled (NLD) 
in DIBROM
®
. Dashed lines denote 95% confidence intervals for the linear relations illustrated. 




Effects in pre-exposure plasma ChE activity data were characterized using ANOVA. 
Firstly, a 4 factor mixed-model ANOVA (OP by Treatment by Time by Replicate) was 
conducted using the entire pre-exposure plasma ChE activity data set (N=593). This ANOVA 
revealed significant effects of OP and OP*Replicate (Table 3.2). Data in the ANOVA were 
pooled first under Treatment and then under Time with similar findings. Effects found in the 
final 2 factor mixed-model ANOVA were those of OP and OP*Replicate (Table 3.2). These 
results were examined graphically (Figure 3.3A). The relationship between the factors OP and 
Replicate appeared random, explaining the absence of any significant main effect of Replicate. 
These same data were then pooled under Replicate and examined with a 3 factor fixed-model 
ANOVA (OP by Treatment by Time). The only significant effect observed was that of OP 
(F3=54.54, p<0.001). No other main or interaction effects approached the significant level. 
 
 
Table 3.2. Results (F statistic, p value) of the analysis of variance (ANOVA) of pre-exposure 
plasma cholinesterase activity data for the entire data set (all treatments) and for simulated field 
data alone. Factors are Organophosphate (OP) insecticide, Treatment (Tr), Time (Ti), and 
Replicate (Rep). Results that did not approach the significant level (p>0.10) are either omitted or 
not reported (-). 
Results (F statistic, p value) from Analysis of Pre-exposure Plasma Data 












OP 6.61, 0.025 4 Factor 
Mixed 
OP 6.47, 0.026 
Tr - Tr - 
Ti - Ti - 
Rep - Rep - 
OP*Rep 9.54, 0.008 OP*Rep 8.19, 0.055 
2 Factor 
Mixed 
OP 6.59, 0.025 2 Factor 
Fixed 
OP 36.07, <0.001 
Rep - Tr - 




The lab in which buffers and reagents were prepared and maintained and the lab which 
contained the microplate reader were both located in older wings of the Toxicology Centre 
known for their aged climate control systems. A thermocouple thermometer (Sper Scientific Inc. 
Model 800005, Scottsdale, AZ, USA) was used to obtain measures of temperature within the 
work space and check the calibration of the microplate reader’s incubator during the period in 
which brain ChE assays were performed. Temperature in the lab where ChE assay buffers and 
reagent solutions were prepared and maintained varied between 2°C and 28°C through the period 
of monitoring. The actual microplate reader incubator temperature was consistently more than 
3°C lower than the temperature reported by the instrument itself (i.e. actual assay temperature 
<22°C while the microplate reader reported 25°C in the incubator). 
OLS regression was used to determine the extent to which ambient temperature 
influenced pre-exposure plasma ChE data. Ambient temperatures recorded at the local airport by 
Environment Canada for the date and time at which pre-exposure plasma ChE assays were 
completed (www.climate.weatheroffice.gc.ca/climateData) significantly explained some of the 
variation in pre-exposure plasma ChE activity (F1=27.269, p<0.001, r
2
=0.124) for assays 
completed during times when ambient temperatures exceeded 22°C but not for assays completed 
during times when ambient temperatures were lower than 22°C. However, the residuals in the 
significant regression were not normally distributed. 
An OLS regression using ChE activity in the analytical standard to predict ChE activity 
in the unknowns for ambient temperatures exceeding 22°C was also significant (F1=6.897, 
p=0.006) but it did not explain as much of the variation in ChE activity in quail plasma 
unknowns (r
2
=0.035) as did ambient temperature. 
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Pre-exposure plasma ChE activity data from the simulated field (FO, FD, and FS collectively) 
and control samples (NC and PC individually) were subject to ANOVA to assess if effects in 
pre-exposure data differed among these groups. A 4 factor mixed-model ANOVA of data from 
the simulated field (OP by Treatment (FO, FD, and FS only) by Time by Replicate) revealed 
only a significant effect of OP and an effect of the OP*Replicate interaction that approached the 
significant level (Table 3.2). These simulated field data were then pooled first under Replicate 
and then under Time with similar results. The only significant effect in the final 2 factor fixed-
model ANOVA (OP by Treatment (FO, FD, and FS only)) was that of OP (Table 3.2). These 
ANOVA results were examined graphically (Figure 3.3B) for comparison with the 2 factor 
mixed-model ANOVA (OP by Replicate) with the entire data set (Figure 3.3A). Temperature-
related effects appeared relatively absent from analysis of data obtained on the simulated field 
within each of the OPs although comparisons between OPs remained compromised. A 3 factor 
mixed-model ANOVA of NC data (OP by Time by Replicate) lacked significant effects although 
the effects of OP and the OP*Replicate interaction were those closest to the significant level 
(Table 3.3). These NC data were pooled first under Replicate and then under Time with similar 
results. The effects observed of OP in the final one-way ANOVA were significant (Table 3.3). 
Similarly, a 3 factor mixed-model ANOVA of PC data (OP by Time by Replicate) lacked 
significant effects with only the effect of OP and the OP*Replicate interaction approaching the 
significant level (Table 3.3). Pooling of data resulted in a final one-way ANOVA revealing a 
significant effect of OP (Table 3.3). Further, the effects evident in pre-exposure NC and PC data 
appeared to be related as OLS regression revealed a significant and well-correlated relationship 




























































































































Figure 3.3. Variation in pre-exposure plasma cholinesterase (ChE) activity in quail within 
different combinations of experimental factors where these factor combinations are: A) 
Organophosphate (OP) insecticide  and Replicate; and B) OP and Treatment (only the three 
levels on the simulated field; field only (FO), field plus diet (FD), and field plus spray (FS)). The 
dashed lines denote the grand mean pre-exposure plasma ChE activity (0.734 mol substrate 
hydrolyzed/min./mL). Error bars denote (+/-) standard error. Statistically significant effects 
include those of OP (p=0.025) and the OP by Replicate interaction (p<0.001) in A) and only that 
of OP (p<0.001) in B). 
58 
 
Table 3.3. Results (F statistics, p value) of the analysis of variance (ANOVA) of pre-exposure 
plasma cholinesterase activity data for control groups (negative, positive). Factors are 
Organophosphate (OP) insecticide, Time (Ti), and Replicate (Rep). Results that did not approach 





Results (F statistic, p value) from Analysis of Pre-exposure 




OP 3.46, 0.093 3.29, 0.100 
Ti - - 
Rep - - 
OP*Rep 3.01, 0.103 4.12, 0.054 
1 Factor OP 9.07, <0.001 12.19, <0.001 
 
Measures of effect size (eta-squared, η2) were used to assess the contributions of different 
sources (i.e. error, factors, and interactions) to variability within the four different factorial fixed-
model ANOVAs produced in the analysis of pre-exposure plasma ChE activity data: 1) the 3 
factor ANOVA of all data (OP by Treatment by Time); 2) the 3 factor ANOVA of data from the 
simulated field (OP by Treatment (FO, FD, and FS only) by Time); the 2 factor ANOVA of NC 
data (OP by Time); and 4) the 2 factor ANOVA of PC data (OP by Time). Regardless of the 
ANOVA considered, error accounted for approximately three-quarters of the variability in the 
models (0.732 ≤ η2 ≤ 0.775), OP accounted for approximately one-fifth of the variability in the 
models (0.193 ≤ η2 ≤ 0.241), and the remaining factors and interactions collectively accounted 
for less than 4% of variability in the models (∑η2<0.04) (Table 3.4). Further, the NC and PC 
treatments comprised approximately 40% of the data but accounted for approximately 47% of 
both variability and error in the models. 
The minimum and maximum mean (95% CI) pre-exposure plasma ChE activities within 
the various combinations of OP, Treatment, and Time were 0.611 (0.537-0.685)( MMP, FS, 24 
hr.; n=15) and 0.901 (0.813-0.989)(ETP, NC, 24 hr.; n=14) µmol substrate hydrolyzed/min./mL, 
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respectively. Pooling of all data resulted in a pre-exposure grand mean (SE) plasma ChE activity 
of 0.734 (0.007, N=593) µmol substrate hydrolyzed/min./mL. 
 
3.3.4 Post-exposure Plasma 
A 4 factor mixed-model ANOVA (OP by Treatment by Time by Replicate) was 
performed with all post-exposure plasma ChE activity data (N=595). The analysis revealed 
significant main effects of Treatment and Time and significant interaction effects OP*Treatment, 
Treatment*Time, and OP*Treatment*Time*Replicate while the main effect of OP approached 
the significant level (Table 3.5). Measures of effect size, partial eta-squared (ηp
2
), were used to 
compare the significant main and interaction effects. The effect of the final interaction term 
involving Replicate was very small relative to effects of the other sources as it explained less 
than 9% of within-source variability (ηp
2
=0.089) while other sources explained approximately 
64% to >99% of within-source variability (0.641≤ ηp
2≤0.999). The significant effect of the final 
interaction term was deemed too small to be either of interest or concern and data were pooled 
under Replicate. The resulting 3 factor fixed-model ANOVA of all post-exposure data (N=595) 
revealed significant effects of all sources (Table 3.5). Relative to the analogous ANOVA with 
pre-exposure data, the introduction of effects from the actual exposures increased variability in 
the ANOVA by greater than two-fold (pre-exposure total sum of squares (SS)=16.756, post-
exposure total SS=37.495) while error was reduced marginally (pre-exposure error SS=12.474, 
post-exposure error SS=10.978). Here error explained less than 30% of variability in the post-
exposure ANOVA (η2=0.293). This ANOVA was compared to the analogous pre-exposure 
plasma ChE activity ANOVA using ηp
2




Table 3.4. Variability (sum of squares (SS)) and measures of effect size (eta-squared (η2) and 
partial eta-squared (ηp
2
)) in fixed-model ANOVA of pre-exposure and post-exposure plasma 
cholinesterase activity data. Information is provided for the entire data set (All) and for portions 
of the data set including data from treatments on the simulated field collectively (Field) and for 





Source SS η2 ηp
2
 Source SS η2 ηp
2
 
All ANOVA Total 16.756   Total 37.495   
OP 3.697 0.221 0.229 OP 2.573 0.069 0.190 
Treatment 0.083 0.005 0.007 Treatment 12.731 0.340 0.537 
Time 0.018 0.001 0.001 Time 6.828 0.182 0.383 
OP*Tr. 0.196 0.012 0.015 OP*Tr. 1.831 0.049 0.143 
OP*Ti. 0.017 0.001 0.001 OP*Ti. 0.279 0.007 0.025 
Tr.*Ti. 0.034 0.002 0.003 Tr.*Ti. 1.735 0.046 0.136 
OP*Tr.*Ti. 0.238 0.014 0.019 OP*Tr.*Ti. 0.540 0.014 0.047 
Error 12.474 0.744  Error 10.978 0.293  
Field ANOVA Total 8.984   Total 16.037   
OP 2.121 0.236 0.244 OP 3.487 0.217 0.398 
Treatment 0.047 0.005 0.007 Treatment 0.659 0.041 0.111 
Time 0.003 <0.001 <0.001 Time 6.604 0.378 0.535 
OP*Tr. 0.094 0.010 0.014 OP*Tr. 0.185 0.012 0.034 
OP*Ti. 0.019 0.002 0.003 OP*Ti. 0.254 0.016 0.046 
Tr.*Ti. 0.004 0.000 0.001 Tr.*Ti. 0.010 0.001 0.002 
OP*Tr.*Ti. 0.120 0.013 0.018 OP*Tr.*Ti. 0.104 0.006 0.019 
Error 6.577 0.732  Error 5.275 0.329  
NC ANOVA Total 3.919   Total 4.170   
OP 0.755 0.193 0.199 OP 0.217 0.052 0.054 
Time 0.045 0.011 0.015 Time <0.001 <0.001 <0.001 
OP*Ti. 0.080 0.020 0.026 OP*Ti. 0.156 0.037 0.039 
Error 3.038 0.775  Error 3.796 0.910  
PC ANOVA Total 3.815   Total 4.876   
OP 0.920 0.241 0.244 OP 0.942 0.193 0.462 
Time <0.001 <0.001 <0.001 Time 2.383 0.489 0.685 
OP*Ti. 0.037 0.010 0.013 OP*Ti. 0.453 0.093 0.292 
Error 2.858 0.749  Error 1.097 0.225  
 
increased variability, the effect size associated with OP decreased slightly from the pre-exposure 
ANOVA (ηp
2
=0.229) to post-exposure ANOVA (ηp
2
=0.190). Instead the effects of the actual 
exposures were manifest largely in other main effects and the interactions. Effect sizes in 
Treatment, Time, OP*Treatment, OP*Time, Treatment*Time, and OP*Treatment*Time as 
measured using ηp
2
 increased by approximately 77-fold, 383-fold, 10-fold, 25-fold, 45-fold, and 
more than 2-fold, respectively, from pre-exposure to post-exposure (Table 3.4). 
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Table 3.5. Results (F statistic, p value) of the analysis of variance (ANOVA) of post-exposure 
plasma cholinesterase activity data for the entire data set (all treatments) and for simulated field 
data alone. Factors are Organophosphate insecticide (OP), Treatment (Tr), Time (Ti), and 
Replicate (Rep). Results that did not approach the significant level (p>0.10) are either omitted or 
not reported (-). 
Results (F statistic, p value) from Analysis of Post-exposure Plasma Data 












OP 4.73, 0.051 4 Factor 
Mixed 
OP 4.92, 0.047 
Tr 64.62, <0.001 Tr 40.30, 0.002 
Ti 1715, <0.001 Ti 802.77, 0.001 
Rep - Rep - 
OP*Tr 3.57, 0.004 OP*Tr 3.95, 0.021 
OP*Rep - OP*Rep 3.42, 0.076 
Tr*Ti 24.15, <0.001 Tr*Ti - 
OP*Tr*Ti - OP*Tr*Ti 2.87, 0.057 
OP*Ti*Rep - OP*Ti*Rep 10.82, <0.001 
OP*Tr*Ti*Rep 1.95, 0.005 OP*Tr*Ti*Rep - 
3 Factor 
Fixed 
OP 43.36, <0.001 3 Factor 
Fixed 
OP 73.37, <0.001 
Tr 160.92, <0.001 Tr 20.80, <0.001 
Ti 345.22, <0.001 Ti 382.84, <0.001 
OP*Tr 7.72, <0.001 OP*Tr 1.94, 0.074 
OP*Ti 4.70, 0.003 OP*Ti - 
Tr*Ti 21.93, <0.001 Tr*Ti - 
OP*Tr*Ti 2.28, 0.008 OP*Tr*Ti - 
 
Post-exposure plasma ChE activity data from the simulated field (FO, FD, and FS 
collectively) and controls (NC and PC individually) were each subject to ANOVA. A 4 factor 
mixed-model ANOVA of post-exposure data from the simulated field (OP by Treatment (FO, 
FD, and FS only) by Time by Replicate) revealed significant main and interaction effects of OP, 
Treatment, Time, OP*Treatment, and OP*Time*Replicate and interaction effects of 
OP*Replicate and OP*Treatment*Time that approached the significant level Table 3.5). 
Interaction effects involving Replicate were ignored here specifically so that data could be 
pooled under Replicate and a 3 factor fixed-model ANOVA of simulated field data could be 
performed and compared with the analogous ANOVA performed with pre-exposure data from 
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the simulated field. This ANOVA of post-exposure plasma data from the simulated field 
revealed significant effects of OP, Treatment, Time, and OP*Time and an OP*Treatment 
interaction effect that approached the significant level (Table 3.5). Variability, error, and effect 
sizes (both η2 and ηp
2
) in this ANOVA were compared with those of the analogous pre-exposure 
simulated field data ANOVA. Variability almost doubled (pre-exposure total SS=8.984, post-
exposure total SS=16.037) while error diminished slightly (pre-exposure error SS=6.577, post-
exposure error SS=5.275). Here error explained about one-third of variability in the post-
exposure ANOVA (η2=0.329), much less than in the pre-exposure ANOVA. Time explained 
approximately 38% of variability (η2=0.378), whereas it explained almost none of the variability 
in the pre-exposure ANOVA. OP explained approximately 22% of the variability (η2=0.217), 
similar to that of the pre-exposure ANOVA. Comparisons of ηp
2
 between the two analogous 
ANOVAs revealed an increase in variability associated with OP and other sources (Table 3.4). 
Effect sizes in OP, Treatment, Time, OP*Treatment, OP*Time, and Treatment*Time as 
measured using ηp
2
 increased by approximately 1.6-fold, 16-fold, 500-fold, 2.4-fold, 15-fold, and 
2-fold, respectively, from pre-exposure to post-exposure (Table 3.4). 
Post-exposure NC plasma ChE activity data were analyzed in the same manner. No 
significant effects were found in any of the post-exposure ANOVAs. Data were pooled into a 
single set having mean (SE) plasma ChE activity of 0.828 (0.017)(n=119) µmol substrate 
hydrolyzed/min./mL. Comparisons of variability and effect size (both both η2 and ηp
2
) in the 
analogous 2 factor fixed-model ANOVAs (OP by Time) using pre-exposure and post-exposure 
data revealed that the post-exposure ANOVA contained marginally more variability (pre-
exposure total SS=3.919, post-exposure total SS=4.170) but 25% more error (pre-exposure error 
SS=3.038, post-exposure error SS=3.796). As a result, error explained 91% of variability in the 
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post-exposure ANOVA (η2=0.910). The decrease in ηp
2
 associated with OP from pre-exposure 
ANOVA to post-exposure ANOVA (Table 3.4) is consistent with the lack of a significant effect 
of OP in the post-exposure analysis. 
A 3 factor mixed-model ANOVA (OP by Time by Replicate) of post-exposure PC 
plasma ChE activity data revealed significant effects of Time and the final interaction of term of 
OP*Time*Replicate as well an OP*Time interaction that approached significance (Table 3.6). 
Inspection of the marginal means revealed a very weak response of plasma ChE activity to the 
oral dose in the third ETP replicate and a similar weak response was also eventually found in 
observations in brain ChE activity in the same replicate (reported later). Data from this replicate 
were deleted and the resulting fractional three factor mixed-model ANOVA was free of 
significant effects involving the factor Replicate. The data were then pooled under Replicate with 
the resulting two factor fixed-model ANOVA showing significant effects of OP, Time, and 
OP*Time interaction (Table 3.6). Mean (SE) plasma ChE activities in quail dosed orally with 
DCP, ETP, MMP, and NLD were 0.323 (0.027, n=15), 0.051(0.035, n=9), 0.491 (0.027, n=15), 
and 0.488 (0.027, n=15) µmol substrate hydrolyzed/min./mL, respectively, at 24 hours post-
exposure and were 0.627 (0.027, n=15), 0.587 (0.033, n=10), 0.695 (0.027, n=15), and 0.671 
(0.027, n=15) µmol substrate hydrolyzed/min./mL, respectively, at 72 hours post-exposure. 
Variability and effect size in the analogous 2 factor fixed-effects ANOVAs (OP by Time) using 
pre-exposure and post-exposure PC data sets were compared. Total variability increased by more 
than a quarter (pre-exposure total SS=3.815, post-exposure total SS=4.876) while the variability 
attributed to error declined by more than half (pre-exposure error SS=2.858, post-exposure error 
SS=1.097). Here error explained approximately 23% of variability while the effects of OP, Time, 
and their interaction explained approximately 19%, 49%, and 9% of variability, respectively 
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(Table 3.4). Effect sizes in OP, Time, and OP*Time as measured using ηp
2
 increased by 
approximately 2-fold, 685-fold, and 22-fold, respectively, from pre-exposure to post-exposure 
(Table 3.4). 
 
Table 3.6. Results (F statistics, p value) of the analysis of variance (ANOVA) of post-exposure 
plasma cholinesterase activity data for control groups (negative, positive). Factors are 
Organophosphate (OP) insecticide, Time (Ti), and Replicate (Rep). Results that did not approach 





Results (F statistic, p value) from Analysis of Post-exposure 
Plasma Data in Control Groups 
Negative Control Positive Control 
3 Factor 
Mixed 
OP - - 
Ti - 168.64, 0.006 
Rep - - 
OP*Ti - 3.70, 0.081 
OP*Ti*Rep - 2.93, 0.012 
2 Factor 
Fixed 
OP - 28.90, <0.001 
Ti - 219.39, <0.001 
OP*Ti - 13.91, <0.001 
 
 
 Post-exposure plasma ChE activity data from the simulated field were analyzed further 
on an OP by OP basis. Three factor mixed-model ANOVA (Time x Treatment (FO, FD, and FS 
only) x Replicate) of DCP data revealed significant effects of Time, Treatment, and the 
Time*Replicate interaction (Table 3.7). Inspection of the data showed that the response varied 
among replicates, being consistent among first two but relatively large in the third. Elimination 
of data in the third replicate resulted in a fractional three factor mixed-model ANOVA that was 
free of significant effects involving the factor Replicate. These data were then pooled under 
Replicate with the resulting two factor fixed-model ANOVA showing significant effects of Time 
and Treatment (Table 3.7). Post hoc tests of Treatment effects using data pooled under Time 
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revealed that the FS treatment was significantly different from either the FO or FD (Tukey HSD, 
p<0.001). Mean (SE) plasma ChE activities in quail in FO, FD, and FS treatments were 0.281 
(0.027, n=10), 0.296 (0.027, n=10), and 0.179 (0.027, n=10) µmol substrate 
hydrolyzed/min./mL, respectively, at 24 hours post-exposure and were 0.532 (0.027, n=10), 
0.546 (0.027, n=10), and 0.390 (0.027, n=10) µmol substrate hydrolyzed/min./mL, respectively, 
at 72 hours post-exposure. 
Three factor mixed-model ANOVA of ETP data revealed significant effects of Time and 
Treatment and an effect in the Treatment*Replicate interaction that approached significance 
(Table 3.7). The interaction term involving Replicate was deemed too small to be either of 
interest or concern. The ANOVA revealed the variability associated with the interaction 
hypothesis (SS=0.079) was a fraction of that associated with the hypotheses of either Treatment 
(SS=2.409) or Time (SS=0.438). Data were pooled under Replicate with the resulting two factor 
fixed-model ANOVA showing significant effects in Time and Treatment (Table 3.7). Post hoc 
tests of Treatment effects using data pooled under Time revealed that the FS treatment was 
significantly different from both the FO and FD (Tukey HSD, p≤0.002). Mean (SE) plasma ChE 
activities in quail in FO, FD, and FS treatments were 0.450 (0.033, n=15), 0.406 (0.033, n=15), 
and 0.250 (0.034, n=14) µmol substrate hydrolyzed/min./mL, respectively, at 24 hours post-
exposure and were 0.754 (0.033, n=15), 0.717 (0.033, n=15), and 0.623 (0.033, n=15) µmol 
substrate hydrolyzed/min./mL, respectively, at 72 hours post-exposure. 
Three factor mixed-model ANOVA of MMP data revealed significant effects of Time, 
Treatment, and the Time*Replicate interaction (Table 3.7). Here the interaction Time*Replicate 




Table 3.7. Results (F statistic, p value) of the analysis of variance (ANOVA) of post-exposure 
plasma cholinesterase data within levels of the factor Organophosphate insecticide, those being 
dicrotophos (DCP), ethoprop (ETP), methamidophos (MMP), and naled (NLD). Factors within 
the ANOVA are Treatment (Tr), Time (Ti), and Replicate (Rep). Results that did not approach 





Results (F statistic, p value) from Analysis of 
Post-exposure Plasma Data 
DCP ETP MMP NLD 
3 Factor 
Mixed 
Tr 61.97, 0.001 11.14, 0.023 11.31, 0.022 4.54, 0.094 
Ti 20.73, 0.045 129.79, 0.008 34.40, 0.028 12.76, 0.070 
Rep - - - 14.60, 0.015 
Tr*Rep - 4.29, 0.094 - - 
Ti*Rep 9.27, 0.031 - 8.76, 0.034 - 
2 Factor 
Fixed 
Tr 16.09, <0.001 13.02, <0.001 4.07, 0.021 - 
Ti 119.72, <0.001 142.76, <0.001 119.27, <0.001 74.59, <0.001 
 
while the contribution of Time was more than an order of magnitude greater (SS=1.948). 
Inspection of marginal means and further analysis revealed that results in Replicate 1 were 
responsible for the Time*Replicate interaction. Quail in Replicate 1 had the lowest plasma ChE 
activity at 24 hours post-exposure but the highest activity at 72 hours post-exposure (i.e. the 
greatest recovery of activity from 24 to 72 hour post-exposure). This difference was sufficient to 
produce the significant interaction but not particularly troubling in interpretation. All data were 
retained and pooled under Replicate. The resulting two factor fixed-model ANOVA showing 
significant effects of Time and Treatment (Table 3.7). Post hoc tests of Treatment effects using 
data pooled under Time revealed that the FS treatment was significantly different from the FD 
(Tukey HSD, p=0.029) but not the FO (Tukey HSD, p=0.151). Mean (SE) plasma ChE activities 
in quail in FO, FD, and FS treatments were 0.444 (0.033, n=15), 0.428 (0.033, n=15), and 0.341 
(0.034, n=14) µmol substrate hydrolyzed/min./mL, respectively, at 24 hours post-exposure and 
were 0.690 (0.033, n=15), 0.755 (0.033, n=15), and 0.658 (0.033, n=15) µmol substrate 
hydrolyzed/min./mL, respectively, at 72 hours post-exposure. 
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 Three factor mixed-model ANOVA of NLD data revealed a significant effect of the 
Time*Replicate interaction and trends towards effects in Time and Treatment (Table 3.7). 
Variability associated with the interaction (SS=0.173) exceeded that of Treatment (SS=0.041) 
but was smaller than that of Time (SS=1.102). Inspection of marginal means revealed that 
although each replicate showed recovery of plasma ChE activity from 24 to 72 hours post-
exposure, these recoveries varied among replicates. This variation was sufficient to produce a 
significant interaction effect but not troubling in interpretation. Further analyses revealed that 
omission of data from Replicate 3 reduced the interaction effect to less than significant but also 
reduced the effects of Time and Treatment. Further, when these data were pooled under 
Replicate and subject to fixed-model ANOVA, the results were consistent with the analogous 
ANOVA using all data but the ANOVA with all data performed better (data set lacking 
Replicate 3, ANOVA r
2
=0.376; all data, ANOVA r
2
=0.456). The significant interaction was 
ignored and analysis proceeded using all data pooled under Replicate. Two factor fixed-model 
ANOVA of pooled data revealed only a significant effect of Time (Table 3.7). Further, no 
significant effect of Treatment was observed when data from 24 and 72 hour post-exposure 
periods were analyzed separately using one-way ANOVA. Mean (SE) plasma ChE activities in 
quail in FO, FD, and FS treatments were 0.365 (0.031, n=15), 0.358 (0.031, n=15), and 0.295 
(0.031, n=15) µmol substrate hydrolyzed/min./mL, respectively, at 24 hours post-exposure and 
were 0.593 (0.031, n=15), 0.528 (0.031, n=15), and 0.561 (0.031, n=15) µmol substrate 







 ChE activity in the brain samples was far more sensitive to temperature fluctuations than 
the activity in either of the equine RBC AChE standard or the quail plasma BChE. Numerous 
comparisons of repeat batches of brain ChE assays conducted on the same unknowns, but on 
different days and with different buffers and reagents, always revealed a strong correlation 
between the two sets of data. Ordinary least squares (OLS) regression was used to investigate the 
relationship between the batches of assays. However, as the intercept was never significant in 
these OLS regressions and as it seemed logical that the regression line pass through the origin, 
regression through the origin (RTO) was thereafter used to explore the relationship between the 
two sets of assay results. RTO using two batches of brain ChE assay that appeared to differ 
greatly revealed a significant relationship between them (F1=4307.185, p<0.001) in which 
variation in one data set explained greater than 99% of the variation about the origin of the other 
data set (r
2
=0.997)(Figure 3.4A). However, the slope of the RTO line (slope=1.373, t=65.629, 
p<0.001) varied from the value expected of repeat analyses of a single sample set (i.e. slope=1). 
These results indicate that the difference in the measured activity in an unknown between the 
two assays was proportional to the measured activity in the unknown itself in either assay. One 
of the data points with relatively high activity (Figure 3.4A, open circle, x=7.066 µmol substrate 
hydrolyzed/min./g wet mass, y=9.703 µmol substrate hydrolyzed/min./g wet mass) was then 
chosen as a surrogate analytical standard of assumed true activity equal to 8.000 µmol substrate 
hydrolyzed/min./g wet mass and ChE activity in the other unknowns of both data sets were 
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Figure 3.4. Regression through the origin between two different batches of brain cholinesterase 
(ChE) activity assays conducted at different temperature regimes but using the same brain 
sample preparations from 11 quail having varying degrees of inhibition of brain ChE activity. 
The regression using raw data (A) is significant and illustrates how the results from the two 
different batches of assays are highly correlated and proportional but not identical due to 
differences in the temperature regimes. The regression using standardized data (B) is also 
significant and illustrates how standardization of the data based upon an analytical standard 
(open circle) having an assumed ‘true’ ChE activity of 8.000 µmol substrate hydrolyzed/min./g 
wet mass brain maintains both the relationship and correlation structure while eliminating 
differences in brain ChE activity in the other samples (solid circles) between batches of assays 
due to differences in temperature regimes. 
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  Unkstd  = Stdtrue/Stdmeas  x Unkmeas    (Eq. 3.1) 
where  Unkstd  = standardized ChE activity of the unknown 
  Stdtrue  = true ChE activity of the surrogate analytical standard 
  Unkmeas = measured ChE activity of the unknown, and 
  Stdmeas  = measured ChE activity of the surrogate analytical standard. 
 
The resulting standardized data sets were again subjected to RTO (Figure 3.4B). The relationship 
between the two data sets was again significant (F1=4310.244, p<0.001) and the correlation 
structure was maintained (r
2
=0.997) while the slope of the regression line became unity 
(slope=1.000, t=65.652, p<0.001). These findings led to the development of an analytical 
standard derived from brains of quail neither exposed to OPs nor used within the experiment. 
This avian brain ChE analytical standard was run concurrently with all brain unknowns. A total 
of 123 analytical standards were run for the 593 brain samples assayed (approx. 5 
samples/standard). The distribution of observed ChE activity in the standard was multimodal 
(kurtosis=-1.586) and possessed a wide range (5.11 µmol substrate hydrolyzed/min./g wet mass). 
The mean and median ChE activities of the standard were 10.66 and 10.35 µmol substrate 
hydrolyzed/min./g wet mass, respectively. The median activity in the standard was assumed to be 
a more robust indicator of central tendency than the mean and was designated as the true activity 
of the analytical standard. The measured activity in all brain ChE unknowns was standardized to 
the median analytical standard activity using Eq. 3.1 prior to analysis. Thereafter analyses 
proceeded on a treatment by treatment basis. 
Analysis of variance of standardized NC brain ChE data revealed neither main effects nor 
any interactions. Pooled standardized NC data failed the Shapiro-Wilk’s normality test (p=0.012) 
71 
 
and inspection of the data revealed three potential outliers having values greater than 3 standard 
deviations from the mean. Omission of these potential outliers resulted in a data set that passed 
tests of normality. Mean (SD) NC brain ChE activities with and without potential outliers were 
7.80 (0.62) (n=113) and 7.83 (0.57) (n=110) µmol substrate hydrolyzed/min./g wet mass, 
respectively. 
 Three factor mixed model ANOVA (OP x Time x Replicate) of PC brain ChE data 
revealed significant effects of OP (F3=7.54, p=0.019), Time (F1=363.35, p=0.003), OP*Time 
(F3=12.24, p=0.006), and OP*Replicate (F6=39.74, p<0.001). Inspection of the marginal means 
revealed a cause for the significant OP*Replicate interaction. Results with ETP and MMP both 
contained anomalous responses in their third replicates, suggesting error in the oral doses given 
to PC quail. Exclusion of data from the third replicates of both ETP and MMP produced 
ANOVA results showing significant effects of OP (F3=153.03, p<0.001) and Time (F1=683.92, 
p=0.005) and a trend towards an OP*Time interaction (F3=5.75, p=0.062) while eliminating the 
OP*Replicate interaction. Two factor fixed model ANOVA of these remaining data pooled 
under Replicate revealed significant effects of OP (F3=69.15, p<0.001) and Time (F1=50.57, 
p<0.001). Mean (SE) PC brain ChE activities for DCP, ETP, MMP, and NLD were 3.68 (0.19, 
n=15), 3.03 (0.24, n=10), 6.50 (0.24, n=10), and 4.35 (0.19, n=15) µmol substrate 
hydrolyzed/min./g wet mass, respectively, at 24 hours post-dose and were 4.63 (0.19, n=15), 
4.32 (0.24, n=10), 6.99 (0.24, n=10), and 5.75 (0.19, n=15) µmol substrate hydrolyzed/min./g 
wet mass, respectively, at 72 hours post-dose. 
 Three factor mixed-model ANOVA (Time x Treatment (FO, FD, and FS only) x 
Replicate) of DCP data revealed only significant interactions while main effects were not 
significant (Table 3.8). Inspection of the marginal means for the interactions did not suggest a 
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simple explanation for the observed effects. Variability among replicates seemed similar to 
variability within replicates. As each of the factors was involved in a significant interaction, the 
effect of Treatment within each combination of Time and Replicate was examined using one 
factor fixed-model ANOVA. A significant effect of Treatment was only observed in the 
comparison at 72 hours post-exposure in Replicate 3 (F2=5.508, p=0.020) with post hoc tests 
differentiating only between the FD and FS levels of Treatment (Tukey’s HSD, p=0.022). Data 
were then pooled under Replicate to examine effects common among all replicates. The resulting 
2 factor fixed-model ANOVA revealed a significant effect of Time while the effect of Treatment 
approached the significant level (Table 3.8). Mean (SE) brain ChE activity in the FO, FD, and FS 
treatments were 5.271 (0.201, n=15), 4.988 (0.201, n=15), and 4.957 (0.201, n=15) µmol 
substrate hydrolyzed/min./ g wet mass, respectively, at 24 hours post-exposure and 5.626 (0.201, 
n=15), 5.562 (0.201, n=15), and 5.012 (0.201, n=15) µmol substrate hydrolyzed/min./g wet 
mass, respectively, at 72 hours post-exposure. 
Analyses of brain ChE data from simulated field exposures with ETP failed to reveal 
significant effects of any factor. Pooled mean (SE) ETP brain ChE activity in quail was 7.760 
(0.058)(n=90) µmol substrate hydrolyzed/min./g wet mass. These ETP data were normally 
distributed and pooled brain ChE activity in quail exposed to ETP on the field differed little from 
that observed in the NC quail. 
Three factor mixed-model ANOVA (Time x Treatment (FO, FD, and FS only) x 
Replicate) of MMP data found no significant effects. Data were pooled under Replicate and the 




Table 3.8. Results (F statistic, p value) of the analysis of variance (ANOVA) of post-exposure 
brain cholinesterase data within levels of the factor Organophosphate insecticide, those being 
dicrotophos (DCP), ethoprop (ETP), methamidophos (MMP), and naled (NLD). Factors within 
the ANOVA are Treatment (Tr), Time (Ti), and Replicate (Rep). Results that did not approach 





Results (F statistic, p value) from Analysis of 
Post-exposure Brain Data 
DCP ETP MMP NLD 
3 Factor 
Mixed 
Tr - - - - 
Ti - - - 13.10, 0.069 
Rep - - - - 
Tr*Ti 7.23, 0.047 - - 9.07, 0.033 
Tr*Rep 24.77, 0.004 - - - 
Ti*Rep 7.84, 0.041 - - 5.12, 0.079 
2 Factor 
Fixed 
Tr 2.72, 0.072 - - 8.63, <0.001 
Ti 3.99, 0.049 - 7.46, 0.008 35.35, <0.001 
Tr*Ti - - - 4.78, 0.011 
 
(SE) brain ChE activity in the FO, FD, and FS treatments were 5.482 (0.138, n=15), 5.690 
(0.138, n=15) and 5.509 (0.138, n=15) µmol substrate hydrolyzed/min./ g wet mass, respectively, 
at 24 hours post-exposure and 6.030 (0.138, n=15), 5.904 (0.138, n=15), and 5.669 (0.138, n=15) 
µmol substrate hydrolyzed/min./g wet mass, respectively, at 72 hours post-exposure. 
Three factor mixed-model ANOVA of NLD data revealed a significant interaction in 
Treatment*Time and a main effect of Time and an interaction of Time*Replicate that both 
approached the significant level (Table 3.8). Data were pooled under Replicate and the resulting 
two factor fixed-model ANOVA showed significant effects of Time, Treatment, and the 
Time*Treatment interaction (Table 3.8).  Data were then split into 24 and 72 hour post-exposure 
groups and one-way ANOVAs performed to investigate Treatment effects in each period. The 24 
hour ANOVA revealed a significant effect of Treatment (F2=10.21, p<0.001) and post hoc tests 
found the FS treatment to be significantly different than either the FO or FD (Tukey HSD, 
p≤0.007). A similar analysis of data in the 72 hour post-exposure group failed to find a 
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significant effect of treatment. Mean (SE) brain ChE activity in the FO, FD, and FS treatments 
were 5.388 (0.192, n=15), 5.715 (0.192, n=15) and 4.488 (0.192, n=15) µmol substrate 
hydrolyzed/min./ g wet mass, respectively, at 24 hours post-exposure and 6.480 (0.192, n=15), 
5.991 (0.192, n=15), and 5.922 (0.192, n=15) µmol substrate hydrolyzed/min./g wet mass, 
respectively, at 72 hours post-exposure. 
 
3.3.6 Gut contents 
 Two factor fixed-model ANOVA (OP x Treatment (FO and FD only)) of gut content wet 
mass data revealed only a significant effect of the OP (F3=10.55, p<0.001). Post hoc tests on 
pooled data (FO and FD combined) found the wet mass of gut contents in quail exposed to the 
ETP spray to be significantly greater than that of quail exposed to other OP sprays (p≤ 
0.006)(Figure 3.5). Similar results were obtained with one factor ANOVA and post hoc tests of 
FO and FD data separately except that in post hoc tests on the FD data where gut content wet 
mass of quail exposed to the ETP spray was significantly greater than that of quail exposed either 
of the MMP or NLD sprays and where results in DCP spray quail were intermediate and not 
significantly different from any other group. No significant differences in gut content wet masses 
were found between FO and FD treatments within any OP using independent samples t tests. 
The contents of crops and gizzards in quail subject to MMP and NLD sprays in both the 
FO and FD treatments were all similar. Crops were empty or contained traces of organics and 
grit. Gizzards contained mostly grit or grit with traces of organics. Quail in the FO treatment 
exposed to the DCP sprayed field had crops that were empty or contained traces of organics and 
gizzards that contained clean grit or grit with some organics whereas quail in the FD treatment of 
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Figure 3.5. Variation in the total wet mass of gut contents (including all material in crop, gizzard, 
and small intestine) in quail immediately following exposure of quail to two different levels of 
the factor Treatment (field only (FO) and field plus diet (FD)) on the sprayed simulated field for 
each level of the factor Organophosphate (OP) insecticide (dicrotophos (DCP), ethoprop (ETP), 
methamidophos (MMP), and naled (NLD)). Error bars denote (+/-) standard error. The asterisk 
(*) denotes a significantly higher wet mass of gut contents in ETP-exposed quail (pooled 
treatments, p<0.05). 
 
the same spray had crops that were empty or contained wet feed and gizzards that contained 
clean grit or grit with feed and/or traces of organics. Quail in the FO treatment exposed to ETP 
had crops that were empty or contained traces or organics and gizzards that contained grit or grit 
with a trace to some organics whereas their counterparts in the FD treatment had crops that 
contained trace to abundant feed and gizzards that contained grit and feed. 
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 A pilot gut contents spray was completed using ETP applied at 2100 g/ha to check that 
the provision of feed on the simulated field pre-spray would result in a post-spray difference in 
the wet mass of gut contents in quail. Although this pilot study examined only the contents of the 
crop and gizzard and excluded the contents of the small intestine, the results were similar to that 
reported previously for ETP at 1310 g/ha. Crops of quail in the FO treatment were empty while 
the gizzards contained primarily grit with traces of organics. In contrast, quail in the FD 
treatments possessed crops that were partly full to full, primarily of the commercial feed used on 
the field, and gizzards that typically contained this feed and grit. Mean (SE) wet mass of crop 
and gizzard contents in quail in the FO and FD treatments in this pilot study were 0.884 (0.102) g 
(n=5) and 1.91 (0.298) g (n=5), respectively. These data failed Levene’s test of equal variances 
and the degrees of freedom in the independent samples t test that followed were adjusted to 
account for this failure. The difference between the wet mass of crop and gizzard contents in the 
FO and FD treatments was significant (t4.924=3.252, p=0.023). 
 
3.3.7 Exposure Reconstruction 
3.3.7.1 Methamidophos 
Recovery of ChE activities in plasma and brain from 24 to 72 hours post-exposure in the 
PC and FO treatments with MMP were plotted as exponential decays to facilitate comparisons 
and the estimation of effects half-lives (Fig. 3.6). No significant differences between mean 
plasma ChE activities in the two treatments were found at either post-exposure period. Mean 
brain ChE activity in the FO treatment was significantly lower than that in the PC treatment at 
both 24 hours (t23=5.12, p<0.001) and 72 hours (t23=4.52, p<0.001) post-exposure. The estimated 
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half-lives of ChE inhibition in plasma and brain were 18.2 and 71.8 hours following the PC 
exposure and 17.7 and 125 hours following the FO exposure, respectively. 
 
3.3.7.2 Dicrotophos 
Recovery of ChE activities in plasma and brain from 24 to 72 hours post-exposure in the 
PC and FO treatments with DCP were plotted as exponential decays (Fig. 3.7). Mean plasma 
ChE activity was not significantly different between the two treatments at 24 hours post-
exposure. However, mean plasma ChE activity in the FO treatment was significantly lower than 
that in the PC treatment at 72 hours (t23=3.705, p=0.001) post-exposure. Mean brain ChE activity 
in the FO treatment was significantly higher than that in the PC treatment at both 24 hours 
(t17.05=-6.49, p<0.001) and 72 hours (t28=-5.853, p<0.001) post-exposure. Data in the brain ChE 
activity comparison at 24 hours post-exposure failed Levene’s test of equal variances and the 
degrees of freedom in the independent samples t test were adjusted to account for this failure. 
The estimated half-lives of ChE inhibition in plasma and brain were 17.6 and 128 hours 
following the PC exposure and 41.3 and 222 hours following the FO exposure, respectively. 
 
3.3.7.3 Naled 
Recovery of ChE activities in quail tissues following the PC and FO treatments using 
NLD were again plotted as exponential decays (Fig. 3.8). Mean plasma ChE activity in the FO 
treatment was significantly lower than that in the PC treatment at 24 hours (t20.63=3.559, 
p=0.002) and but not 72 hours post-exposure. Mean brain ChE activity in the PC treatment was 
significantly lower than that in the FO treatment at both 24 hours (t21.42=-2.85, p=0.009) and 72 
hours (t28=-3.52, p=0.001) post-exposure. Data in the plasma and brain ChE activity comparisons 
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at 24 hours post-exposure failed Levene’s test of equal variances and the degrees of freedom in 
these independent samples t tests were adjusted accordingly. The estimated half-lives of ChE 
inhibition in plasma and brain were 24.5 and 64.8 hours following the PC exposure and 34.7 and 
56.4 hours following the FO exposure, respectively. 
 
3.3.7.4 Ethoprop 
Exponential decay plots of recovery of ChE activities in quail tissues following PC and 
FO exposures to ETP (Fig. 3.9) revealed obvious differences between the treatments. The PC 
treatment resulted in pronounced inhibition of ChE activity in both plasma and brain at both 24 
hours and 72 hours post-exposure whereas the FO treatment produced only a moderate inhibition 
of ChE activity in plasma at 24 hours post-exposure but almost no response in plasma ChE 
activity at 72 hours post-exposure and almost no response in brain ChE activity at either time 
period. No statistical comparisons were made as the effects were evident upon inspection of the 
data. The estimated half-lives of ChE inhibition in plasma and brain were 21.7 and 106.5 hours 




Effects following exposures on the simulated field were inconsistent with the assumption 
upon which screening level avian ERA for pesticide sprays is based, that consumption of 
contaminated feed is the only route by which birds are exposed. Consumption of contaminated 




























































Figure 3.6. Recovery from inhibition of cholinesterase activity in quail plasma (solid line) and 
brain (dashed line) from 24 to 72 hours post-exposure in two different treatments; A) positive 
control by oral gavage and B) exposure to a methamidophos-sprayed simulated field. The 
recovery curves illustrated are exponential decays. Sample size for each data point is 15 except 




























































Figure 3.7. Recovery from inhibition of cholinesterase activity in quail plasma (solid line) and 
brain (dashed line) from 24 to 72 hours post-exposure in two different treatments; A) positive 
control by oral gavage and B) exposure to a dicrotophos-sprayed simulated field. The recovery 
curves illustrated are exponential decays. Sample size for each data point is 15 except for 




























































Figure 3.8. Recovery from inhibition of cholinesterase activity in quail plasma (solid line) and 
brain (dashed line) from 24 to 72 hours post-exposure in two different treatments; A) positive 
control by oral gavage and B) exposure to a naled-sprayed simulated field. All the recovery 





























































Figure 3.9. Recovery from inhibition of cholinesterase activity in quail plasma (solid line) and 
brain (dashed line) from 24 to 72 hours post-exposure in two different treatments; A) positive 
control by oral gavage and B) exposure to an ethoprop-sprayed field simulated field. All the 
recovery curves illustrated are exponential decays expect for that in simulated field brain in 
which is linear. Sample size for data points from the simulated field is 15. Sample size for data 
points from positive controls is 10 except for plasma at 24 hours post-exposure where sample 
size is 9. Error bars denote (+/-) standard error. 
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demonstrated that all four OPs were bioavailable via the oral route. Rather the response of quail 
to simulated field exposures appeared to be typical of dermal absorption and highly influenced 
by the solubility of the OP. Recovery from ChE inhibition in avian tissues following simulated 
field exposures displayed reservoir effects consistent with that known of dermal exposures in 
mammals and these reservoir effects became more pronounced as log Kow of the active 
ingredient increased. 
 
3.4.2 Plasma Data and Error Structure 
Variation in assay temperature between batches of plasma ChE activity assays caused 
significant effects in pre-exposure plasma data. While the significant regression of ambient 
temperature on pre-exposure plasma data indicated that variation in assay temperature was 
causative, the non-normal distribution of residuals in this regression indicated that sub-optimal 
laboratory environmental controls were also a source of these effects. As pre-exposure plasma 
ChE activity assays were generally performed in batches containing either samples from control 
groups (NC and PC collectively) or samples from treatments on the simulated field (FO, FD, and 
FS collectively) and proceeded on a replicate by replicate basis within each OP (Appendix B), 
the significant effects in pre-exposure plasma data were manifest in the factor OP and its 
interaction with Replicate. Further, the pre-exposure plasma ChE activity in NC and PC groups 
varied similarly among the OPs and comparisons of effects on the simulated field (i.e. FO vs. FD 
vs. FS) were relatively free of the confounding influence of assay temperature variation. 
Post-exposure plasma ChE activity assays were completed in a manner consistent with 
pre-exposure plasma samples (Appendix B) and a similar error structure was anticipated. Instead 
the effects of OP and its interaction with Replicate on post-exposure NC plasma ChE activity 
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were not significant. Mean ChE activity in post-exposure NC plasma was elevated slightly 
relative to the grand mean plasma ChE activity calculated from pre-exposure data suggesting that 
post-exposure plasma ChE assay temperatures were more uniform and typically slightly warmer 
than those of pre-exposure assays and so less confounded by variation in assay temperature. 
Further, the influence of between-batch temperature effects and the effects of actual exposures 
were generally divergent. Significant inhibition of plasma ChE activity at the magnitudes 
observed simply could not have been the product of between-batch temperature variation. In 
addition, measures of effect size reveal substantial increases in the effects of the factors 
Treatment and Time from pre- to post-exposure periods. Inferences made based upon the effects 
of these factors in post-exposure plasma ChE activity data were not confounded by the effects of 
between-batch ChE assay temperature variation. 
 
3.4.3 Brain Data and Use of In House Brain Analytical Standard 
The avian brain ChE standard proved useful in quantifying between-batch temperature 
effects on brain ChE assays and the method developed for standardizing activity in the unknowns 
to median activity in the new analytical standard was found useful in correcting for the effects of 
assay temperature variation. The multimodal distribution and wide range of activity in measures 
of activity in the analytical standard suggest that the brain ChE data set for the unknowns would 
be of questionable utility. Yet the standardized NC brain ChE activity data set passed tests of 
normality and is almost unmatched in its precision. A limited review of published studies 
containing measures of reference or control brain ChE activity in birds determined using the 
assay of Ellman et al. (1961) revealed only one measure of greater precision derived from a 
reasonable sample size (i.e. n≥ 10), that in nonincubating control mallard hens (Fairbrother et al. 
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1989), while other authors list reference or control brain ChE activity almost as precise (Vyas et 
al. 2006, Prijono and Leighton 1991, Burn and Leighton 1996). Otherwise, reference or control 
measures of greater precision were those developed from small sample sizes (i.e. 2 or 3) and so 
are not truly comparable as small sample sizes result in underestimation of dispersion in a 
population (Zar 1999). This method also appears to be novel and may prove useful to others, 
particularly those conducting assays under suboptimal conditions where between-batch 
temperature effects may be problematic. 
 
3.4.4 Control Groups 
3.4.4.1 Negative Control Group 
Mean pre-exposure plasma and NC brain ChE activity, 0.734 µmol substrate 
hydrolyzed/min./mL and 7.83 µmol substrate hydrolyzed/min./g wet mass, respectively, were 
both consistent with the findings of Soler-Rodriguez et al. (1998) for the same species, 0.838 
µmol substrate hydrolyzed/min./mL and 7.32 µmol substrate hydrolyzed/min./g wet mass, 
respectively. 
 
3.4.4.2 Positive Control Group 
Oral dosing demonstrated the ChE-inhibiting properties and oral availability of all four 
OPs. However, the response in one of the three PC replicates with each of ETP and MMP varied 
substantially from the responses in the remaining two. This difference was apparent in both 
tissues with both OPs, being statistically significant in both tissues with ETP and statistically 
significant in brain with MMP. Data in these replicates were attributed to errors in oral doses 
within those replicates and excluded from further analyses. 
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The oral doses of the OPs in the PC treatment were all intended to be one-third the 
respective LD50 in quail. However, the responses varied among OPs. Responses in brain 
indicated that the oral dose of ETP was high relative to the others while the MMP oral dose 
appeared relatively low and the oral doses of DCP and NLD appeared intermediate. Regardless 
of the variation in responses to the oral doses of the OPs, inhibition of ChE activity in plasma 
and brain and subsequent recovery of ChE activity were typical of a gavage exposure. Recovery 
from inhibition of ChE activity in plasma was rapid and fairly uniform among the OPs although 
the extremes of recovery rate in brain varied by a factor of two. 
Only the effects following the oral dose of NLD appeared atypical in any way. Inhibition 
of plasma ChE activity was already lower than that in brain by 24 hours post-dose while 
recovery of ChE activity in brain was the most rapid among any of the OPs. These effects were 
interpreted as potentially being a function of extremely rapid recovery of ChE activity in both 
tissues. Extremely rapid recovery of inhibited ChE activity following an acute exposure to NLD 
is a phenomenon previously observed in mice (Berteau and Deen 1978). Berteau and Deen 
(1978) observed rapid recovery of plasma ChE activity in mice from approximately 90% 
inhibition to approximately 10% induction over a 24 hour period following an acute inhalation 
exposure to NLD. This recovery of plasma ChE activity was far more rapid than that observed 
with similar exposures to either of the OPs malathion or chlorpyrifos (Berteau and Deen 1978). 
 
3.4.5 Field Treatments 
The addition of feed to the soil surface of the simulated field prior to application of the 
spray had little impact on the response of quail in the FD treatment. Feed may have been 
sheltered under the barley canopy during application of the spray and therefore not highly 
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contaminated and thus of little consequence when it was consumed. In contrast, the FS treatment 
resulted in the lowest 24 hour post-exposure plasma ChE activity in any of the simulated field 
treatments with all four OPs, being significantly lower with all except NLD. The presence of 
birds on the simulated field during application of the spray was a larger contributor to exposure 
and effects than the presence of feed on the field during application of the spray. The significant 
increase in inhibition of plasma ChE activity in the FS treatment relative to the other simulated 
field treatments may have resulted from increases in coverage and concentration in dermal dose 
associated with exposure to the spray itself. However it is also possible that the spray was 
inhaled or consumed in preening or entered via the ocular route. 
 
3.4.6 Gut Contents 
Inspection and analysis of gut contents from MMP and NLD feeding trials suggest quail 
in these trials fed little if at all, regardless of which treatment they received. There were also no 
significant statistical differences in the wet mass of gut contents between either of these two OPs 
or treatments within them. The measured wet mass of gut contents in feeding trials with these 
two compounds may, in the majority, simply reflect the sum of a pre-existing burden of grit and 
secretions. MMP is an irritant (http://www.inchem.org/documents/jmpr/jmpmono/ ). Hydrolysis 
of MMP produces methyl mercaptan, another irritant more volatile than MMP itself (Dowling 
and Seiber 2002). NLD is a fumigant (http://pmep.cce.cornell.edu/profiles/etoxnet) and corrosive 
to tissues (Berteau and Deen 1978). Quail in MMP and NLD trials may have experienced a 
degree of discomfort while on the simulated field that deterred them from feeding. In contrast, 
feed was visible in both the crop and gizzard of quail of the ETP feeding trial and these birds had 
gut content wet masses significantly higher than quail in feeding trials with other compounds. 
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Quail on the DCP-sprayed simulated field appeared intermediate with some feeding and others 
not. A lack of feeding activity on the MMP- and NLD-sprayed simulated field is consistent with 
findings that the FD treatment had no significant impact on ChE activity in either tissue relative 
to the response to the FO treatment.  
There are two seemingly paradoxical findings that must be explained if one accepts that 
the alimentary route of exposure is the main contributor to toxicity under field conditions. First, 
there was an obvious discrepancy in the effects observed in brain when comparing the ETP PC 
exposures with the ETP simulated field exposures. The ETP gavage resulted in significant 
inhibition in both plasma and brain while the simulated field exposure resulted in significant 
inhibition in plasma but no meaningful nor significant inhibition in brain, regardless of 
treatment. Indeed, the high dose group used in the ETP simulated field pilot study spray had 
significant inhibition in plasma comparable to that produced by the ETP gavage but only a 
negligible and not significant inhibition in brain. Quail fed while on the ETP-sprayed simulated 
field yet effects in brain are lacking. If the route of exposure in both the gavage and simulated 
field exposures is alimentary, then this discrepancy in effects on brain requires explanation. 
Second, if quail on the ETP-sprayed field ate too little for effects to develop in brain and they are 
the group that evidently ate the most while on the simulated field, then how is it that quail 
exposed on the DCP-, MMP-, and NLD-sprayed simulated field developed effects in brain? It is 
evident from the feeding trials that quail exposed to MMP and NLD on the simulated field fed 
little if at all, yet ChE activity in their brain ChE activity was significantly inhibited. Together 
these two seemingly paradoxical findings imply that a route of exposure other than alimentary 




3.4.7 Reconstruction of Exposure and Effects 
Inhibition and subsequent recovery of ChE activity in quail tissues following exposures 
on the simulated field varied among the OPs and differed from the patterns observed following 
oral gavage exposures. Recovery from inhibition of ChE activity following simulated field 
exposures was explained more parsimoniously by exposure via the dermal route and a dermal 
reservoir effect that increased with increasing log Kow of the active ingredient. 
 
3.4.7.1 Methamidophos 
Recovery of ChE activity in both tissues of MMP-exposed quail was similar between the 
PC and FO treatments although the FO exposure produced a greater response. With MMP, the 
most hydrophilic of the OPs, where quail evidently did not feed while on the simulated field, the 
observed responses are primarily the result of dermal exposure, but the pattern of recovery of 
ChE activity in both tissues shows no evidence of a reservoir effect. 
 
3.4.7.2 Dicrotophos 
The FO treatment produced a lower inhibition of ChE activity in brain but a greater and 
more persistent inhibition of ChE activity in plasma relative to the PC treatment. Effects in brain 
indicate a lower dose in the FO treatment while effects in plasma indicate the opposite. The 
paradox is avoided if dermal exposure is used to explain effects in the FO treatment. The 
persistent and seemingly greater effects in plasma of the FO treatment relative to the PC 
treatment are simply the product of a reservoir effect and not the result of a greater dose on the 
simulated field. DCP was retained in quail skin and then slowly released into circulation after 
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removal from the simulated field. This slow release of DCP was sufficient to offset some of the 
recovery of ChE activity in plasma between 24 and 72 hours post-exposure. 
 
3.4.7.3 Naled 
Recovery of ChE activity in both tissues following the FO treatment resulted in a typical 
pattern of ChE inhibition in which inhibition in plasma exceeded inhibition in brain. With DCP, 
the effects in brain indicate the dose on the simulated field was lower than the gavage dose while 
results in plasma indicate the opposite. Gradual release of NLD from a dermal reservoir into 
circulation could have caused the apparent slower rate of recovery of plasma ChE activity in the 
FO treatment relative to the NLD gavage. The combination of a reservoir effect and extremely 
rapid recovery combine to explain why such a high application rate was required to achieve the 
desired 60% inhibition of plasma ChE in pilot study sprays with NLD. Hence, the nearly 60% 
inhibition of plasma ChE activity produced in the FO treatment relied upon the lag in inhibition 




Inhibition in both tissues following the oral gavage was the greatest observed with any of 
the OPs. In contrast, the absence of effects in brains of quail in the ETP simulated field 
treatments, birds which did consume contaminated feed in the FD treatment, is consistent with 
dermal absorption and storage of a highly lipophilic compound. The rate of diffusion of ETP 
from the lipophilic regions of quail skin into circulation was very slow such that esterases in 
quail plasma may have readily scavenged and metabolized ETP entering circulation, thereby 
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preventing ETP from being distributed to brain. The 6 hour field exposure and relatively low 
ETP spray application rate were simply insufficient to develop a tissue concentration gradient 
capable of forcing ETP from the skin reservoir into circulation at a rate high enough to 
overwhelm the esterases in quail plasma. 
 
3.4.8 Conclusions 
This was an exercise in exposure reconstruction. Biomarkers of exposure and effect in 
quail tissues taken at two different post-exposure intervals revealed differences between the 
toxicodynamics of two different exposures, the first a gavage which was undeniably of 
alimentary origin and the second a simulated field exposure in which multiple routes of exposure 
may have contributed to effects. As the exposures were controlled and replicated experimentally, 
there was an abundance of supporting exposure data on the oral doses, spray application rates, 
exposure durations and timing, simulated field conditions, and the experimental OPs. What 
remained was ignorance regarding how the routes of exposure contributed to toxicity on the 
simulated field. 
Contrasts and similarities in responses in quail among the OPs within the two treatments 
and between the treatments within each OP proved paradoxical when both treatments were 
interpreted as resulting from alimentary exposure. Paradoxes were resolved and interpretation 
simplified when effects on the simulated field were interpreted as resulting primarily from 
dermal exposure. Dermal reservoir effects varied with log Kow of the OP, being absent with 
MMP, the most hydrophilic of the OPs used, and so pronounced with ETP, the most lipophilic of 
the OPs used, that results from pilot study sprays led the author to think that ETP could not cross 
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the blood-brain barrier in quail (a notion later abandoned when tissues from gavage exposures 
were analyzed). 
Unfortunately, as quail evidently consumed little if any contaminated feed in the FD 
treatments on the simulated field with MMP and NLD and as feed generally may have been 
sheltered from spray by the overhanging barley canopy, little may have been learned of how oral 
and dermal exposures are integrated in the live bird. Regardless, it was evident from these 
experiments that the response to the 6 hour simulated field exposures resulted primarily from 
dermal absorption and that the presence of birds on the simulated field during application of the 
spray was associated with a significant increase in effects beyond that associated with the 




4.0 SIMULATED FIELD EXPOSURES OF COTURNIX QUAIL TO 
ORGANOPHOSPHATE INSECTICIDE SPRAYS II: PREDICTIVE EMPIRICAL 
MODELS FOR ESTIMATING FIELD EXPOSURES 
 
4.1 INTRODUCTION 
Environment Canada seeks to improve its methods and practice in assessing the risks of 
pesticides to birds (Mineau 2007). Specific efforts have been made to develop a risk-based 
assessment model and incorporate routes of exposure other than through consumption of 
contaminated feed (Mineau 2007). This model, based largely on prior work (Mineau 2002), 
seeks to incorporate dermal exposure into the assessment process without having to measure 
dermal absorption in birds directly (Mineau 2007). Both models (Mineau 2002, 2007) indicate 
that log Kow of the active ingredient is important in predicting the risks to birds from pesticide 
sprays and suggest that the more lipophilic, direct acting OPs are delayed in dermal absorption 
(i.e. slowed by interactions with the lipid-rich SC) and therefore less likely to cause acute 
toxicity. 
The findings of Chapter 3 indicate that effects of the FO treatment on the simulated field 
are primarily the result of dermal exposure and suggest a reservoir effect is associated with lipids 
in quail skin. Studies with mammals have revealed significant quadratic polynomial relationships 
between maximum skin permeation rate, Jmax (Hinz et al. 1991), or percent of dermal dose 
absorbed (%Abs) (Yano et al. 1986), and log Kow of the compound under study. The 
relationships developed by Hinz et al. (1991) and Yano et al. (1986) reflect current thinking that 
a dermal lipophilic reservoir does exist in mammalian skin and can delay absorption of lipophilic 
compounds. Here for the FO brain ChE activity inhibition data of Chapter 3 associated with the 
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nearly equipotent effects in plasma (effects that are irreversible and may result from either slow 
or rapid dermal absorption), it is assumed that the response in brain is indicative of the extent to 
which dermal absorption and subsequent distribution exceeded the capacity of plasma esterases 
to scavenge the OP molecules being distributed from skin to other tissues via the circulatory 
system. Inhibition of ChE activity in brain resulting from dermal exposure on the simulated field 
serves as a simple, if somewhat crude, proxy for Jmax during the exposure. 
The objectives of this chapter are to determine the extent to which log Kow of the OPs 
used in the simulated field experiments described in Chapter 3 predict the responses observed in 
the FO and FS treatments and to comment on how these findings inform the ecological risk 




Data generated in the simulated field exposures described in Chapter 3 were used in this 
curve fitting exercise. Data from the FO treatments with each OP, inferred as resulting primarily 
from dermal exposure, were used directly in curve fitting. Data from the FD treatments were 
excluded from the exercise as consumption of contaminated feed was not uniform among the 
OPs and as effects from consumption of contaminated feed were not expected to be predicted by 
the solubility of the active ingredient. Estimates of the effect of direct exposure to the OP spray 
application alone were prepared by assuming the effect of spray would be in addition to the 
effect of spending six hours on the simulated field. Hence, the effect of spray was estimated by 
subtracting the effect in the FO treatment from the effect in the FS treatment. 
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Data points from simulated field exposures used in curve fitting were percent inhibition 
measured as mean plasma and brain ChE activity in treatment groups (each n=5) relative to the 
mean pre-exposure plasma ChE activity (n=593) and mean NC brain ChE activity (N=110), 
respectively. Plasma and brain data points were obtained from simulated field exposures (FO and  
(FS-FO)) for each combination of OP (DCP, ETP, MMP, and NLD) and Replicate (3 
experimental replicates with each OP) used in the simulated field experiments and then fit within 
each post-exposure period (24 and 72 hours). Twelve data points were generated for each of 
eight different curve fitting exercises, those being the eight possible combinations of tissue 
(plasma and brain), post-exposure period (24 and 72 hours), and treatment (FO and (FS-FO)). 
 
4.2.2 Estimates of Solubility for the Active Ingredients 
The solubility of the four active ingredients was estimated based upon published octanol-
water partition coefficients, as log Kow, for the compounds. These coefficients were obtained 
from multiple sources including the International Programme on Chemical Safety database 
(http://www.inchem.org/) and unpublished Environment Canada data provided by a coauthor 
(Mineau) and then compared. The reported coefficients varied among sources. The octanol-water 
partition coefficients, as log Kow, used in curve fitting were -0.49, 3.59, -0.80, and 1.38 for DCP, 
ETP, MMP, and NLD, respectively. 
 
4.2.3 Polynomial Regression 
Curve fitting was completed using polynomial regression (Hocking 1996). Linear, 
quadratic, and cubic curves were fit to the data and then compared. Fit was evaluated based upon 
the recommendations of Hocking (1996) with consideration being given to the significance of 
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the relationship, the explanatory ability of the regression equation, the width of confidence 
intervals, normality in the distribution of residuals, and reasonableness of interpolated 




Polynomial curves could not be fit significantly to the FO and (FS-FO) plasma ChE 
activity inhibition data sets at either 24 or 72 hours post-exposure. Linear, quadratic, and cubic 
curves were either not significant, contained residuals that were not normally distributed, or 
contained interpolated predictions that were nonsensical. 
 
4.3.2 Brain 
Quadratic polynomial regressions were significant and found to be the best fit to the FO 
brain ChE inhibition data sets at both 24 and 72 hours post-exposure (Figure 4.1). The quadratic 
curve had the most significant fit at 24 hours post-exposure (F=35.655, p<0.001, r
2
=0.888). The 
linear curve had the most significant fit at 72 hours post-exposure but possessed wider 
confidence intervals than the quadratic curve and residuals that were not normally distributed.  
This linear fit was rejected in favour of the quadratic curve (F=30.360, p<0.001, r
2
=0.871). The 
resulting quadratic polynomial models fit to the FO brain ChE activity inhibition data sets at 24 
and 72 hours post-exposure were Eqs. 4.1 and 4.2, respectively: 
 
Inhibition (%) = 34.028 + 2.128(log Kow) – 2.922(log Kow)
2
  (Eq. 4.1) 
Inhibition (%) = 23.986 - 2.805(log Kow) – 1.021(log Kow)
2
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Figure 4.1. Quadratic polynomial curves describing variation in inhibition of brain cholinesterase 
(ChE) activity in quail with variation of log octanol:water partition coefficient (Kow) of the active 
ingredient of four different organophosphate insecticide sprays (dicrotophos, log Kow=-0.49; 
ethoprop, log Kow=3.59; methamidophos, log Kow=-0.80; naled, log Kow=1.38) following six 
hour simulated field (FO) exposures. Inhibition was determined both at 24 hours post-exposure 
(closed circles, solid line) and at 72 hours post-exposure (open circles, dashed line). Each data 
point represents the mean inhibition of a treatment group (n=5) relative to control brain ChE 
activity (n=110). 
 
A quadratic polynomial regression was found most significant and best fit to the (FS-FO) 
brain ChE inhibition data set at 24 hours post-exposure (F=7.360, p=0.013, r
2
=0.621)(Figure 
4.2). No significant fits were obtained for any polynomials for the (FS-FO) data at 72 hours post-
exposure. The polynomial model fit to the (FS-FO) brain ChE activity inhibition data set at 24 
hours post-exposure was Eqs. 4.3: 
 
Inhibition (%) = 7.469 + 6.909(log Kow) – 2.816(log Kow)
2







 of Active Ingredient































































Figure 4.2. Quadratic polynomial curves describing variation in inhibition of brain cholinesterase 
(ChE) activity in quail with variation of log octanol:water partition coefficient (Kow) of the active 
ingredient of four different organophosphate insecticide sprays (dicrotophos, log Kow=-0.49; 
ethoprop, log Kow=3.59; methamidophos, log Kow=-0.80; naled, log Kow=1.38) following direct 
exposure to the insecticidal spray (FS-FO) exposures. Inhibition was determined at 24 hours 
post-exposure. Each data point represents the mean inhibition of a treatment group (n=5) relative 
to control brain ChE activity (n=110). 
 
4.4 Discussion 
Log Kow of the active ingredient was significantly predictive of toxicity in brain for these 
experimental pesticide spray exposures. This was demonstrated for both the 6 hour exposures on 
the simulated field and for the additional response to the discreet exposure to the spray itself. The 
quadratic models produced in curve fitting predict that directly acting OPs having log Kow in the 
range of 0 to 1.5 are those that will be most toxic under field conditions. The findings are also 
generally consistent with the risk models of Mineau (2002, 2007) in that they indicate that 
directly acting OPs of balanced lipid:water solubility carry a greater risk to birds relative to more 
lipophilic ones. The implication is that directly acting OPs with balanced lipid:water solubility 
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are those most rapidly absorbed and distributed via the dermal route. This appears to be a 
reasonable conclusion given that it is generally consistent with what is known of mammals (Lane 
et al. 2012). 
It is important to acknowledge the limitations of this data set. Arguably the use of three 
data points for each OP, one for each experimental spray replicate, represents an instance of 
pseudoreplication and the data presented here might more cautiously be interpreted as consisting 
of four data points for each of the three curves developed (Figs. 4.1 and 4.2). Log Kow was the 
only predictor considered in this effort to avoid an obvious case of overfitting with limited data. 
Although there is confidence that the observed predictive relationship between inhibition and 
brain ChE activity and log Kow of the active ingredient has a mechanistic basis consistent with 
that known in mammals, there is also an acknowledgement that the shape of the curve is poorly 
characterized due to a lack of data and that it should be confirmed through additional research. In 
this regard, it is recommended that the relationship between penetration rates through avian skin 
and the solubility of penetrating compounds be investigated directly. The Organisation for 
Economic Co-operation and Development (OECD) have established protocols for in vivo and in 
vitro skin absorption study methods (OECD 2004a, OECD 2004b, respectively) that have been 
broadly used with mammals and that presumably could be readily adapted for use with birds. 
Such efforts could reveal not only the differences (or similarities) in dermal absorption rates 
between birds and mammals but also the differences (or similarities) in dermal absorption rates 
between different areas of the bird body (i.e. foot web versus apteria). Arguably this is exactly 
the type of work Mineau (2007) hopes to avoid. 
Although this effort (Chapter 3 and 4, collectively) is constrained by experimental 
conditions and the use of biomarkers as both surrogates of exposure and toxicity and as proxies 
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for dermal absorption rates, it suggests that it should be possible to estimate dermal exposures 
and commensurate risks of directly acting OPs from spray application rates and log Kow and/or 
other physicochemical properties of the active ingredient. Pilot simulated field study sprays 
(Chapter 3) revealed that effects in plasma following exposure to the pesticide-sprayed simulated 
field were linearly related to spray application rate. The quadratic curves developed in this 
chapter revealed that for a relatively uniform response in plasma, log Kow of the active ingredient 
predicted effects in brain. These imply that a larger data set covering a range of pesticide 
concentrations and solubilities can provide estimates of dose and risk. Such a data set is unlikely 
to be developed based upon field or simulated field studies using live birds due to the time and 
expense. In vitro models, like those of OECD (2004a), seem a more expedient and cost-effective 
means to compile such data and thereby validate risk-based assessment models. 
It should also be noted that the lack of any response associated with consumption of 
contaminated feed in the FD treatment, either due to avoidance of feed or lack of contamination 
of feed on the simulated field, made it impossible to gain any insight into how exposures via 
different routes are integrated into a single response (i.e. ChE inhibition in either plasma or 
brain). The conventional approach is to assume that responses produced by exposures from 
different routes are additive, as was utilized by Driver et al. (1991) in estimating toxicity from 
the dermal route of exposure in their simulated field work. However, this premise remains an 






5.0 COMBINED EFFECT OF SHORT-TERM DEHYDRATION AND SUBLETHAL 
ACUTE ORAL DICROTOPHOS EXPOSURE CONFOUNDS THE DIAGNOSIS OF 
ANTICHOLINESTERASE EXPOSURE IN COTURNIX QUAIL (Coturnix coturnix) 
USING PLASMA CHOLINESTERASE ACTIVITY 
 
5.1 INTRODUCTION 
Inhibition of cholinesterase (ChE) activity in the brain of wild birds is used to diagnose 
exposure to anticholinesterase (organophosphorus and carbamate) pesticides (Thompson, 1999). 
Brain is the preferred tissue for investigating anticholinesterase exposure in bird carcasses 
because of the preponderance of ChE activity in the organ (Rattner and Fairbrother, 1991) and 
the persistence of inhibition in the brain (Westlake et al., 1981). Plasma is used to assess 
exposure in live birds as sampling is non-lethal (Thompson, 1991; Fossi et al., 1992) and as 
plasma ChE is more sensitive than brain ChE to anticholinesterase exposure (Ludke et al., 1975). 
The use of plasma also provides for repeated sampling and the ability to perceive changes in 
activity within a bird over time (Fairbrother et al., 1989; Elliot et al., 2008). However, the utility 
of plasma in diagnosing exposure is diminished by the high variability in normal plasma ChE 
activity (Rattner and Fairbrother, 1991; Thompson, 1999). 
Several potentially confounding factors must be considered in making a diagnosis of 
exposure using ChE inhibition (Rattner and Fairbrother, 1991). Within a species, brain ChE 
activity may vary with age (Grue and Hunter, 1984; Custer and Ohlendorf, 1989) and nutrition 
(Rattner, 1982) while that in plasma may vary with sex (Ludke et al., 1975; Hill, 1989; Maul and 
Farris, 2004), age (Ludke et al., 1975; Fairbrother et al., 1990), hormone status (Fairbrother et 
al., 1989), time of day (Cobos et al., 2010), and season (Hill and Murray, 1987). Studies of the 
effect of dehydration on ChE activity in birds appear limited to waterfowl possessing salt glands. 
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The effects of anticholinesterase exposure and an osmoregulatory challenge on ChE activity has 
been studied in mallards (Herin et al., 1978) and black ducks (Rattner et al., 1983). Salt gland 
and brain acetylcholinesterase (AChE) activity in mallard ducklings were significantly inhibited 
by dietary chlorpyrifos exposure while the effect of salt loading in drinking water on these 
endpoints was not significant (Herin et al., 1978). Similarly, ingestion of fenthion by black ducks 
caused significant inhibition of both brain and plasma ChE activity while the effect of saline 
drinking water on these endpoints was not significant (Rattner et al., 1983). Curiously, the 
combination of fenthion exposure and saline drinking water resulted in plasma ChE inhibition 
that was significantly different from either fenthion or saline drinking water alone (Rattner et al., 
1983). Saline drinking water appeared to dampen the response to fenthion exposure in black 
ducks (Rattner et al., 1983). 
Responses to dehydration have been monitored using measures of plasma osmolality 
(Posm)(Arad et al., 1989) and hematocrit (Hct)(Takei et al., 1988). Increase in Posm was associated 
with loss of extracellular fluid volume (ECV)(Arad et al., 1989) while increase in Hct was 
associated with loss of plasma volume (PV)(Takei et al., 1988). No data are available on the 
effect of hydration state on ChE activity in plasma. However, dehydration is a very common 
consequence of disease in wildlife. Sick birds may become dehydrated as a result of infection 
(Joyner et al., 2006), toxicosis (Neimanis et al., 2007; Wynne and Stringfield, 2007) or 
secondary to reduced mobility and access to water. If dehydration causes a change in ChE 
activity in the plasma or brain of birds, this effect could confound the diagnosis of 




This study tests the hypothesis that dehydration can cause changes in ChE activity in 
avian brain and plasma and confound the diagnosis of anticholinesterase pesticide exposure. 
 
5.2 MATERIALS AND METHODS 
5.2.1 Experimental Species 
Male coturnix quail (Coturnix coturnix) between 6 and 26 weeks of age were purchased 
from Fircrest Farms Ltd. (Langley, BC, Canada). 
 
5.2.2 Animal Care and Housing 
The study was conducted in accordance with Protocol #20070071 approved by the 
Research Ethics Board of the University Committee on Animal Care and Supply at the 
University of Saskatchewan. Quail were housed communally indoors in a room at the Animal 
Care Unit in the Western College of Veterinary Medicine, University of Saskatchewan. Quail 
were provided a commercial, medicated (amprolium 125 mg/kg), crumbled turkey starter feed 
(Federated Co-operatives Limited, Saskatoon, SK, Canada) and water ad libidum. An 8 hours 
light:16 hours dark cycle was maintained throughout the study. Temperature in the quail room 
varied from 18 to 22°C during the experiment. Quail deprived of water were isolated within 1.8 
meter square cages in the quail room and provided only feed for periods of either 3 or 5 days. 
 
5.2.3 Experimental Designs 
Two experimental designs were used in this study, one to assess the response of the quail 
to different periods of dehydration and another to assess the interaction between dehydration and 
organophosphorus (OP) pesticide exposure in quail (Figure 5.1). Quail in the dehydration 
104 
 
experiment were grouped by two factors; treatment and replicate. Quail in the combined 
dehydration-dicrotophos experiment were grouped by three factors; dehydration, OP pesticide 
exposure, and replicate. The two experimental designs shared several groups of quail. A total of 
five different combinations of dehydration and OP pesticide exposure in each of three replicates 
created fifteen groups of quail between the two designs. The sample size in each group was 
seven and the study required 105 birds. Quail were randomly assigned to different groups. 
Dependent variables measured included cholinesterase activity in brain and plasma and two 
measures of hydration state in blood – Posm and Hct. 
 







Rep. 1 n=7 n=7 n=7 n=7 
Rep. 2 n=7 n=7 n=7 n=7 
Rep. 3 n=7 n=7 n=7 n=7 
     
B   Rep. 3  
  Rep. 2   
Dehyd. Rep. 1    
0 Days n=7 n=7   






 DCP Exposure   
 
Figure 5.1. The experimental designs for the dehydration experiment (A) illustrating grouping by 
dehydration and replicate and for the combined dehydration-dicrotophos (DCP) experiment (B) 
illustrating grouping by dehydration, DCP exposure and replicate. 
 
5.2.4 Organophosphate Insecticide 
 Quail were exposed to a dilute (v/v)(dilution factor (DF)=600) aqueous solution of 
BIDRIN
®
 8 (dicrotophos 82.0%)(Amvac Chemical Corporation, Los Angeles, CA, USA) by 
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post-oral gavage at the rate of 1.9 mg a.i./kg, one-third of the estimated LD50 for dicrotophos 
(Environment Canada, unpublished data) provided by a coauthor (Mineau). The gavage was 
administered 24 hours prior to termination of treatment and collection of tissues such that quail 
in the 3 and 5 days dehydration treatments had been deprived of water for 2 and 4 days, 
respectively, when exposed. 
 
5.2.5 Tissue Collection and Storage 
Blood samples were obtained before and after the experiment. Approximately 400 µL of 
blood was collected by jugular veinipuncture using heparinized 1 mL syringes with 27 gauge 
needles. A portion of the collected blood was used for determination of Hct. Remaining blood 
samples were centrifuged immediately at 2400xg for 10 minutes at 4°C to separate plasma from 
red blood cells. Plasma was collected and stored at -80°C until prepared for assay. Quail were 
euthanized by cervical dislocation following collection of the terminal blood sample. Brains 
were dissected from carcasses and stored at -80°C until prepared for assay. 
 
5.2.6 Sample Preparation 
Plasma samples were diluted (v/v)(DF=12) in 0.5 M phosphate buffer (pH 8) prior to 
assay. Brain samples were first homogenized in 0.5 M phosphate buffer containing 0.5% Triton 
X-100 (v/v) while in an ice bath using a Sonic Dismembrator Model 100 tissue homogenizer 






5.2.7 Measures of Hydration State in Plasma 
Two measures of hydration state were obtained from plasma; 1) Posm and 2) Hct. Posm was 
measured on a VAPRO
®
 5520 Vapor Pressure Osmometer (Wescor Inc.). Multiple standards 
were run on the osmometer at regular intervals to ensure calibration. Hct was determined by 
centrifugation of whole blood samples in heparinized microcapillary tubes at 10,000xg for 5 
minutes. All measures were made in triplicate. 
 
5.2.8 Cholinesterase Assay 
Determination of ChE activity in tissues was accomplished using the assay of Ellman et 
al. (1961) as modified for a microplate reader by Gard and Hooper (1993). Briefly, enzyme 
activity was measured colorimetrically at 412 nm using acetylthiocholine iodide (AThCh)(>99%, 
Sigma-Aldrich, UK) as a substrate. Buffer (0.5 M phosphate, pH=8), a solution of 5,5’-
dithiobis(2-nitrobenzoic acid) (DTNB)(Sigma-Aldrich, USA) in buffer (0.5 M phosphate, pH=7) 
(final concentration (FC)=3.23x10
-4
 M), sample preparation, and substrate in buffer (0.5 M 
phosphate, pH=8)(FC=1x10
-3
 M) were added to 96 well microtiter plates (Nalge Nunc 
International)(total volume=260 µL). Buffer was maintained at 25°C while reagent solutions and 
samples were maintained in ice baths. Substrate was added lastly and immediately prior to assay 
to initiate the reaction. ChE assay results were read on a SpectraMax
®
 190 microplate reader 
(Molecular Devices Corporation, Sunnyvale, CA, USA) set in absorbance mode and at 25°C. An 
analytical acetylcholinesterase standard was prepared from the membranes of equine red blood 
cells in general accordance with the method developed for human red blood cells by Dodge et al. 
(1963) as modified by Hansen and Wilson (1999). The standard was run on all microplates 




Hypotheses were tested using analysis of variance (ANOVA)(Zar, 1999). Both 
dehydration and OP exposure were treated as fixed-effects factors while replicate was treated as 
a random-effects factor and fixed- or mixed-model ANOVA was employed, as appropriate. Post 
hoc means tests were completed using Tukey’s HSD method. Linear regression was employed to 
investigate correlations between plasma ChE activity and other plasma parameters. Significance 




5.3.1 Sample Losses 
One quail in the control treatment group did not yield sufficient blood at the end of the 
protocol for determination of post-exposure Posm and Hct. Plasma ChE activity was the sole 
blood parameter determined for that bird. Another quail in the combined dehydration-
dicrotophos exposure died in housing and post-exposure samples were not obtained. 
 
5.3.2 Control Brain Cholinesterase Activity and Pre-exposure Plasma Parameters 
Mean (coefficient of variation (CV)) brain ChE activity in control quail was 6.99 (16%) 
µmol substrate hydrolyzed/min./g wet mass (n=21). Pre-exposure values for Posm, Hct, and 
plasma ChE activity were measured in the experimental and other quail kept in housing  between 
1 and 2 weeks prior to the start of the experiment to establish reference values for these 
parameters (Table 5.1). The coefficients of variation for the plasma parameters revealed a 
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ranking of normal homeostatic ranges from narrowest to broadest being Posm<Hct<plasma ChE 
activity. 
Table 5.1. Mean, coefficient of variation (CV), and sample size (n) for plasma osmolality (Posm), 
hematocrit (Hct), and plasma cholinesterase (ChE) activity in experimental and extra quail prior 
to experimentation. 
 
Parameter Posm Hct Plasma ChE Activity 
Mean 298.7 mosmol/kg 42.7 % 0.765 µmol substrate hydrolyzed/min./mL 
CV 2.5 % 7.5 % 21 % 
n 111 111 111 
 
Measures and variability of cholinesterase activities in tissues of our quail were 
consistent with that observed in this species by Soler-Rodriguez et al. (1998) who reported mean 
(CV) brain and plasma ChE activities of 7.32 (11%) µmol substrate hydrolyzed/min./g wet mass 
and 0.838 (32%) µmol substrate hydrolyzed/min./mL, respectively. 
 
5.3.3 Effects on Brain ChE Activity 
 No replicate effect was observed in either of the dehydration or combined dehydration-
dicrotophos experiments and data from replicates were pooled within each experiment. 
Treatment had a significant effect on brain ChE activity in the dehydration experiment 
(F3=55.28, p<0.001). Post hoc tests revealed that brain ChE activity in dicrotophos-exposed 
quail was significantly lower than the activity in other treatments (Figure 5.2). Similarly, 
dicrotophos exposure had a significant effect on brain ChE activity in the combined dehydration-
OP exposure experiment (F1=211.79, p<0.001)(Figure 5.3) while dehydration and the 
dehydration*dicrotophos interaction were not significant. 
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Figure 5.2. Variation in brain cholinesterase activity in quail within treatments: control (n=21); 3 
days dehydration (n=21); 5 days dehydration (n=21); and dicrotophos (DCP)(n=21). Error bars 
denote (+/-) standard error. The asterisk (*) denotes a significantly lower brain cholinesterase 

























































Figure 5.3. Variation in brain cholinesterase activity in quail within different combined 
treatments of dicrotophos (DCP) exposure and dehydration: no DCP, no dehydration (n=21); no 
DCP, 5 days dehydration (n=21); DCP (1.9 mg/kg), no dehydration (n=21); and DCP (1.9 
mg/kg), 5 days dehydration (n=20). Error bars denote (+/-) standard error. The asterisk (*) 
denotes a significantly lower brain cholinesterase activity in DCP-exposed quail than in quail not 
receiving DCP (p<0.05). 
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5.3.4 Effects on Plasma Parameters 
 The replicate effect on Posm and Hct was not significant in either of the experiments and 
data in these experiments were pooled. Treatment had a significant effect on both Posm 
(F3=83.02, p<0.001) and Hct (F3=14.38, p<0.001) in the dehydration experiment. Post hoc tests 
showed significant increases in Posm (Figure 5.4A) and Hct (Figure 5.4B) with increases in the 
period of dehydration. Dehydration had a significant effect on Posm (F1=212.87, p<0.001) in the 
combined dehydration-dicrotophos experiment while the other effects were not significant. Both 
dehydration and dicrotophos exposure had significant effects on Hct (F1=31.88, p<0.001 and 
F1=5.96, p=0.017, respectively) in the combined dehydration-dicrotophos experiment while the 
interaction was not significant. 
 The replicate effect on plasma ChE activity was not significant in either 
experiment although analysis of both experiments did reveal significant effects of the final 
interaction terms (dehydration experiment, treatment*replicate, F2,6=3.85, p=0.002; combined 
dehydration-dicrotophos experiment, dehydration*dicrotophos*replicate, F2,71=6.50, p=0.003). 
These interactions were thought to result from experimental error. A comparison of the 
ANOVAs for each replicate and pooled data in the interaction experiment (Table 5.2) revealed 
significant dehydration*dicrotophos interactions in Replicates 1 and 2 and an effect of 
dicrotophos that is not significant in Replicate 2, none of which influence the results using 
pooled data. This is consistent with the effects of random experimental errors in the replicates 
that weaken when data are pooled. The failure of ANOVA to reveal a significant effect of 
dicrotophos in Replicate 2 can be attributed to anomalously low plasma ChE activity in the 5 























































































































Figure 5.4. Variation in plasma osmolality (A), hematocrit (B), and plasma cholinesterase (ChE) 
activity (C) within treatments: control (n=20 for A and B, n=21 for C); 3 days dehydration 
(n=21); 5 days dehydration (n=21); and dicrotophos (DCP)(n=21). Error bars denote (+/-) 




Table 5.2. Significance of main and interaction effects on plasma ChE activity within the 
interaction experiment for each replicate and the pooled data. 
 
Data Source Replicate 1 Replicate 2 Replicate 3 Pooled Data 
Dehydration <0.001 0.001 0.001 <0.001 
Dicrotophos <0.001 0.883 0.003 <0.001 
Interaction 0.013 0.045 0.342 0.427 
 
dicrotophos-exposed groups does reveal the effect (t=3.31, p=0.002). Analysis of pooled data in 
the dehydration experiment revealed a highly significant effect of treatment (F3=21.33, p<0.001) 
and post hoc tests showed significant increases in plasma ChE activity with dehydration (Figure 
5.4C). A similar analysis in the combined dehydration-dicrotophos experiment revealed highly 
significant and opposing effects of dehydration (F1=39.32, p<0.001) and dicrotophos (F1=15.22, 
p<0.001) while the interaction was not significant. 
Ordinary least-squares (OLS) regression using measures of within-bird change in Posm 
and within-bird change in plasma ChE activity from 69 quail in the control and dehydrated 
treatment groups revealed a significant positive correlation between the parameters (F1=26.52, 
p<0.001)(Figure 5.5A). Observations in the 5 days dehydration group of Replicate 2 (Figure 
5.5A, open circles) plotted below the regression line suggesting that the increase in plasma ChE 
activity in this group was lower than should be expected, arguably the result of experimental 
error. Further, variation in the within-bird change in Posm accounted for approximately 28% of 
the variation in within-bird change in plasma ChE activity. The regression slope was 0.00910 
(p<0.001). The regression intercept was -0.010 and not significant. Regression through the origin 
(RTO) (Eisenhauer 2003) was performed to assess whether the origin was a better fit to the data 
than the intercept of the OLS regression line. The standard errors of the intercepts for the OLS 
and RTO lines were 0.234 and 0.232, respectively, suggesting that the origin was indeed a better 
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Figure 5.5. Linear regressions between plasma parameters in quail not exposed to dicrotophos 
using change in plasma osmolality from pre- to post-exposure and change in plasma 
cholinesterase activity from pre- to post-exposure (A)(n=69); and change in hematocrit from pre- 
to post-exposure and change in plasma cholinesterase activity from pre- to post-exposure 
(B)(n=69). Open circles denote observations in the 5 days dehydration group of Replicate 2 
while filled circles denote all other observations. 
114 
 
fit to the data than the OLS line intercept. Changes in Posm and plasma ChE activity apparently 
commenced simultaneously in response to dehydration. A similar regression using measures of 
within-bird change in Hct and within-bird change in plasma ChE activity from the same 69 quail 
revealed a significant positive correlation between these parameters (F1=5.89, p=0.018) (Figure 
5.5B). However, within-bird change in Hct accounted for only 8.1% of the variation in within-
bird plasma ChE activity. The regression slope was 0.0215 (p=0.018). The intercept was 0.137 
(p=0.006). This intercept was both significant and greater than zero, suggesting that increases in 
both Posm and plasma ChE activity preceded the increase in Hct in response to dehydration. 
The potential for the combined effects of dehydration and dicrotophos to confound the 
diagnosis of anticholinesterase exposure using plasma ChE activity was investigated by pooling 
the data from all replicates and comparing the resulting data set with the reference pre-exposure 
plasma ChE activity using one factor ANOVA. The ANOVA revealed a significant effect of 
treatment (F4=22.81, p<0.001). Post hoc tests were performed to compare treatments (Figure 
5.6A). Both the dehydration and dicrotophos treatment groups were significantly different from 
all others while there was no significant difference between the reference pre-exposure, control 
and combined dehydration-dicrotophos exposure groups. 
Plasma ChE activities in the four treatment groups were then adjusted using the OLS 
regression line between within-bird change in Posm and within-bird change in plasma ChE 
activity (Figure 5.5A). Adjusted plasma ChE activities (ChEadj) were calculated from observed 
plasma ChE activities (ChEobs) and the within-bird change in Posm (ΔPosm) using Eq. 5.1: 
ChEadj = ChEobs – 0.009(ΔPosm)      (Eq. 5.1) 
where the coefficient, 0.009, is the slope of the regression line. The ANOVA was then rerun 















































































































Fig. 5.6. Plasma total ChE activity in quail by treatment group using (A) original data and (B) 
data adjusted using change in plasma osmolality from pre- to post-exposure where treatment 
groups are: 1) reference (pre-exposure) quail (n=111), 2) control quail (n=20), 3) dehydrated (5 
days) quail (n=21), 4) dicrotophos (DCP) exposed quail (n=21), and 5) dehydrated (5 days) and 
DCP exposed quail (n=20). Lower case letters denote homogenous subsets within each data set 
(p<0.05). Error bars denote (+/-) standard error. 
116 
 
activities from the reference pre-exposure observations. A significant effect of treatment was 
revealed (F4=20.47, p<0.001) and a more robust portrayal of dicrotophos exposure emerged in 
post hoc tests (Figure 5.6B). Two homogenous subsets were found, each associated by their 
exposure (or lack of) to dicrotophos. 
 
5.4 DISCUSSION 
The induction of dehydration in quail using water deprivation resulted in significant 
effects in all dependent variables measured except brain ChE activity. Dehydration neither 
affected the ability of dicrotophos to inhibit ChE activity in brain nor altered ChE concentrations 
in that tissue by causing a change in brain wet mass. This may reflect preferential maintenance of 
the hydration state in the brains of quail at the expense of water loss from other body 
compartments during dehydration, a response known in mammals (Nose et al., 1983). 
The observed increases in Posm and Hct are likely indicative of decreased extracellular 
fluid volume (ECV) and plasma volume (PV) during water deprivation, respectively. Increases in 
these plasma parameters have been observed in birds in response to water deprivation, although 
not always concurrently. Significant increases in Posm have resulted from short term water 
deprivation in chickens (Arad et al., 1985), pigeons (Arad et al., 1989; Carmi et al., 1994), 
starlings (Roberts and Dantzler, 1989) and Japanese quail (Takei et al., 1988). However, among 
these studies, only the work with Japanese quail found a significant increase in hematocrit 
associated with water deprivation (Takei et al., 1988). Arad et al. (1985) examined the response 
of chickens subjected to 48 hours of water deprivation and observed significant increases in Posm. 
However, their work focused on the relation between osmoregulation and hormones and no 
inferences were made regarding ECV and PV (Arad et al., 1985). Arad et al. (1989) later 
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conducted similar work with pigeons and measured both Posm and Hct. Forty-eight hours of water 
deprivation caused a significant increase in Posm but little variation in Hct, from which they 
inferred that PV had been maintained at the expense of water loss from other compartments of 
the ECV (Arad et al., 1989). The authors also noted that their test pigeons had been conditioned 
to heat stress and mentioned contrasting findings in their unpublished work with pigeons not 
acclimated to heat, wherein PV was lost during water deprivation (Arad et al., 1989). Carmi et al. 
(1994) subjected pigeons to water deprivation under different temperature regimes and observed 
a significant increase in Posm and non-significant variation in Hct in all treatments. Both total 
body water (TBW) and PV were measured directly and it was found that the pigeons were 
capable of maintaining PV but not TBW during water deprivation except under the highest 
ambient temperature tested (40°C), wherein PV was reduced significantly (Carmi et al., 1994). 
Concurrent significant increases in Posm and non-significant changes in Hct were also observed 
(Carmi et al., 1994). The findings of Roberts and Dantzler (1989) with starlings were similar. 
Starlings subjected to 24 hours of water deprivation had significantly lower body weight and 
significantly increased Posm while Hct varied little and PV was maintained (Roberts and Dantzler, 
1989). In contrast, Takei et al. (1988) deprived Japanese quail of water and measured body 
weight, blood volume, Posm and Hct. Increases in both Posm and Hct were observed shortly after 
water deprivation commenced and became significant after only 10 hours (Takei et al., 1988). 
Concurrent decreases in body weight and blood volume were also observed and became 
significant after only 4 and 7 hours, respectively (Takei et al., 1988). Takei et al. (1988) 
concluded that their quail were not capable of maintaining blood volume during water 
deprivation. This observation is noteworthy given the close taxonomic relation between Japanese 
quail and the species we used, as our findings suggest a similar phenomenon in Coturnix quail. 
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This work was not intended as an investigation of osmoregulatory function in quail and 
so we lack measures of body weight, TBW, ECV and PV from which we could make inferences 
regarding the movement of water between various body compartments. We instead rely on our 
measures of Posm and Hct as proxies for change in ECV and PV, respectively. Quail in our 
experiments had significant increases in Posm after both 3 and 5 days of water deprivation and in 
Hct after 5 days of water deprivation which we associate with loss of ECV and PV, respectively. 
The linear regression relationships used to explore correlations between Posm and plasma ChE 
activity and between Hct and plasma ChE activity then inform us as to the timing of these 
changes and the distribution of plasma ChE activity within body water compartments. The 
regression constants indicate that changes in Posm and plasma ChE activity were concurrent and 
preceded change in Hct. This suggests that plasma ChE occupies a larger pool of body fluid than 
just the PV. Further, the regression slopes indicate that changes in Posm, plasma ChE activity and 
Hct were not proportional. A 1% change in Posm was associated with a 3.5% change in plasma 
ChE activity which, in turn, was associated with a 3.0% change in Hct. This also suggests 
differences among the volumes of the body water compartments associated with each of Posm, 
plasma ChE activity and Hct. Posm variation is associated with change in the concentration of 
electrolytes which are distributed throughout the ECV. Hct is a measure unique to PV. It appears 
that plasma ChE activity is therefore not limited to plasma but instead occupies a larger pool of 
body fluid intermediate between PV and ECV and we suggest lymph as a repository for ChE 
activity. Observations in mammals suggest that ChE in plasma and thoracic duct lymph are 
coupled (Lindena et al., 1986). Lindena et al. (1986) measured the thoracic duct lymph to plasma 
ratio of ChE activity in dogs, rabbits, rats and mice and inferred a concentration gradient forcing 
the transport of ChE from plasma to lymph. If these observations in mammals are true for our 
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quail, then we have a mechanism that explains our observations. Dehydration initially caused a 
reduction in the ECV while PV was maintained. Posm and plasma ChE activity both increased but 
the proportional increase in Posm was less than that of plasma ChE activity as plasma ChE 
activity is confined to a smaller subset of the ECV than Posm. Eventually, as dehydration 
proceeded, the ability of the quail to maintain PV was exceeded and loss of PV resulted. Then 
Hct increased with both Posm and plasma ChE activity. Here the proportional increase in Hct was 
smaller than that in plasma ChE activity, suggesting the quail continued to favor conservation of 
PV over other compartments of the ECV as dehydration progressed. 
The combination of 5 days dehydration and sublethal acute oral dicrotophos exposure at 
one-third the estimated oral LD50 of dicrotophos in quail resulted in near normal plasma ChE 
activity. Dehydration confounded the diagnosis of dicrotophos exposure in quail using plasma 
ChE activity. This finding is similar in trend with that observed by Rattner et al. (1983) in which 
an osmoregulatory challenge associated with saline drinking water dampened the plasma ChE 
inhibition response of black ducks to fenthion exposure. It is also apparent that if a correlation 
between changes in Posm and plasma ChE activity can be established, then it may be possible to 
adjust plasma ChE activities for dehydration effects. 
 These findings are of importance for two reasons. Firstly, the effect of 
dehydration on plasma ChE activity in this species is antagonistic to the effect of dicrotophos. 
Clinicians and investigators using plasma ChE activity to diagnose or quantify exposure to the 
anticholinesterase pesticides should note that dehydration can mask the effects of 
anticholinesterase agents on plasma ChE activity. Secondly, the observed relationships between 
changes in Posm and Hct with change in plasma ChE activity reveal that ChE of plasma actually 
occupies a larger pool of body fluid. This suggests that the mechanisms involved in 
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osmoregulation contribute to some of the natural variability of plasma ChE activity. We note that 
much effort has been put into characterizing the variation of plasma ChE activity with season, 
time of day, cohort, hormone status, etc. while little effort, if any, has been put into describing 
the mechanisms underlying this natural variation. Here we postulate that the loss of plasma ChE 
activity through daytime hours known in some bird species, as observed in clay-colored robin 
(Turdus grayi) by Cobos et al. (2010), for example, may simply reflect a net gain in body water 
with daytime feeding and drinking. In that regard, we suggest that study of the mechanisms 
responsible for natural variation in plasma ChE activity is warranted and recommend 




6.0 TELEMETRY OBSERVATIONS OF  HYPOTHERMIA AND TACHYCARDIA IN 
COTURNIX QUAIL IN RESPONSE TO SUBLETHAL ORAL DOSES OF 
ORGANOPHOSPHATE PESTICIDES AND COLD-STRESS 
 
6.1 INTRODUCTION 
 Heinz (1989) asked if the sublethal effects of environmental pollutants are truly harmful 
to bird populations and noted two principal failings in the science of the day in answering the 
question. Firstly, there was little evidence that the sublethal effects of contaminants observed in 
the lab actually occurred in the field (Heinz 1989). Secondly, proof was required that a sublethal 
effect observed in the lab would cause mortality in the field (Heinz 1989). Two years later, the 
review of Grue et al. (1991) summarized many of the sublethal effects associated with exposure 
to cholinesterase (ChE) inhibitors, the organophosphorus (OP) and carbamate pesticides. In that 
same year, Mineau (1991) commented upon some of the sublethal effects of ChE inhibitors that 
may influence the long term survival of exposed wildlife. Grue et al. (1997) revisited the topic in 
1997 and discussed at length the sublethal effects they thought most likely to adversely impact 
wildlife populations within regions where ChE inhibitors are used. Each noted either that the 
data of the day either provided only for generalizations about the effects likely to result from 
given levels of exposure (Grue et al. 1991, Mineau 1991) or were of limited utility to regulators 
(Grue et al. 1997). Regrettably, it appears that there has been little progress in the many years 
since these publications. 
Outward clinical signs in birds of sublethal cholinergic toxicity include ataxia, blindness, 
convulsions, dyspnea, hyperexcitability, lethargy, piloerection, slurred vocalizations, and 
tremors, among others (Grue et al. 1991). Sublethal behavioural effects include altered activity 
patterns, reduced food and water intake, aggression, and adverse effects on nest defense and 
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parental care (Grue et al. 1991, Grue et al. 1997). These behavioral deficits may impair survival 
or reproduction (Grue et al. 1991, Grue et al. 1997). Adverse effects on thermoregulation (Grue 
et al. 1991, Grue et al. 1997) and cardiac function (Grue et al. 1991) have also been observed. It 
is these latter effects on thermoregulation and cardiac function that were the focus of this study. 
The use of radio telemetry implants to monitor physiological responses to OP pesticides 
is a better developed practice in mammals (Gordon 1996, Gordon and Padnos 2000, Smith and 
Gordon 2005) than it is with birds. Telemetry has been used to investigate OP-induced changes 
in cardiovascular function or thermoregulation in mammals (Gordon and Padnos 2000, Smith 
and Gordon 2005), but we are not aware of any similar application in birds. McFarland and Lacy 
(1968) investigated parathion’s effects on heart rate in quail and ducks using restrained birds 
hard-wired to an Offner Dynograph. Underwood (1994) later used telemetry to investigate the 
diurnal rhythm of a regulated hypothermia in Japanese quail but never explored the effects of 
toxicants on the phenomenon. This study’s use of radio telemetry implants to monitor the 
sublethal effects of OP exposure on thermoregulatory and cardiac function in birds therefore 
appears to be the first published application of telemetry for this purpose with the potential to 
both yield empirical data about the sublethal affects of OP pesticides on birds and demonstrate 
the feasibility and utility of using telemetry in avian studies of this nature. 
This study uses radio telemetry implant techniques to test the hypothesis that sublethal 







6.2 MATERIALS AND METHODS 
6.2.1 Experimental Species 
Coturnix quail (Coturnix coturnix) were purchased from Fircrest Farms Ltd. (Langley, 
BC, Canada). All quail used in the study were males between 6 and 26 weeks of age. 
 
6.2.2 Animal Care and Housing 
The study was conducted in accordance with Protocol #20070071 approved by the 
Research Ethics Board of the University Committee on Animal Care and Supply at the 
University of Saskatchewan. All quail were housed indoors at the Animal Care Unit in the 
Western College of Veterinary Medicine, University of Saskatchewan, from their date of arrival 
until surgical implantation of radio telemetry devices. After surgery, quail were transferred to the 
Toxicology Centre at the university during the post-surgical recovery period and held within 
well-ventilated individual containers in an anteroom to an environmental chamber. Quail were 
maintained under a 8 hours light:16 hours dark cycle and were provided a commercial, 
medicated (amprolium 125 mg/kg), crumbled turkey starter feed (Federated Co-operatives 
Limited, Saskatoon, SK, Canada) and water ad libitum. 
 
6.2.3 Experimental Design 
A completely randomized design was used to assess the effect of sublethal oral 
organophosphate pesticide exposures on heart rate and body temperature. Quail were assigned to 
three groups; sublethal oral exposure to two different OP pesticides and one sham. Heart rate and 
body temperature were measured in each quail repeatedly over a five day period both before and 
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after exposure and under both simulated day-time thermoneutral and night-time cold-stressed 
conditions. The sample size was five birds per trial. 
 
6.2.4 Organophosphate Insecticide Exposures 
Spray formulations of dicrotophos (DCP)(BIDRIN
®
, 82.0% DCP by weight, Amvac 
Chemical Corporation) and ethoprop (ETP)(MOCAP
®
, 69.6% ETP by weight, Bayer 
CropScience) were used in the experiment. These formulations were diluted in reverse osmosis 
water as needed and quail were dosed by oral gavage at approximately one-third the estimated 
LD50 for this species. Oral dose rates were 1.9 and 2.5 mg/kg for DCP and ETP, respectively. 
Additional trials were completed with the OPs methamidophos and naled but these efforts are not 
reported here (Supplemental Material). 
 
6.2.5 Radio Telemetry Equipment and Surgeries 
Five battery-free implantable transponders (G2-HR E-Mitter), a single energizer/receiver 
(ER-4000 Energizer/Receiver), and related software (VitalView Data Acquisition Software) 
were purchased from Mini Mitter Company Inc (Bend, OR, USA).  
Quail were anaesthetized by isoflurane inhalation and prepared for sterile surgery. The 
temperature sensors were placed subcutaneously in the abdominal wall along the fold formed by 
the inner thigh and belly on the right side. The electrodes were located over the heart and 
attached to breast muscle with metal suture wire. Following recovery from anaesthesia, quail 
were housed in individual containers and placed under observation for a minimum of 1 week 
prior to data collection. All implanted quail recovered from surgery without complication. 
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The battery-free transponders had to be held immediately above the energizer/receiver to 
be energized and so collect and transmit data. The use of a single energizer/receiver for the five 
transponders required rotating implanted quail on and off of the energizer/receiver. This was 
accomplished without direct physical contact with the quail by moving entire individual housing 
containers. 
It was necessary to reuse the implants for each trial. Implants were removed from the 
quail carcasses following euthanasia, cleaned and gas-sterilized using ethylene oxide. Data were 
collected in the various trials in sequence. 
 
6.2.6 Body Temperature and Heart Rate Data Collection 
Data were collected on 4 days over a 5 day protocol: Day -1 (one day pre-exposure); Day 
0 (exposure day); Day 1 (one day post-exposure); and Day 3 (three days post-exposure). The 
sham and sublethal pesticide exposures were administered by oral gavage between 1000 and 
1100 hours on Day 0. The gavages were given to the telemetred quail in sequence, one every 
twelve minutes, over the one hour exposure period. The sham consisted of vehicle alone at 
volumes similar to those used to deliver the pesticides. Discrete measures of body temperature 
and heart rate data were collected hourly under simulated day-time thermoneutral conditions (18-
21°C) from 1300 to 1600 hours and under simulated night-time cold-stressed conditions (4-5°C) 
from 1700 to 2100 hours on each of the four observation days. Data were collected from the 
telemetred quail sequentially, one quail every twelve minutes, in a manner consistent with their 
dosing. Observations under thermoneutral conditions were recorded in the anteroom to the 
environmental chamber where quail were held for post-surgery recovery. Observations under 




All data used in statistical analyses were normalized to a zero-mean on the pre-exposure 
day (Day -1). Data were examined using repeated measures analysis of variance (ANOVA). Post 
hoc multiple comparisons were completed using paired t-tests with Bonferroni corrections. The 
relationship between effects on thermoregulation and effects on heart rate were investigated 
using ordinary least squares regression. Significance was associated with p<0.05. All statistical 
analyses were completed on PASW Statistics 18.0 software (SPSS Inc.). 
 
6.3 RESULTS 
6.3.1 Body Temperature and Heart Rate in Unstressed Quail 
Body temperature and heart rate in quail under thermoneutral conditions on the pre-
exposure day were assumed representative of an unstressed condition. Differences in body 
temperature and heart rate among trials existed but were not significant and observations were 
pooled. Mean (SE) body temperature and heart rate were 41.0°C (0.4°C)(n=14) and 242 beats 
per minute (bpm)(28 bpm)(n=14), respectively. 
 
6.3.2 Sample Losses 
One quail in the ETP-exposed group was removed from cold-stressed conditions on Day 
0 when its body temperature dropped to 36.3°C. This bird was ataxic with shivering or tremors 







The multiple hourly discrete measures of body temperature obtained during observations 
in each of the day-time thermoneutral and night-time cold-stressed conditions were used to 
generate single measures of body temperature for each quail in each temperature regime on each 
day. Body temperatures were generally consistent throughout the day-time thermoneutral 
observations and the average of all discrete measures collected during each daily thermoneutral 
period served as the daily single measure of body temperature under thermoneutral conditions 
(Tt). Body temperatures declined to a stable level during the first couple of hours of observations 
under night-time cold-stressed conditions and the average of the last two hourly measures of 
body temperature served as the daily single measure of body temperature under cold-stressed 
conditions (Tc). 
The effect of day on Tt in the sham was not significant. Both OP trials showed a 
significant effect of day (DCP, F3=15.15, p<0.001; ETP, F3=9.45, p=0.004). Post hoc tests were 
performed on data in the OP trials to examine differences between effects among days (Figure 
6.1). Hypothermia was evident in both the DCP and ETP quail on Days 0 and +1. 
Tc data were analyzed in a manner consistent with that used for Tt. No significant effect 
of day was found in any trial. 
 
6.3.4 Heart Rate 
Some quail were clearly agitated by the environmental chamber as indicated by increases 
in heart rate upon entry into the chamber. Noise from the compressor in the environmental 
chamber was suspected to cause stress in quail within the chamber. This stress is also clearly not 
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Day of Exposure Protocol




























































































Figure 6.1. Variation in body temperature under thermoneutral conditions (Tt) in sham-exposed 
and organophosphate-exposed quail among days where days are: -1) one day pre-exposure; 0) 
the day of exposure; 1) one day post-exposure; and 3) three days post-exposure. Error bars 
denote (+/-) standard error. Upper and lower case letters denote homogenous subsets within the 
dicrotophos and ethoprop trials, respectively (p<0.05). 
 
related to OP-exposure as it was observed in some sham-exposed quail and in some pesticide-
exposed quail in the pre-exposure days. Heart rate was also elevated in response to handling of 
the housing containers but rapidly returned to normal. 
 The effect of day in HRt data of the sham trial was not significant. The DCP and ETP 
trials both showed highly significant effects of day (DCP, F3=22.53, p<0.001; ETP, F3=26.52, 
p<0.001). Post hoc tests revealed differences between effects among days (Figure 6.2). In both 
cases that response was an ephemeral tachycardia apparent on Day 0. 
 Analysis of HRc data in the ETP trial revealed an effect of day (p=0.035). However, as 
post hoc tests failed to find any differences between HRc on Day 0 and any other day in the ETP 




6.3.5 Linear Regressions 
 Regression using measures of the change in HRt and change in Tt (both Day 0 minus Day 
-1) in quail from all treatments (n=14) revealed a significant negative correlation between the 
parameters (F1=9.264, p=0.010)(Figure 6.3). Variation in the change in HRt explained 
approximately 44% of the variation in change in Tt. The intercept was -0.401°C but not 
significant. A similar regression using change in both HRc and Tc failed to find a relationship 
between these variables. 
 
6.3.6 Observed Thermoregulatory Failure and Mortality 
 Observations in three quail excluded from statistical analyses are exceptional in that the 
hypothermia observed in these quail was extreme and suggests an almost complete failure in 
thermoregulatory ability in response to cold stress. Tt in the ETP-exposed quail that died 
following data collection on the day of exposure was 37.0°C. Hourly body temperature data 
indicate that this quail was actually recovering from an extreme hypothermia in the first few 
hours immediately following dosing. At 7 hours post-dose when the quail was introduced into 
the environmental chamber its body temperature was 38.3C°. One hour later it was removed 
from the environmental chamber with a body temperature of 36.3°C. The maximum heart rate 
observed in this bird was 533 bpm, a tachycardia of 291 bpm relative to the mean unstressed 
heart rate. Two quail from a preliminary trial with naled had obviously compromised 
thermoregulatory abilities that persisted into Day +3. Both of these quail had to be rescued from 
the cold chamber in Days 0, +1 and +3. On Day 0, the lowest observed body temperatures in 
these quail were 37.0 and 36.9°C. The extreme in heart rate on the day of exposure was 563 bpm 
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Fig. 6.2. Variation in heart rate under thermoneutral conditions (HRt) in sham-exposed and 
organophosphate-exposed quail within days where days are: -1) one day pre-exposure; 0) the day 
of exposure; 1) one day post-exposure; and 3) three days post-exposure. Error bars denote (+/-) 
standard error. Upper and lower case letters denote homogenous subsets within the dicrotophos 
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Fig. 6.3. Linear regression between effects in heart rate and thermoregulation in quail exposed to 
dicrotophos using change in heart rate under thermoneutral conditions (HRt) and change in body 
temperature (Tt) from the day of exposure (Day 0) to the pre-exposure day (Day -1)(n=14). 
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 in one bird. The thermoregulatory abilities of these two quail in response to cold-stress were 
compromised for 80 hours post-dose when the experiment was terminated. 
 
6.4 DISCUSSION 
 Quail exposed to DCP and ETP presented with significant hypothermia of 1.21 and 
1.20°C and significant tachycardia of 98.4 and 133 bpm, respectively, under thermoneutral 
conditions in a period 3 to 6 hours post-dose on the day of exposure relative to their condition 
during the same time period on the pre-exposure day. The observed hypothermia in the DCP and 
ETP quail persisted into the first post-exposure day although the effects, 0.76 and 0.50°C, 
respectively, were reduced. Effects on heart rate in these birds had dissipated by 1 day post-
exposure. Effects on thermoregulation persisted for longer than effects on heart rate. 
 Although significant hypothermia was evident in both the DCP and ETP quail under 
thermoneutral conditions on Days 0 and +1, no significant hypothermia was observed in the 
intermediate period (i.e. under cold-stressed conditions on Day 0) for either compound. A 
probable confounding factor is the presence of a diurnal regulated hypothermia. Underwood 
(1994) examined the circadian rhythm of thermoregulation in telemetred Japanese quail, a 
species closely related to the Coturnix quail utilized in this work, and found them to possess a 
circadian rhythm in regulation of body temperature that was strongly entrained to light-dark 
cycles. We postulate that a similar diurnal regulated hypothermia exists in our species and that it 
and any regulated hypothermia in response to the OP insult and any unregulated hypothermia in 
response to cold-stressed conditions were not additive but coincident. This suggests that 




Quail were obviously stressed by handling and many were sensitive to the environmental 
chamber in which measurements of HRc were made. Heart rate in these quail was elevated in 
response to these stimuli. Quail in the DCP and ETP trial did display tachycardia under cold-
stressed conditions on the day of exposure, 64.8 and 102 bpm relative to the pre-exposure 
condition, respectively, but this response was highly variable and statistical analyses were 
inconclusive. 
 The coincidence of effects in heart rate with effects on thermoregulation is of interest as 
the cardiovascular and thermoregulatory systems are coupled. There is the possibility that OP 
effects on the cardiovascular system may interfere with thermoregulatory ability (i.e. prevent 
thermoeffector control over vasoconstriction/vasodilation).Whether or not the observed 
tachycardia is indicative of such effects is unknown. Nonetheless, the adverse effects on 
thermoregulation may have been exacerbated by dysfunction in the cardiovascular system. 
 These findings are important for several reasons. Firstly, the observations with DCP and 
ETP appear to offer only the second record of significant OP-induced effects on heart rate in 
birds and the first record using unrestrained telemetered birds. Secondly, the observations with 
these OPs describe a progression of effects on body temperature and thermoregulation with 
increasing OP toxicity ranging from a mild and potentially beneficial regulated hypothermia in 
response to OP-exposure under thermoneutral conditions to a severe dysfunction in 
thermoregulatory ability that is tolerable under thermoneutral conditions but potentially lethal 
under cold-stressed conditions. Lastly, this work demonstrates the utility of telemetry in 
observing sublethal effects on the physiology of birds in response to OP-exposure. 
 It may be that the use of telemetred birds in pen studies could finally provide the answers 
to the questions posed by Heinz (1989). However, it is also apparent that further laboratory work 
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is necessary to better describe how sublethal effects progress and potentially interact in causing 
mortality. Although interactions between anticholinesterase toxicity and thermal stresses have 
been observed (Rattner et al. 1987, Martin and Solomon 1991), the mechanisms involved in 




7.0 SUMMARY AND CONCLUSIONS 
7.1 CONCLUSIONS 
The research objectives and related conclusions are: 
1. To determine the contributions of various routes of exposure to total toxicity in birds from 
spray applications of a set of OP pesticides of varying physicochemical properties under 
simulated field conditions. 
 
The dermal route of exposure was the primary contributor to total toxicity in quail under 
simulated field conditions regardless of the exposure scenario tested, the OP pesticide used, or 
the post-exposure period at which toxicity was determined. The oral route of exposure 
contributed little to toxicity either as quail were deterred from feeding, as was the case with 
MMP and NLD (thought due to their irritant properties), or as the feed consumed produced no 
significant effect in brain, as was the case with DCP and ETP (thought due to the sheltering 
effect of the vegetative canopy limiting contamination of the feed). Consumption of feed on the 
simulated field failed to explain the toxicity observed in brain. Exposure to the pesticide spray 
itself produced significant increases in toxicity as measured in plasma (DCP, ETP, and MMP) 
and brain (NLD). Differences in inhibition and recovery of ChE activity in quail between control 
oral gavage exposures and simulated field exposures suggest the presence of a skin reservoir for 
storage and delayed release of dermally absorbed OPs. The effect of this reservoir increased with 





2. To develop an exposure model for predicting the contributions of the oral, dermal, and 
potentially other routes of exposure to total toxicity of OP pesticide sprays in birds based 
upon the physicochemical properties of the OP itself and its application rate. 
 
Log Kow of the OPs significantly predicted inhibition of brain ChE activity in simulated field 
exposures at both 24 and 72 hours post-exposure and also significantly predicted further 
inhibition of brain ChE activity associated with additional direct exposure to the pesticide spray 
itself, although this relationship was relatively weak. Quadratic polynomial curves were fit to the 
data in each case. The findings predict that directly acting OPs of log Kow in the range of 0 to 1.5 
are those most readily absorbed and distributed via the dermal route under field conditions. 
These findings are generally consistent with observations in mammals. 
 
3. To determine if short term dehydration of birds confounds the diagnosis of OP-exposure 
using measures of ChE activity in brain or plasma. 
 
Short term dehydration resulting from water deprivation over a period of 5 days caused an 
apparent increase in plasma ChE activity in quail. This effect in quail was antagonistic to that 
which resulted from a sublethal oral dose of dicrotophos (one-third the LD50). The two stressors 
in combination produced plasma ChE activity that appeared slightly induced, although it was not 
significantly different from that of control quail. Under these circumstances, dehydration 
confounded the diagnosis of dicrotophos exposure using plasma ChE activity. A method for 
correcting the observed plasma ChE activity for the effects of dehydration using measures of 
Posm and the observed relationship between Posm and plasma ChE activity was developed. 
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Application of this method to the data provided a more robust portrayal of dicrotophos exposure 
and eliminated the confounding affect of dehydration. 
 
4. To determine if sublethal oral exposure to OPs adversely affects cardiac and 
thermoregulatory function in birds under different temperature regimes (18°C and 4°C) using 
radio telemetry implants. 
 
Sublethal oral doses of DCP and ETP at one-third the estimated LD50 caused significant 
hypothermia and tachycardia in quail as measured using telemetry implants. These effects were 
ephemeral and evident only in the day immediately following the exposure under thermoneutral 
conditions. Analyses of brain ChE activity of other similarly exposed quail suggest that 
telemetred quail exposed to DCP and ETP had greater than 50% inhibition of brain ChE activity 
in the day following exposure. The effects on body temperature and heart rate in quail using 
doses of MMP and NLD were not significant and this was attributed to a much lower inhibition 
of brain ChE activity in these birds. Observations in three quail excluded from statistical 
analyses suggest that effects on thermoregulation which are sublethal under thermoneutral 
conditions can become lethal under cold-stressed conditions. The effects observed in these three 
quail included an extreme ephemeral tachycardia and a failure of thermoregulatory ability under 
cold-stressed conditions that persisted to the end of the protocol at three days post-exposure. 
 
7.2 CONTRIBUTIONS 
1. This appears to be one of few published uses of measures of effect size in ANOVA with 
avian cholinesterase data. A literature search using the Google Scholar search engine using 
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the key words ‘birds cholinesterase’ first, ‘birds cholinesterase ANOVA’ second, and ‘birds 
cholinesterase ANOVA eta-squared’ lastly produced ~10,300 results, ~1,170 results, and 3 
results, respectively. None of the 3 results found in the last search were actually related to 
avian cholinesterase research. Similar searches with academic search engines (TOXLINE, 
PubMed, CABI, Scopus) were even less fruitful. Although eta-squared first appeared in the 
literature in 1911 (Pearson 1911) and although practitioners in other fields in past decades 
have both espoused the utility of eta-squared and partial eta-squared and offered direction on 
how to conduct such analyses (Cohen 1973, Cohen 1988, Levine and Hullett 2002), 
researchers studying the effects of anticholinesterase pesticides on birds appear ignorant of 
the utility of measures of effect size. This may simply reflect a lack of complex experimental 
designs in this field. Regardless, the author offers his own results in dealing with significant 
effects in pre-exposure plasma ChE activity as evidence in seconding the opinion of Levine 
and Hullett (2002) that “there are good reasons to report estimates of effect size in addition to 
p-values”. 
2. This appears to be the first instance in which cholinesterase activity as measured in 
unknowns, here the brains of Coturnix quail, has been normalized to the median activity in a 
highly variable in-house cholinesterase assay analytical standard. Rather it is common 
practice to reject and repeat cholinesterase assays when activity in the standard falls outside a 
narrow range about the mean. Indeed the author would have preferred such circumstances in 
this work. Nonetheless, the method developed for normalizing activity in unknowns to a 
measure of central tendency in the in-house standard may prove useful to others as the 
evidence presented here suggests the method has practical benefits. Firstly, variability in the 
activity of an in-house analytical standard may be more tolerable than is generally believed 
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and this ‘noise’ may be better interpreted as a ‘signal’ upon which one can base corrections 
to observations in unknowns. The result is that time and materials need not be wasted on the 
unnecessary repetition of cholinesterase assays and this has obvious benefits in the saving of 
money, sample, and frustration. Secondly, it appears that this method resulted in an estimate 
of reference brain cholinesterase activity among the most precise published in the primary 
literature with a comparable sample size. This new use of the in-house standard appears to be 
an improvement to current practice in estimating brain cholinesterase activity in birds. 
3. An influence of the dermal route of exposure on the toxicodynamics (inhibition and recovery 
of ChE activity in plasma and brain) to spray applications of DCP, NLD, and ETP under 
simulated field conditions was demonstrated. Dermal absorption appeared to be the main 
contributor to the toxicity observed under simulated field conditions. Although differences in 
the toxicodynamics of the oral and dermal routes of exposure routes have been demonstrated 
under laboratory conditions with controlled exposures (i.e. oral gavage and solvent-deposited 
dermal doses) with both mammals (Kramer et al. 2002b) and birds (Henderson et al. 1994), 
this is the first instance in which the influence of route of exposure on toxicodynamics has 
been observed with exposures approximating those expected under field conditions (i.e. with 
DCP and ETP). Further, the inferences made herein differ from those of Driver et al. (1991), 
who also inferred dermal exposure as being the primary contributor to the toxicity of an OP 
under simulated field conditions, in that these inferences were made based upon observations 
resulting from experiments with a set of OPs of varying solubility properties and in that a 
single mechanism was proposed to explain both the common influence of the dermal route of 
exposure on simulated field exposures among DCP, NLD, and ETP collectively and the 
differences in the toxicodynamics of the simulated field exposures between them. This 
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mechanism, the reservoir effect, is well-documented in research on transdermal drug delivery 
in humans (Roberts et al. 2004) but its relevance in avian ecotoxicology is uncertain. The 
evidence here indicates that the formation of a pesticide reservoir in avian skin is of 
relevance to avian ecotoxicology. 
4. This is the first demonstration that the solubility properties of OPs influence the absorption, 
distribution, and toxicity (i.e. inhibition of ChE activity) of an OP following pesticide spray 
application under conditions approximately those in the field. Herein, all else being generally 
equal, OPs with balanced lipid:water solubility appeared to be more hazardous to quail than 
OPs more extreme in their solubility properties. Further, this finding was generally consistent 
with prior work (Mineau 2002) that found adding a term integrating several physicochemical 
properties of anticholinesterase pesticides into logistic regression models of mortality risk 
based upon a field study data set significantly improved model performance. The term added 
to the models was negatively correlated with log Kow of the active ingredient, implying 
anticholinesterases of lower log Kow (i.e. balanced lipid:water solubility) were more 
hazardous in the field than more lipophilic anticholinesterases. Collectively, the work here 
and that of Mineau (2002) indicate the current screening level pesticide risk assessment 
model (i.e. the quotient method) could be improved by giving consideration to the 
physicochemical properties of the active ingredient in pesticide sprays using OPs specifically 
and anticholinesterases generally. 
5. The effect of dehydration on quail as observed in measures of Posm and Hct and the 
consequent significantly related variation in plasma ChE activity suggest that variation in the 
water balance within birds explains some of the known variation in plasma ChE activity. 
This is the first physiological mechanism proposed to explain variation in plasma ChE 
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activity and, as such, is important given the high degree of variability known in this 
parameter. Indeed the utilization of plasma ChE activity in the investigation of 
anticholinesterase exposure and effects is diminished by its highly variable nature. The 
advice to clinicians and researchers taking measures of plasma ChE activity is therefore 
simply this: You have covariates in Posm and Hct and you should measure them! Admittedly, 
the degree to which measures of Posm and Hct prove useful in observational studies involving 
plasma ChE activity in wild birds is unknown. If the bird population under study has easy 
access to water, then measures of Posm and Hct may be of little benefit. However, the 
potential for variation in the water balance as measured with Posm and Hct, surrogates for the 
ECV and PV, respectively, to explain the presence of outlier measures of plasma ChE 
activity or relate autocorrelated variation (i.e. diurnal, seasonal) in plasma ChE activity to 
behaviour, feeding strategies, and potentially life history traits is undeniable. Indeed, as there 
is evidence that suggests variation in the water balance in birds may be part of a generalized 
short term stress response (Olanrewaju et al. 2007), then monitoring the water balance in 
birds may reveal relations between plasma ChE activity and stressors other than water 
deprivation, including toxicity from xenobiotics other than anticholinesterases, infection and 
disease, and injury. 
6. The utility of telemetry techniques in the investigation of anticholinesterase exposure-
induced effects on the cardiovascular and thermoregulatory systems of birds was 
demonstrated. Telemetrey implants designed for use with laboratory rodents were adapted for 
use in quail. The observations of concurrent significant tachycardia and hypothermia in quail 
resulting from anticholinesterase exposure are the first such records using telemetred birds. 
These records also describe a progression of effects from mild and not significant to strong 
141 
 
and significant dysfunction in the cardiovascular and thermoregulatory systems which in 
three quail were at once tolerable under thermoneutral conditions but potentially lethal under 
cold-stressed conditions. 
 
7.3 FUTURE RESEARCH 
7.3.1 Use of In-House Cholinesterase Assay Analytical Standards 
The in-house analytical brain cholinesterase assay standard used in this work provided a 
means to correct observations in brain unknowns for unwanted effects thought to result primarily 
from between-batch variation in the assay temperature. The end result was a measure of control 
quail brain ChE activity that was remarkable in its precision given the variability in the standard. 
Although the utility of this method is evident in these results, the method has not been subject to 
a rigorous validation study. Therefore, the degree to which this method will prove useful where 
the source of error is between-batch variability in assay temperature or some other factor (i.e. 
between-batch variability in reagent solutions) or prove useful with other tissues (i.e. plasma 
ChE) is deserving of further investigation. 









ATj      (Eq. 7.1) 
where 
std
ATi =   ChE activity in the standard at a given temperature, Ti 
 
std
ATj =   ChE activity in the standard at some other temperature, Tj 
 
unk
ATi =   ChE activity in an unknown at a temperature, Ti 
 
unk
ATj =   ChE activity in the same unknown at temperature, Tj. 
Hypothetically, this equation may be extended to include fixed concentrations of the reagent, Ri, 











ATjRiSi.    (Eq. 7.2) 
One can then envision an investigation of how variation in assay temperature and concentrations 
of reagent and substrate solutions, each alone and in all possible combinations, influence 
measures of ChE activity in a single set of unknowns (including one unknown as a standard) 
using a factorial experimental design in which there are three factors, assay temperature and 
concentrations of the reagent and the substrate. Analyses would proceed using both RTO and 
ANOVA. RTO would be used to test the null hypothesis that there is no relationship between the 
different measures of activity in the unknowns and the standard resulting from variation in one or 
more of the factors, alone or in combination, here for example assay temperature and 
concentration of the reagent: 












ATjRj =… …= 0 (Eq. 7.3). 
Further, ANOVA would be used to compare the mean activity in the unknowns, Ā, in each 
treatment (different levels of the factors in all combinations) once normalized to the activity of 
the standard, 
std
ATiRiSi, and so test the null hypothesis: 
Ho: ĀTiRiSi = 
normĀTjRiSi = 
normĀTiRjSi =… …= 
normĀTjRjSj    (Eq. 7.4). 
This effort would provide a statistically rigorous validation of the method developed for 
normalizing the activity in unknowns to a measure of central tendency in the standard. 
 The use of this method in the measurement of ChE activity in avian plasma is a more 
complicated matter. Avian plasma typically includes both AChE and BChE whereas the method 
developed in this thesis relies on the in-house standard being the same single enzyme as is being 
measured in the unknowns and so being similarly sensitive to variation in assay temperature and 
other factors contributing to variability in the assay. An extension of this method to plasma, if 
possible, will rely on the use of a selective inhibitor to discriminate between the activity 
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associated with each of the two enzymes, AChE and BChE. Thereafter, the experimental design 
described above may provide some insight. Such an investigation would also obviously require 
the use of two standards. 
 
7.3.2 Dermal Exposure of Birds to Pesticides 
This work indicates that the dermal route of exposure contributes to the toxicity of OP 
insecticidal sprays in birds in the field. However, the evidence presented here is indirect in that it 
relies on inhibition and recovery of ChE activity in tissues, biomarkers of exposure and effect, 
and not on direct measures of the amount of the compounds being absorbed through skin. Given 
the lack of direct evidence that the observed effects are the result of doses absorbed through skin, 
the inferences made may be doubted. It is therefore the author’s opinion that a necessary next 
step is to better characterize dermal absorption in birds and how it varies with the 
physicochemical properties of the compound of interest. 
Numerous methods have been developed to investigate dermal absorption in mammals 
due to interest in occupational exposure to pesticides, cosmetics, and transdermal drug delivery. 
Both the Organisation for Economic Co-operation and Development (OECD) and the EPA have 
developed guidelines for the in vitro and in vivo assessment of dermal absorption (van de Sandt 
et al. 2004). An investigation into how intra- and inter-laboratory variation affected predictions 
of skin absorption in compounds of varying physicochemical properties found that the 
standardized methods employed by the OECD yielded robust predictions of dermal absorption 
(van de Sandt et al. 2004). These established, standardized, and validated methods for dermal 
absorption studies in mammals can likely be adapted for use with birds. It would then be possible 
to confirm experimentally how dermal absorption in birds is similar to and different from dermal 
144 
 
absorption in mammals. For example, the observations herein indicate that compounds of 
balanced lipid:water solubility are more readily absorbed through bird skin than compounds that 
are either more hydrophilic or more lipophilic but no inference can be made as to whether the 
absorption rates were slower or faster than rates observed in mammals. Initial efforts could be 
focused on in vitro methods (i.e. diffusion cells) and non-toxic reference compounds of varying 
properties, like those recommended by the OECD (i.e. benzoic acid, caffeine, testosterone) (van 
de Sandt et al. 2004), thereby avoiding at least some of the issues related to animal welfare and 
hazardous materials handling that complicated this work. As with investigations using mammals, 
efforts could be focused on obtaining measures of maximum rate of absorption, time to 
maximum rate of absorption, and the mass balance (i.e. recoveries in donor and receptor 
solutions and in isolated skin samples) (van de Sandt et al. 2004) for comparisons among 
compounds and between species. 
 
7.3.3 Modeling of Exposure and Effects 
The intent of this work was to provide insight into what routes of exposure contribute to 
the toxicity of OP insecticidal sprays in birds in the field and subsequently develop methods for 
improving the accuracy in predictions of effects. This work therefore indirectly tested one of the 
central assumptions inherent in the QM of screening level avian ERA for pesticide registration: 
that alimentary exposure is the only route of exposure of relevance in assessing the risk to birds 
from pesticide use. This study indicates otherwise. The author’s own opinions on the matter are 
that exposures in the field are extremely complex and involve multiple routes of exposure 
concurrently. Assuming complex, multiroute exposures, then a logical next step is to question 
another central assumption in avian pesticide effects studies: that effects among exposure routes 
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are additive. This assumption is well-enough embraced to have been adopted in experimental 
methods, those used for estimating toxicity resulting from dermal exposure in the work of Driver 
et al. (1991), for example, yet to the author’s knowledge it has never been validated. The 
author’s interest is therefore in a tool for modeling exposure and effects that is capable of 
handling the complexity of multiroute exposures and that does not rely on the assumption of 
additivity in effects among exposure routes. 
Physiologically-based, pharmacokinetic, pharmacodynamic (PBTKTD) modeling offers 
exactly such a tool. There appear to be few avian PBTKTD models published in the primary 
literature. A literature search using the Google Scholar search engine and the key words ‘birds 
physiologically based pharmacokinetic pharmacodynamic model’ produced approximately 2,790 
results. A review of the first 100 results found only 5 publications actually involving avian 
physiologically-based pharmacokinetic models, none of which included pharmacodynamic 
parameters. Four of the 5 were studies on drug residues in poultry intended for human 
consumption and the fifth was on the accumulation of persistent organic pollutants in avian 
wildlife. The author knows of no published avian PBPKPD models for OP exposure although 
such models have been developed for mammals (Timchalk et al. 2002). The interest in PBPKPD 
models lies in the ability of such models to combine doses from different routes in estimating the 
effects of complex multiroute exposures (Tan et al. 2006). Further, these models provide for the 
reconstruction of exposures from biomarker data (Mosquin et al. 2009), an modeling exercise 
analogous to the reasoning applied in Chapter 3 where patterns of recovery of ChE activity in 





7.3.4 Stressors and Variability in Plasma Cholinesterase Activity in Birds 
The observation that dehydration induced by deprivation of water caused an apparent 
increase in plasma ChE activity implies that changes in the body water balance of birds 
generally, regardless of cause, might contribute to substantially to the known high degree of 
variability in this parameter. As the high degree of variability in plasma ChE activity reduces its 
utility as a measure of anticholinesterase exposure, any effort that characterizes or explains this 
variability is bound to be of utility. 
It will be prudent to collect measures of Posm and Hct concurrently with measures of 
plasma ChE activity and treat them as covariates in statistical analyses in observational studies 
conducted in the field and so attempt to differentiate between affects related to variation related 
to maintenance of water balance from affects related to anticholinesterase exposure. Both 
analysis of covariance and multivariate ANOVA are statistical tools that could be applied in field 
studies comparing plasma ChE activity in birds on reference and exposure sites. 
Of greater interest to the author, however, is the potential for stress generally, or at least 
some other stressors in addition to water deprivation, or behaviour, or feeding strategies, etc. to 
explain variation in avian plasma ChE activity. Fundamentally, the author questions whether or 
not the high degree of variability inherent in plasma ChE activity can be  placed in a 
physiological and ecological context and not simply characterized with respect to species, date, 
time, and place. Hence efforts to characterize the variability of plasma ChE activity in some 
species in some location based upon season and time, as has been and remains practice, although 
undeniably informative, is necessarily delimited by the species, place, and time of the 




Among the questions of interest are: Does stress in birds generally result in changes in 
the avian water balance that indirectly also cause changes in apparent plasma ChE activity? Are 
there multiple stressors that can confound the diagnosis anticholinesterase exposure using plasma 
ChE activity via their effect on water balance? These questions are prompted in part by the 
observations of Olanrewaju et al. (2007). They induced physiological stress in broiler chickens 
with implanted osmotic pumps continuously delivering adrenocorticotropic hormone into 
circulation, observed both significant losses of body weight and significant increases in Posm 
following seven days of treatment, and then inferred loss of body water and difficulty in 
maintenance of the water balance as resulting from the induced stress (Olanrewaju et al. 2007). 
Indeed the author is interested in expanding upon the work of Olanrewaju et al. (2007) but with 
an additional focus on the effects on plasma ChE activity. 
 
7.3.5 Telemetry and Observations of Sublethal Effects 
 Constraints on budget and the small size of the quail imposed limitations on the type and 
quantity of experimental work that could be performed using telemetry equipment. Quail were 
too small to receive battery-powered implants and instead received implants containing copper 
coils which when implanted quail were placed within an electrical field produced by the receiver 
were then energized and capable of collecting and transmitting data. Only five implants and a 
single energizer/receiver were purchased as these materials were more expensive than 
anticipated. The result was that collection of data from implanted quail was labour intensive as 
quail had to be rotated on and off the energizer/receiver in sequence. The full potential of 
telemetry equipment was not realized in this work. Nonetheless, the data obtained and the 
experience gained did give the author sufficient information to postulate a mechanism that might 
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explain how effects in the cardiovascular and thermoregulatory systems that are tolerable under 
thermoneutral conditions can become lethal under cold-stressed conditions. 
 The cardiovascular and thermoregulatory systems of birds and mammals are coupled. 
Thermosensors perceive cold-stress and then cue thermoeffectors to respond. Among the 
responses produced is vasoconstriction within the cardiovascular system. Vascoconstriction 
reduces blood flow to peripheral tissues and thereby reduces heat loss under cold-stress. The 
three quail which exhibited failure in thermoregulatory ability under cold-stressed conditions 
were all identified by a continuous drop in body temperature as time passed under cold-stressed 
conditions. In one quail this was lethal and in the other two it prompted their rescue from cold-
stress conditions in all three post-exposure days of the study protocol. These quail evidently 
could not prevent heat loss from their bodies. Is this simply a matter of these quail, at least to 
some degree, being unable to respond to cold-stress with vasoconstriction? Does 
anticholinesterase exposure at sufficient dose eventually cause the uncoupling of the 
thermoregulatory and cardiovascular systems that leads to thermoregulatory failure under cold-
stressed conditions? Such questions are relevant if anticholinesterase pesticides are used on crops 
in temperate climates where night time temperatures impose cold-stress on wildlife. 
There exist radio telemetry implants capable of simultaneous measurements of blood 
pressure, body temperature, and electrical activity in the heart and brain (i.e. those of TSE 
Systems, Inc., Chesterfield, MO, USA). These implants are intended for use with larger 
laboratory mammals (i.e. body mass of 170 g or more) in group housing and could therefore 
likely be adapted for use with waterfowl or game birds in pen studies. The use of such implants 
with birds in pen studies would allow the sublethal effects of anticholinesterase pesticides on 
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aspects of avian physiology to be investigated and potentially provide insight into the conditions 
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Fig. A1. Distribution of quail plasma samples from dicrotophos negative control (NC) and 
positive control (PC) exposures within cholinesterase assays by experimental replicate and date 
























































Fig. A2. Distribution of quail plasma samples from ethoprop negative control (NC) and positive 
control (PC) exposures within cholinesterase assays by experimental replicate and date for both 





















































Fig. A3. Distribution of quail plasma samples from methamidophos negative control (NC) and 
positive control (PC) exposures within cholinesterase assays by experimental replicate and date 



















































Fig. A4. Distribution of quail plasma samples from naled negative control (NC) and positive 
control (PC) exposures within cholinesterase assays by experimental replicate and date for both 
















































Fig. A5. Distribution of quail plasma samples from dicrotophos simulated field exposures within 
cholinesterase assays by experimental replicate and date for both the pre-exposure (A) and post-
















































Fig. A6. Distribution of quail plasma samples from ethoprop simulated field exposures within 
cholinesterase assays by experimental replicate and date for both the pre-exposure (A) and post-
exposure (B) sampling periods. 
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Fig. A7. Distribution of quail plasma samples from methamidophos simulated field exposures 
within cholinesterase assays by experimental replicate and date for both the pre-exposure (A) 
















































Fig. A8. Distribution of quail plasma samples from naled simulated field exposures within 
cholinesterase assays by experimental replicate and date for both the pre-exposure (A) and post-
exposure (B) sampling periods. 
